:START_ID,:END_ID,:TYPE,indication,doseAmount,doseUnit,drugSequence,route
0,7160,IS_PRIMARY_SUSPECT,Glioblastoma,5,MG,1,Oral
1,7170,IS_PRIMARY_SUSPECT,Systemic lupus erythematosus,10,MG/KG,1,Intravenous (not otherwise specified)
2,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3,7178,IS_PRIMARY_SUSPECT,Neuralgia,200,MG,1,Unknown
4,7179,IS_PRIMARY_SUSPECT,Fabry's disease,70,MG,1,Intravenous drip
5,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,50,MG,1,Oral
6,7186,IS_PRIMARY_SUSPECT,Gaucher's disease,3600,IU,1,Intravenous drip
7,7187,IS_PRIMARY_SUSPECT,Basal cell carcinoma,150,MG,1,Oral
8,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
9,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
10,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
11,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
12,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
13,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
15,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
16,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
17,7191,IS_PRIMARY_SUSPECT,Narcolepsy,3,G,1,Oral
18,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
19,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
20,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
21,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
22,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
23,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
24,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
25,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
26,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
27,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
28,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
29,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
30,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
31,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,100,MG,1,Oral
32,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
33,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
34,7178,IS_PRIMARY_SUSPECT,Post herpetic neuralgia,75,MG,1,Unknown
35,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
36,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
37,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
38,7179,IS_PRIMARY_SUSPECT,Fabry's disease,0.99,MG/KG,1,Intravenous drip
40,7191,IS_PRIMARY_SUSPECT,Fibromyalgia,3,G,1,Oral
41,7191,IS_PRIMARY_SUSPECT,Narcolepsy,1.5,G,1,Oral
42,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
43,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
44,7233,IS_PRIMARY_SUSPECT,Anaemia,150,MG,1,Intravenous (not otherwise specified)
45,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
46,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
47,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
48,7235,IS_PRIMARY_SUSPECT,Hormone replacement therapy,1.25,MG,1,Unknown
49,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
50,7191,IS_PRIMARY_SUSPECT,Fibromyalgia,3,G,1,Oral
51,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
52,7243,IS_PRIMARY_SUSPECT,Hodgkin's disease,1.8,MG/KG,1,Intravenous (not otherwise specified)
53,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
54,7248,IS_PRIMARY_SUSPECT,Gait disturbance,10,MG,1,Oral
55,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,225,MG,1,Oral
56,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,75,MG,1,Unknown
57,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
59,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,240,MG,1,Oral
60,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.5,MG/KG,1,Subcutaneous
61,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
62,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,200,MG,1,Oral
63,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
64,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
65,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
66,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
67,7235,IS_PRIMARY_SUSPECT,Hormone replacement therapy,0.625,MG,1,Oral
68,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
69,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,200,MG,1,Oral
70,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
71,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
72,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
73,7288,IS_PRIMARY_SUSPECT,Partial lipodystrophy,5,MG,1,Subcutaneous
74,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
75,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
76,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
77,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
78,7291,IS_PRIMARY_SUSPECT,Basal cell carcinoma,150,MG,1,Oral
79,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
80,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
81,7178,IS_PRIMARY_SUSPECT,Nerve injury,50,MG,1,Unknown
82,7178,IS_PRIMARY_SUSPECT,Paralysis,75,MG,1,Oral
83,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
84,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
85,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
86,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
87,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
88,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
89,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
90,7305,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,2,MG,1,Oral
91,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,75,UG,1,Intravenous (not otherwise specified)
92,7233,IS_PRIMARY_SUSPECT,Unknown,150,UG,1,Unknown
93,7233,IS_PRIMARY_SUSPECT,Unknown,100,UG,1,Unknown
94,7233,IS_PRIMARY_SUSPECT,Unknown,100,UG,1,Unknown
95,7233,IS_PRIMARY_SUSPECT,Unknown,50,UG,1,Unknown
96,7233,IS_PRIMARY_SUSPECT,Unknown,150,UG,1,Unknown
97,7233,IS_PRIMARY_SUSPECT,Unknown,150,UG,1,Unknown
98,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,50,UG,1,Unknown
99,7233,IS_PRIMARY_SUSPECT,Unknown,50,UG,1,Unknown
100,7233,IS_PRIMARY_SUSPECT,Anaemia,75,UG,1,Unknown
101,7233,IS_PRIMARY_SUSPECT,Unknown,50,UG,1,Intravenous (not otherwise specified)
102,7233,IS_PRIMARY_SUSPECT,Unknown,50,UG,1,Intravenous (not otherwise specified)
103,7233,IS_PRIMARY_SUSPECT,Anaemia,75,UG,1,Intravenous (not otherwise specified)
104,7233,IS_PRIMARY_SUSPECT,Unknown,50,UG,1,Unknown
106,7233,IS_PRIMARY_SUSPECT,Unknown,50,MG,1,Unknown
107,7233,IS_PRIMARY_SUSPECT,Unknown,100,UG,1,Unknown
108,7233,IS_PRIMARY_SUSPECT,Unknown,50,UG,1,Unknown
109,7233,IS_PRIMARY_SUSPECT,Anaemia,75,UG,1,Intravenous (not otherwise specified)
110,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,200,MG,1,Unknown
111,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,50,UG,1,Unknown
112,7233,IS_PRIMARY_SUSPECT,Unknown,75,UG,1,Unknown
113,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
114,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,100,MG,1,Oral
115,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
116,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
117,7314,IS_PRIMARY_SUSPECT,Multiple sclerosis,7,MG,1,Oral
118,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
119,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
120,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
121,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Unknown
122,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
123,7288,IS_PRIMARY_SUSPECT,Partial lipodystrophy,2.5,MG,1,Subcutaneous
124,7321,IS_PRIMARY_SUSPECT,Lupus nephritis,1000,MG,1,Oral
125,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
126,7288,IS_PRIMARY_SUSPECT,Non-alcoholic steatohepatitis,7.5,MG,1,Subcutaneous
127,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,50,MG,1,Oral
145,7334,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,30,G,1,Intravenous (not otherwise specified)
146,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
147,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
148,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
149,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
150,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
151,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
152,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
153,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,100,MG,1,Oral
154,7280,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,125,MG,1,Oral
155,7351,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.25,ML,1,Subcutaneous
156,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
157,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
158,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
159,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
160,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
161,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
162,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
163,7352,IS_PRIMARY_SUSPECT,Chemotherapy,1.97,MG,1,Intravenous (not otherwise specified)
164,7356,IS_PRIMARY_SUSPECT,Hypertonic bladder,8,MG,1,Oral
165,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Unknown
166,7357,IS_PRIMARY_SUSPECT,Migraine,40,MG,1,Oral
167,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
168,7359,IS_PRIMARY_SUSPECT,Myeloid leukaemia,500,MG,1,Oral
169,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
170,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
171,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
172,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,14,MG,1,Oral
173,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
174,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Unknown
175,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
176,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
177,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
178,7365,IS_PRIMARY_SUSPECT,Thrombosis prophylaxis,2.5,MG,1,Oral
179,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
180,7178,IS_PRIMARY_SUSPECT,Arthralgia,300,MG,1,Oral
181,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
182,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
183,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
184,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
185,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
186,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
187,7383,IS_PRIMARY_SUSPECT,Malignant melanoma,150,MG,1,Oral
188,7178,IS_PRIMARY_SUSPECT,Drug dependence,150,MG,1,Oral
189,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
190,7401,IS_PRIMARY_SUSPECT,Plasma cell myeloma,56,MG/M**2,1,Intravenous (not otherwise specified)
191,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
192,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,100,MG,1,Oral
193,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
194,7415,IS_PRIMARY_SUSPECT,Unknown,75,MG,1,Unknown
195,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
196,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,300,MG,1,Oral
197,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
198,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
199,7432,IS_PRIMARY_SUSPECT,Renal transplant,500,MG,1,Oral
200,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
201,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
202,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
203,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
204,7218,IS_PRIMARY_SUSPECT,Hypertonic bladder,25,MG,1,Oral
205,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
206,7437,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia recurrent,45,MG,1,Oral
207,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
208,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
209,7438,IS_PRIMARY_SUSPECT,Heritable pulmonary arterial hypertension,0.08,UG/KG,1,Subcutaneous
210,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
211,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
212,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
213,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
214,7444,IS_PRIMARY_SUSPECT,Light anaesthesia,250,UG,3,Intravenous (not otherwise specified)
215,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.5,G,1,Oral
216,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
217,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,200,MG,1,Oral
218,7446,IS_PRIMARY_SUSPECT,Fabry's disease,1,MG/KG,1,Intravenous drip
219,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma recurrent,25,MG,1,Oral
220,7452,IS_PRIMARY_SUSPECT,Hyperkalaemia,8.4,G,1,Oral
221,7191,IS_PRIMARY_SUSPECT,Narcolepsy,1.5,G,1,Oral
222,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
223,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
224,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
225,7291,IS_PRIMARY_SUSPECT,Ovarian epithelial cancer,150,MG,1,Oral
227,7460,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis VI,25,MG,1,Intravenous (not otherwise specified)
228,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
229,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
231,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
232,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
233,7469,IS_PRIMARY_SUSPECT,Juvenile idiopathic arthritis,4,MG/KG,1,Intravenous (not otherwise specified)
234,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
235,7472,IS_PRIMARY_SUSPECT,Neoplasm,600,MG,1,Oral
236,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
237,7476,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia recurrent,1,DF,1,Intravenous (not otherwise specified)
238,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.3,MG,1,Oral
239,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.5,MG,1,Oral
240,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
241,7478,IS_PRIMARY_SUSPECT,Metastatic renal cell carcinoma,37.5,MG,1,Oral
242,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
243,7178,IS_PRIMARY_SUSPECT,Paraesthesia,150,MG,1,Oral
244,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
245,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
246,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
247,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
248,7469,IS_PRIMARY_SUSPECT,Takayasu's arteritis,8,MG/KG,1,Intravenous (not otherwise specified)
249,7490,IS_PRIMARY_SUSPECT,Menopause,1,DF,1,Oral
250,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
251,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
252,7496,IS_PRIMARY_SUSPECT,Progressive multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
254,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
255,7502,IS_PRIMARY_SUSPECT,Rosai-Dorfman syndrome,60,MG,1,Oral
256,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
257,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
258,7519,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Subcutaneous
259,7520,IS_PRIMARY_SUSPECT,Breast cancer female,1,MG,1,Unknown
260,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
261,7248,IS_PRIMARY_SUSPECT,Multiple sclerosis,10,MG,1,Oral
262,7188,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Subcutaneous
263,7526,IS_PRIMARY_SUSPECT,Atrial fibrillation,500,MG,1,Oral
264,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
265,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
267,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
268,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
269,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
270,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
271,7530,IS_PRIMARY_SUSPECT,Hypophysectomy,0.4,MG,1,Unknown
272,7178,IS_PRIMARY_SUSPECT,Intervertebral disc degeneration,100,MG,1,Unknown
282,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
283,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
284,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
285,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
286,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,1200,MG,1,Intravenous (not otherwise specified)
287,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
288,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
289,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
290,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
291,7416,IS_PRIMARY_SUSPECT,Ovarian cancer stage III,300,MG,1,Oral
292,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
293,7541,IS_PRIMARY_SUSPECT,Pain,8,MG,1,Transplacental
294,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
295,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
299,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
304,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
305,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
314,7496,IS_PRIMARY_SUSPECT,Primary progressive multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
315,7571,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,1,Oral
316,7325,IS_PRIMARY_SUSPECT,Flatulence,40,MG,1,Oral
319,7611,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis IV,2,MG/KG,1,Intravenous (not otherwise specified)
320,7162,IS_PRIMARY_SUSPECT,Anxiety,2,MG,1,Unknown
324,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
326,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
327,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
329,7632,IS_PRIMARY_SUSPECT,Neuroblastoma,1.4,MG,1,Subcutaneous
330,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
331,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
332,7634,IS_PRIMARY_SUSPECT,HER2 positive breast cancer,180,MG,1,Unknown
333,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,5,MG,1,Unknown
334,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
336,7646,IS_PRIMARY_SUSPECT,Dyslipidaemia,1,ML,1,Subcutaneous
337,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
338,7451,IS_PRIMARY_SUSPECT,Plasma cell myeloma,40,MG,1,Intravenous drip
340,7478,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,50,MG,1,Oral
341,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,50,MG,1,Oral
342,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
344,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
345,7502,IS_PRIMARY_SUSPECT,Langerhans' cell histiocytosis,60,MG,1,Oral
346,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,240,MG,2,Intravenous (not otherwise specified)
347,7669,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,200,MG,6,Oral
348,7502,IS_PRIMARY_SUSPECT,Erdheim-Chester disease,60,MG,1,Oral
349,7401,IS_PRIMARY_SUSPECT,Plasma cell myeloma,56,MG/M**2,1,Intravenous (not otherwise specified)
350,7681,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,20,MG,1,Subcutaneous
351,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
352,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
353,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
354,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG/M**2,1,Intravenous (not otherwise specified)
355,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
356,7686,IS_PRIMARY_SUSPECT,Unknown,250,MG,1,Unknown
357,7338,IS_PRIMARY_SUSPECT,Unknown,5,MG,1,Unknown
358,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
359,7520,IS_PRIMARY_SUSPECT,Breast cancer female,145,MG,1,Unknown
360,7687,IS_PRIMARY_SUSPECT,Insulin-like growth factor increased,20,MG,1,Unknown
361,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
362,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Oral
363,7688,IS_PRIMARY_SUSPECT,Hormone-refractory prostate cancer,160,MG,1,Oral
364,7178,IS_PRIMARY_SUSPECT,Unknown,150,MG,1,Oral
365,7695,IS_PRIMARY_SUSPECT,Prostate cancer,22.5,MG,1,Intramuscular
366,7178,IS_PRIMARY_SUSPECT,Routine health maintenance,75,MG,1,Oral
367,7338,IS_PRIMARY_SUSPECT,Crohn's disease,5,MG,1,Oral
368,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
370,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
371,7698,IS_PRIMARY_SUSPECT,Breast cancer female,124,MG/KG,1,Intravenous (not otherwise specified)
372,7698,IS_PRIMARY_SUSPECT,Breast cancer,141,MG/KG,1,Intravenous (not otherwise specified)
373,7698,IS_PRIMARY_SUSPECT,Breast cancer metastatic,1,MG,1,Intravenous (not otherwise specified)
374,7698,IS_PRIMARY_SUSPECT,Breast cancer,116,MG,1,Intravenous (not otherwise specified)
375,7698,IS_PRIMARY_SUSPECT,Breast cancer,148,MG,1,Unknown
376,7698,IS_PRIMARY_SUSPECT,Breast cancer,150,MG,1,Unknown
377,7698,IS_PRIMARY_SUSPECT,Breast cancer,75,MG/M**2,1,Unknown
378,7698,IS_PRIMARY_SUSPECT,Breast cancer,134,MG,1,Unknown
379,7698,IS_PRIMARY_SUSPECT,Breast cancer,75,MG,1,Unknown
380,7698,IS_PRIMARY_SUSPECT,Breast cancer,140,MG,1,Intravenous (not otherwise specified)
381,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,240,MG,2,Intravenous (not otherwise specified)
382,7698,IS_PRIMARY_SUSPECT,Breast cancer,150,MG,1,Unknown
383,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
384,7698,IS_PRIMARY_SUSPECT,Breast cancer metastatic,138,MG,1,Unknown
385,7715,IS_PRIMARY_SUSPECT,Mycobacterium avium complex infection,100,MG,1,Oral
386,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
389,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
391,7338,IS_PRIMARY_SUSPECT,Arthritis,5,MG,1,Oral
392,7536,IS_PRIMARY_SUSPECT,Alveolar soft part sarcoma,1200,MG,1,Intravenous (not otherwise specified)
393,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
394,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
395,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,300,MG,1,Oral
396,7520,IS_PRIMARY_SUSPECT,Breast cancer female,124,MG,1,Intravenous (not otherwise specified)
397,7733,IS_PRIMARY_SUSPECT,Bronchial carcinoma,600,MG,1,Oral
398,7734,IS_PRIMARY_SUSPECT,Breast cancer female,131,MG,1,Unknown
400,7739,IS_PRIMARY_SUSPECT,Hot flush,1.53,MG,1,Transdermal
401,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
402,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.4,MG,1,Unknown
403,7384,IS_PRIMARY_SUSPECT,Langerhans' cell histiocytosis,0.5,MG,1,Oral
404,7178,IS_PRIMARY_SUSPECT,Migraine,300,MG,1,Oral
405,7687,IS_PRIMARY_SUSPECT,Insulin-like growth factor increased,30,MG,1,Subcutaneous
406,7371,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,12,Unknown
407,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,200,MG,1,Oral
408,7160,IS_PRIMARY_SUSPECT,"Astrocytoma, low grade",10,MG,1,Oral
409,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Unknown
416,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
417,7519,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Subcutaneous
418,7199,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
419,7759,IS_PRIMARY_SUSPECT,Colon cancer metastatic,2,MG,1,Oral
420,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
421,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
422,7451,IS_PRIMARY_SUSPECT,Plasma cell myeloma,8,MG,1,Intravenous drip
423,7764,IS_PRIMARY_SUSPECT,Unknown,50,MG,1,Unknown
424,7416,IS_PRIMARY_SUSPECT,Neoplasm malignant,300,MG,1,Oral
425,7766,IS_PRIMARY_SUSPECT,Multiple sclerosis,40,MG,1,Subcutaneous
426,7767,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,40,MG,1,Subcutaneous
427,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,5,MG,1,Unknown
428,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
429,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
430,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
431,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
432,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
433,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
434,7365,IS_PRIMARY_SUSPECT,Thrombosis prophylaxis,2.5,MG,1,Oral
435,7520,IS_PRIMARY_SUSPECT,Breast cancer female,197,MG,1,Unknown
436,7520,IS_PRIMARY_SUSPECT,Breast cancer female,20,MG,1,Unknown
437,7361,IS_PRIMARY_SUSPECT,Psoriasis,11,MG,1,Unknown
438,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
439,7783,IS_PRIMARY_SUSPECT,HIV infection,300,MG,1,Oral
440,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
441,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,1200,MG,1,Intravenous (not otherwise specified)
442,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
443,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,2.4,MG,1,Unknown
444,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,1200,MG,1,Intravenous drip
445,7787,IS_PRIMARY_SUSPECT,Agoraphobia,37.5,MG,1,Oral
447,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
448,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,22,G,1,Unknown
449,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Unknown
450,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
451,7537,IS_PRIMARY_SUSPECT,Ovarian cancer stage III,737.5,MG,2,Intravenous (not otherwise specified)
452,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
453,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,100,MG,1,Oral
454,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Unknown
455,7476,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,30,ML,1,Intravenous (not otherwise specified)
456,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
458,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,3.1,MG,1,Unknown
459,7338,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,5,MG,1,Oral
460,7766,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
461,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,300,MG,3,Oral
462,7361,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,11,MG,1,Oral
463,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
464,7271,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,1,Unknown
465,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
466,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
469,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
470,7817,IS_PRIMARY_SUSPECT,Macular degeneration,0.3,MG,1,Other
471,7687,IS_PRIMARY_SUSPECT,Acromegaly,10,MG,1,Unknown
473,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
474,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,50,MG,1,Oral
475,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
477,7338,IS_PRIMARY_SUSPECT,Neurodermatitis,10,MG,1,Oral
478,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,300,MG,1,Oral
481,7178,IS_PRIMARY_SUSPECT,Sciatica,150,MG,1,Oral
482,7178,IS_PRIMARY_SUSPECT,Sciatica,50,MG,1,Oral
483,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
485,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,300,MG,1,Oral
487,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
488,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
489,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
490,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
491,7352,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,1,Intravenous (not otherwise specified)
492,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
493,7268,IS_PRIMARY_SUSPECT,Blood pressure abnormal,40,MG,1,Oral
494,7519,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Subcutaneous
495,7519,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Subcutaneous
496,7536,IS_PRIMARY_SUSPECT,Cholangiocarcinoma,840,MG,1,Intravenous (not otherwise specified)
497,7519,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Subcutaneous
498,7536,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,1200,MG,1,Intravenous (not otherwise specified)
500,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
501,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
502,7478,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,37.5,MG,1,Oral
503,7851,IS_PRIMARY_SUSPECT,Hormone replacement therapy,30,MG,1,Topical
504,7178,IS_PRIMARY_SUSPECT,Neuralgia,300,MG,1,Oral
505,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
506,7519,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Subcutaneous
507,7437,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,15,MG,1,Oral
508,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.6,MG,1,Unknown
509,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
510,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
511,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
512,7853,IS_PRIMARY_SUSPECT,Asthma,600,MG,1,Subcutaneous
513,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Unknown
514,7235,IS_PRIMARY_SUSPECT,Cystitis,1,G,1,Vaginal
515,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
516,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
518,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
519,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
521,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,300,MG,1,Oral
522,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
523,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
524,7613,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,278,MG,1,Intravenous (not otherwise specified)
525,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
526,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.3,MG,1,Oral
527,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
528,7178,IS_PRIMARY_SUSPECT,Neuralgia,300,MG,1,Oral
529,7235,IS_PRIMARY_SUSPECT,Bone disorder,0.625,MG,1,Oral
530,7860,IS_PRIMARY_SUSPECT,Neoplasm,20,MG,1,Oral
531,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
532,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Intravenous (not otherwise specified)
533,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,300,MG,1,Subcutaneous
534,7863,IS_PRIMARY_SUSPECT,Menopause,0.025,MG,1,Transdermal
535,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,75,MG,1,Oral
536,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
537,7178,IS_PRIMARY_SUSPECT,Pain,75,MG,1,Unknown
538,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,200,MG,1,Oral
539,7874,IS_PRIMARY_SUSPECT,Factor VIII deficiency,2235,IU,1,Intravenous (not otherwise specified)
540,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,300,MG,1,Unknown
541,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
542,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
543,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
549,7571,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,1,Oral
551,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
552,7851,IS_PRIMARY_SUSPECT,Androgen deficiency,30,MG,1,Topical
553,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
554,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1309,MG,1,Intravenous (not otherwise specified)
555,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
556,7537,IS_PRIMARY_SUSPECT,Ovarian cancer,15,MG/KG,2,Intravenous (not otherwise specified)
558,7884,IS_PRIMARY_SUSPECT,Cystitis interstitial,100,MG,1,Oral
559,7178,IS_PRIMARY_SUSPECT,Pain,150,MG,1,Oral
561,7886,IS_PRIMARY_SUSPECT,Hypertension,2.5,MG,1,Oral
562,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,75,MG,1,Oral
563,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1,MG,1,Oral
564,7553,IS_PRIMARY_SUSPECT,Hiatus hernia,60,MG,1,Oral
565,7359,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,500,MG,1,Oral
567,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
568,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
569,7683,IS_PRIMARY_SUSPECT,Plasma cell myeloma,16,MG/KG,1,Intravenous (not otherwise specified)
570,7613,IS_PRIMARY_SUSPECT,Colon cancer metastatic,240,MG,1,Intravenous (not otherwise specified)
571,7893,IS_PRIMARY_SUSPECT,Breast cancer metastatic,300,MG,1,Oral
572,7537,IS_PRIMARY_SUSPECT,Ovarian cancer,15,MG/KG,4,Intravenous (not otherwise specified)
574,7896,IS_PRIMARY_SUSPECT,Cardiac amyloidosis,61,MG,1,Oral
575,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
576,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
577,7520,IS_PRIMARY_SUSPECT,Breast cancer female,135,MG,1,Intravenous (not otherwise specified)
578,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
579,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
580,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,2,DF,1,Unknown
581,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
582,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,150,MG,1,Oral
583,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
586,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,1200,MG,1,Intravenous (not otherwise specified)
587,7243,IS_PRIMARY_SUSPECT,Hodgkin's disease,1.8,MG/KG,1,Intravenous (not otherwise specified)
588,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
589,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.5,MG,1,Oral
590,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
591,7899,IS_PRIMARY_SUSPECT,Hepatic cancer,240,MG,1,Unknown
592,7218,IS_PRIMARY_SUSPECT,Unknown,50,MG,1,Unknown
593,7218,IS_PRIMARY_SUSPECT,Incontinence,25,MG,1,Oral
594,7218,IS_PRIMARY_SUSPECT,Hypertonic bladder,75,MG,1,Unknown
595,7218,IS_PRIMARY_SUSPECT,Pollakiuria,25,MG,1,Unknown
596,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
597,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
598,7901,IS_PRIMARY_SUSPECT,Still's disease,82,MG,1,Unknown
599,7178,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,100,MG,1,Oral
600,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,1,IU,1,Intravenous (not otherwise specified)
601,7536,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,1200,MG,1,Intravenous (not otherwise specified)
602,7862,IS_PRIMARY_SUSPECT,Asthma,300,MG,1,Subcutaneous
603,7914,IS_PRIMARY_SUSPECT,Pollakiuria,4,MG,1,Oral
604,7918,IS_PRIMARY_SUSPECT,Crohn's disease,400,MG,1,Subcutaneous
605,7919,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,267,MG,1,Oral
606,7920,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
607,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
608,7922,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
610,7698,IS_PRIMARY_SUSPECT,Breast cancer,158.2,MG,1,Unknown
611,7698,IS_PRIMARY_SUSPECT,Breast cancer,180,MG,1,Unknown
612,7698,IS_PRIMARY_SUSPECT,Breast cancer,75,MG/M**2,1,Unknown
613,7698,IS_PRIMARY_SUSPECT,Breast cancer,140,MG,1,Unknown
614,7736,IS_PRIMARY_SUSPECT,Breast cancer,123,MG,1,Unknown
615,7698,IS_PRIMARY_SUSPECT,Invasive ductal breast carcinoma,143,MG,1,Unknown
616,7698,IS_PRIMARY_SUSPECT,Breast cancer,143,MG,1,Unknown
617,7734,IS_PRIMARY_SUSPECT,Breast cancer,142,MG,1,Unknown
618,7698,IS_PRIMARY_SUSPECT,Breast cancer,130,MG,1,Unknown
619,7698,IS_PRIMARY_SUSPECT,Breast cancer,140,MG,1,Unknown
620,7698,IS_PRIMARY_SUSPECT,Breast cancer,20,MG,1,Unknown
621,7736,IS_PRIMARY_SUSPECT,Breast cancer,130,MG/M**2,1,Unknown
622,7688,IS_PRIMARY_SUSPECT,Prostate cancer,160,MG,1,Oral
623,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,75,MG,1,Oral
624,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,8,G,1,Subcutaneous
625,7178,IS_PRIMARY_SUSPECT,Neuralgia,150,MG,1,Oral
626,7178,IS_PRIMARY_SUSPECT,Pain,75,MG,1,Oral
627,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
628,7930,IS_PRIMARY_SUSPECT,Hypertension,80,MG,1,Oral
629,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
630,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
631,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,1200,MG,1,Intravenous (not otherwise specified)
632,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
633,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,4.35,MG,1,Unknown
634,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,50,MG,1,Oral
635,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,50,MG,1,Oral
636,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
637,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
638,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Unknown
639,7939,IS_PRIMARY_SUSPECT,Neoplasm malignant,3.6,MG/KG,1,Intravenous (not otherwise specified)
640,7178,IS_PRIMARY_SUSPECT,Restless legs syndrome,150,MG,1,Oral
641,7338,IS_PRIMARY_SUSPECT,Colitis ulcerative,5,MG,1,Unknown
642,7245,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,2,MG,2,Intravenous (not otherwise specified)
643,7944,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,5,MG,1,Oral
644,7945,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,12,MG,1,Unknown
645,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
647,7178,IS_PRIMARY_SUSPECT,Headache,400,MG,1,Unknown
648,7520,IS_PRIMARY_SUSPECT,Breast cancer female,110,MG,1,Intravenous (not otherwise specified)
649,7178,IS_PRIMARY_SUSPECT,Spinal stenosis,75,MG,1,Oral
650,7951,IS_PRIMARY_SUSPECT,Neoplasm,0.75,MG,2,Oral
651,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
652,7496,IS_PRIMARY_SUSPECT,Secondary progressive multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
654,7954,IS_PRIMARY_SUSPECT,Metastatic neoplasm,38,UG,1,Intravenous (not otherwise specified)
655,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,600,MG,1,Subcutaneous
656,7961,IS_PRIMARY_SUSPECT,Post procedural hypoparathyroidism,25,UG,1,Subcutaneous
657,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Unknown
658,7520,IS_PRIMARY_SUSPECT,Breast cancer female,60,MG,1,Intravenous (not otherwise specified)
659,7178,IS_PRIMARY_SUSPECT,Nervous system disorder,50,MG,1,Oral
660,7520,IS_PRIMARY_SUSPECT,Breast cancer female,150,MG,1,Unknown
661,7520,IS_PRIMARY_SUSPECT,Breast cancer female,150,MG,1,Unknown
662,7520,IS_PRIMARY_SUSPECT,Breast cancer female,180,G,1,Unknown
663,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,84,MG,1,Unknown
664,7897,IS_PRIMARY_SUSPECT,On and off phenomenon,84,MG,1,Unknown
665,7190,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3.1,MG,1,Subcutaneous
666,7965,IS_PRIMARY_SUSPECT,Psoriasis,45,MG,1,Subcutaneous
668,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1800,MG,3,Subcutaneous
669,7179,IS_PRIMARY_SUSPECT,Fabry's disease,80,MG,1,Intravenous drip
670,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
671,7961,IS_PRIMARY_SUSPECT,Post procedural hypoparathyroidism,50,UG,1,Subcutaneous
672,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,75,MG,1,Oral
673,7536,IS_PRIMARY_SUSPECT,Cholangiocarcinoma,840,MG,1,Intravenous (not otherwise specified)
674,7333,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,260,MG,1,Intravenous drip
675,7975,IS_PRIMARY_SUSPECT,Peripheral T-cell lymphoma unspecified,50,MG/M**2,1,Intravenous (not otherwise specified)
676,7613,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,257,MG,1,Intravenous (not otherwise specified)
682,7536,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,840,MG,1,Intravenous (not otherwise specified)
683,7979,IS_PRIMARY_SUSPECT,Immunodeficiency,30,G,1,Subcutaneous
684,7359,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,100,MG,1,Unknown
685,7520,IS_PRIMARY_SUSPECT,Breast cancer female,160,MG,1,Unknown
686,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,60,G,1,Intravenous (not otherwise specified)
687,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Subcutaneous
688,7179,IS_PRIMARY_SUSPECT,Fabry's disease,45,MG,1,Intravenous drip
689,7505,IS_PRIMARY_SUSPECT,Unknown,225,MG,1,Unknown
690,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
692,7983,IS_PRIMARY_SUSPECT,Renal transplant,450,MG,1,Subcutaneous
693,7984,IS_PRIMARY_SUSPECT,Chronic spontaneous urticaria,300,MG,1,Unknown
694,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
695,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,240,MG,1,Intravenous (not otherwise specified)
696,7896,IS_PRIMARY_SUSPECT,Cardiac amyloidosis,61,MG,1,Oral
697,7790,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,12,G,1,Subcutaneous
698,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.8,MG,1,Unknown
699,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
700,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
701,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
702,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
703,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
704,7996,IS_PRIMARY_SUSPECT,Combined immunodeficiency,7.5,G,2,Subcutaneous
705,7790,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,12,G,1,Subcutaneous
706,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
707,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,MG/KG,1,Intravenous (not otherwise specified)
708,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
709,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,12,G,1,Subcutaneous
710,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,20,MG,1,Subcutaneous
711,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Unknown
712,7520,IS_PRIMARY_SUSPECT,Breast cancer female,140,MG,1,Intravenous (not otherwise specified)
714,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma refractory,4,MG,1,Oral
715,8003,IS_PRIMARY_SUSPECT,Constipation,12,MG,1,Subcutaneous
716,8004,IS_PRIMARY_SUSPECT,Depression,84,MG,1,Unknown
717,7476,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,12,ML,1,Intravenous (not otherwise specified)
718,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
719,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Unknown
720,7662,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,170.1,MG,2,Intravenous (not otherwise specified)
721,7782,IS_PRIMARY_SUSPECT,Atrial fibrillation,20,MG,1,Oral
722,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Unknown
723,7767,IS_PRIMARY_SUSPECT,Multiple sclerosis,40,MG,1,Subcutaneous
724,8012,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
725,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,16,G,1,Subcutaneous
726,7918,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,400,MG,1,Subcutaneous
727,8013,IS_PRIMARY_SUSPECT,Prophylaxis,300,MG,1,Oral
728,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
730,7734,IS_PRIMARY_SUSPECT,Breast cancer metastatic,1,MG,1,Unknown
731,7982,IS_PRIMARY_SUSPECT,Unknown,70,G,1,Intravenous (not otherwise specified)
732,7338,IS_PRIMARY_SUSPECT,Colitis ulcerative,5,MG,1,Unknown
733,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,400,MG/KG,1,Intravenous (not otherwise specified)
734,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,1,Oral
735,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
736,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
737,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
738,7178,IS_PRIMARY_SUSPECT,Unknown,75,MG,1,Unknown
739,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,18,G,1,Subcutaneous
741,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,100,UG,1,Unknown
742,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,75,MG,1,Oral
743,7520,IS_PRIMARY_SUSPECT,Breast cancer female,120,MG,1,Intravenous (not otherwise specified)
744,7520,IS_PRIMARY_SUSPECT,Breast cancer female,140,MG,1,Intravenous (not otherwise specified)
745,7790,IS_PRIMARY_SUSPECT,Unknown,2,G,1,Subcutaneous
746,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
747,8027,IS_PRIMARY_SUSPECT,Myelofibrosis,300,MG,1,Oral
748,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,280,MG,1,Oral
749,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,16,G,1,Subcutaneous
750,7982,IS_PRIMARY_SUSPECT,Immunodeficiency,20,G,1,Subcutaneous
751,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,84,MG,1,Unknown
752,7979,IS_PRIMARY_SUSPECT,Immune system disorder,300,G,1,Subcutaneous
753,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
755,7961,IS_PRIMARY_SUSPECT,Hypocalcaemia,75,UG,1,Subcutaneous
756,7360,IS_PRIMARY_SUSPECT,Peripheral T-cell lymphoma unspecified refractory,4,MG,1,Oral
757,7715,IS_PRIMARY_SUSPECT,Mycobacterium abscessus infection,100,MG,1,Oral
758,7452,IS_PRIMARY_SUSPECT,Hyperkalaemia,8.4,G,1,Oral
759,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
760,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,100,MG,1,Oral
761,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
764,8047,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,760,MG,1,Intravenous (not otherwise specified)
765,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
766,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
767,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
768,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
769,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
770,7536,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,1200,MG,1,Intravenous drip
771,8054,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
772,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis relapse,300,MG,1,Intravenous (not otherwise specified)
773,7352,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,1.14,MG,1,Intravenous (not otherwise specified)
774,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,1,Intravenous (not otherwise specified)
775,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
777,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
778,7982,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,12.5,G,1,Subcutaneous
779,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
780,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,32,G,1,Subcutaneous
781,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,4328,MG,1,Intravenous (not otherwise specified)
782,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,16,MG/KG,2,Intravenous (not otherwise specified)
783,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,280,MG,1,Oral
786,7234,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.5,MG,1,Oral
787,7874,IS_PRIMARY_SUSPECT,Factor VIII deficiency,2500,IU,1,Intravenous drip
788,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
789,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
792,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
793,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
794,7536,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,840,MG,1,Intravenous drip
795,7982,IS_PRIMARY_SUSPECT,Polymyositis,100,G,1,Intravenous (not otherwise specified)
796,8069,IS_PRIMARY_SUSPECT,Non-24-hour sleep-wake disorder,20,MG,1,Oral
797,8069,IS_PRIMARY_SUSPECT,Non-24-hour sleep-wake disorder,20,MG,1,Oral
798,8069,IS_PRIMARY_SUSPECT,Non-24-hour sleep-wake disorder,20,MG,1,Oral
799,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,35,G,1,Intravenous (not otherwise specified)
800,7163,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,4,MG,1,Oral
801,7333,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,5,G,1,Intravenous (not otherwise specified)
802,7178,IS_PRIMARY_SUSPECT,Neuralgia,75,MG,1,Unknown
803,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
804,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
805,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
806,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
807,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,5,G,1,Subcutaneous
808,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
809,8086,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,150,MG,2,Intravenous (not otherwise specified)
814,7234,IS_PRIMARY_SUSPECT,Unknown,0.5,MG,1,Oral
815,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,11,G,1,Subcutaneous
816,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
817,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.09,ML,1,Subcutaneous
818,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
821,7893,IS_PRIMARY_SUSPECT,Vascular malformation,250,MG,1,Oral
822,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,1000,MG,1,Intravenous (not otherwise specified)
823,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
824,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
825,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.93,MG,1,Unknown
826,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
827,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,16,G,1,Subcutaneous
828,7613,IS_PRIMARY_SUSPECT,Transitional cell cancer of renal pelvis and ureter metastatic,360,MG,1,Intravenous (not otherwise specified)
829,7919,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,267,MG,1,Oral
830,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
831,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Unknown
832,7280,IS_PRIMARY_SUSPECT,Metastatic uterine cancer,100,MG,1,Oral
833,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,16,G,1,Subcutaneous
834,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
835,7982,IS_PRIMARY_SUSPECT,Unknown,25,G,1,Intravenous (not otherwise specified)
836,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Intravenous (not otherwise specified)
837,7519,IS_PRIMARY_SUSPECT,Plasma cell myeloma,130,MG,1,Subcutaneous
838,7979,IS_PRIMARY_SUSPECT,Combined immunodeficiency,40,G,1,Subcutaneous
839,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
840,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,25,G,1,Subcutaneous
841,8091,IS_PRIMARY_SUSPECT,Amyloidosis,80,MG,1,Oral
842,7365,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
843,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
844,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,27,G,1,Intravenous (not otherwise specified)
846,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
847,7783,IS_PRIMARY_SUSPECT,HIV infection,300,MG,1,Oral
848,7790,IS_PRIMARY_SUSPECT,Immune reconstitution inflammatory syndrome,18,G,1,Subcutaneous
849,7982,IS_PRIMARY_SUSPECT,Immunodeficiency,67.5,G,1,Intravenous (not otherwise specified)
850,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
851,8097,IS_PRIMARY_SUSPECT,Iron overload,90,MG,1,Oral
852,8098,IS_PRIMARY_SUSPECT,Urinary tract infection,2,MG,1,Vaginal
853,7536,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,1200,MG,1,Intravenous (not otherwise specified)
855,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
856,7734,IS_PRIMARY_SUSPECT,Invasive ductal breast carcinoma,165,MG,1,Unknown
857,7790,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,4,G,1,Subcutaneous
858,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
859,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
860,7179,IS_PRIMARY_SUSPECT,Fabry's disease,85,MG,1,Intravenous (not otherwise specified)
861,8114,IS_PRIMARY_SUSPECT,Sickle cell disease,1500,MG,1,Oral
862,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
863,8118,IS_PRIMARY_SUSPECT,Multiple sclerosis,2,MG,1,Oral
864,8119,IS_PRIMARY_SUSPECT,Thyroid cancer,300,MG,1,Oral
865,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
866,7190,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,1,Subcutaneous
867,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
869,7352,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,1,Intravenous (not otherwise specified)
870,8123,IS_PRIMARY_SUSPECT,Nausea,19.96,MG/KG,1,Intravenous (not otherwise specified)
871,8124,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,1,Intrathecal
872,8126,IS_PRIMARY_SUSPECT,Parkinson's disease,1,DF,1,Oral
873,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,50,MG,1,Oral
874,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Unknown
875,8132,IS_PRIMARY_SUSPECT,Ischaemic stroke,6.1,MG,1,Intravenous bolus
876,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Intravenous (not otherwise specified)
877,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
878,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
879,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
880,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,24,G,1,Subcutaneous
881,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.318,ML,1,Subcutaneous
882,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
884,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
885,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
886,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
887,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
888,7662,IS_PRIMARY_SUSPECT,Angiosarcoma,100,MG,1,Intravenous (not otherwise specified)
889,7333,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,160,MG,1,Intravenous (not otherwise specified)
890,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Subcutaneous
891,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
892,8150,IS_PRIMARY_SUSPECT,MG,Intravenous (not otherwise specified),350,1,INFLIXIMAB
894,8151,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,600,MG,1,Unknown
896,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
897,7467,IS_PRIMARY_SUSPECT,Hypertension,100,MG,1,Oral
898,7979,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,30,G,1,Subcutaneous
899,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,3,MG,1,Unknown
900,7539,IS_PRIMARY_SUSPECT,Triple negative breast cancer,530,MG,1,Intravenous (not otherwise specified)
901,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,3387,MG,1,Intravenous (not otherwise specified)
902,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,16,G,1,Subcutaneous
903,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Unknown
904,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia stage 4,140,MG,1,Oral
905,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
906,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
907,7979,IS_PRIMARY_SUSPECT,Unknown,25,G,1,Subcutaneous
908,7832,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,30,G,1,Intravenous (not otherwise specified)
909,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Unknown
910,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
911,7178,IS_PRIMARY_SUSPECT,Paraesthesia,200,MG,1,Unknown
912,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,33,G,1,Subcutaneous
913,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
914,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,50,UG,1,Unknown
916,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
917,8167,IS_PRIMARY_SUSPECT,HIV infection,50,MG,1,Oral
918,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
919,8172,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Respiratory (inhalation)
920,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
921,7982,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,35,G,1,Intravenous (not otherwise specified)
923,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
924,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,35,G,1,Intravenous (not otherwise specified)
925,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
926,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
928,7571,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,30,MG,1,Unknown
929,8184,IS_PRIMARY_SUSPECT,Cystic fibrosis,2.5,ML,1,Respiratory (inhalation)
930,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
931,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
932,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
933,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,40,G,1,Intravenous (not otherwise specified)
934,7536,IS_PRIMARY_SUSPECT,Bladder cancer,1200,MG,1,Intravenous (not otherwise specified)
936,7365,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
937,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Intravenous (not otherwise specified)
938,7520,IS_PRIMARY_SUSPECT,Breast cancer female,75,MG,1,Intravenous (not otherwise specified)
939,8099,IS_PRIMARY_SUSPECT,Hormone-refractory prostate cancer,40,MG,1,Oral
940,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.54,MG,1,Subcutaneous
941,7790,IS_PRIMARY_SUSPECT,Selective IgA immunodeficiency,8,G,1,Subcutaneous
951,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,14,G,1,Subcutaneous
952,7536,IS_PRIMARY_SUSPECT,Hormone-refractory prostate cancer,1200,MG,1,Intravenous (not otherwise specified)
954,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
956,8063,IS_PRIMARY_SUSPECT,Hypoparathyroidism,50,UG,1,Subcutaneous
957,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.35,DF,1,Other
959,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
960,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,1,Intravenous (not otherwise specified)
961,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,280,MG,1,Oral
962,8201,IS_PRIMARY_SUSPECT,Amyloidosis,61,MG,1,Oral
963,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,11,G,1,Subcutaneous
964,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,1,Intravenous (not otherwise specified)
965,7832,IS_PRIMARY_SUSPECT,Colitis ulcerative,50,G,1,Intravenous (not otherwise specified)
966,7300,IS_PRIMARY_SUSPECT,Pain,1,MG,1,Oral
967,7504,IS_PRIMARY_SUSPECT,Back pain,40,MG,1,Oral
968,7338,IS_PRIMARY_SUSPECT,Polychondritis,5,MG,1,Unknown
969,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
970,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,4,G,1,Subcutaneous
971,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
972,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
973,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
975,7901,IS_PRIMARY_SUSPECT,Unknown,150,MG,1,Subcutaneous
976,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
977,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
980,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
981,7356,IS_PRIMARY_SUSPECT,Calculus urinary,8,MG,1,Oral
982,7613,IS_PRIMARY_SUSPECT,Ovarian cancer,480,MG,2,Intravenous (not otherwise specified)
983,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
984,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
985,7790,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,5,G,1,Subcutaneous
986,7982,IS_PRIMARY_SUSPECT,Selective IgM immunodeficiency,10,G,1,Subcutaneous
987,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,240,MG,1,Unknown
988,7832,IS_PRIMARY_SUSPECT,Transient hypogammaglobulinaemia of infancy,5,G,1,Subcutaneous
989,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,16,G,1,Subcutaneous
990,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
991,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Unknown
992,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
993,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
994,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
995,7498,IS_PRIMARY_SUSPECT,Pain,300,UG,1,Buccal
996,7767,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,40,MG,1,Subcutaneous
997,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
998,7734,IS_PRIMARY_SUSPECT,Triple positive breast cancer,75,MG/M**2,1,Unknown
999,8218,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,1000,MG,1,Intravenous (not otherwise specified)
1000,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,3.6,MG,1,Unknown
1001,8222,IS_PRIMARY_SUSPECT,Immune system disorder,1000,IU,1,Unknown
1002,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,10,G,1,Subcutaneous
1003,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1004,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
1007,7234,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.5,MG,1,Oral
1008,7790,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,14,G,1,Subcutaneous
1009,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,55,ML,1,Intravenous (not otherwise specified)
1010,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,100,MG,1,Unknown
1011,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1012,8123,IS_PRIMARY_SUSPECT,Glycogen storage disease type II,1000,MG,1,Intravenous drip
1013,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,300,MG,1,Oral
1014,8224,IS_PRIMARY_SUSPECT,Uterine leiomyoma,1,DF,1,Oral
1015,8118,IS_PRIMARY_SUSPECT,Multiple sclerosis,2,MG,1,Oral
1016,7356,IS_PRIMARY_SUSPECT,Pollakiuria,4,MG,1,Oral
1017,8228,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma refractory,68,ML,1,Intravenous (not otherwise specified)
1019,7437,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,30,MG,1,Oral
1020,7178,IS_PRIMARY_SUSPECT,Spinal stenosis,200,MG,1,Oral
1021,7734,IS_PRIMARY_SUSPECT,Breast cancer,100,MG,1,Unknown
1023,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,34,G,1,Subcutaneous
1024,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Subcutaneous
1025,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Subcutaneous
1026,7662,IS_PRIMARY_SUSPECT,Neoplasm,3,MG/KG,1,Intravenous (not otherwise specified)
1027,7862,IS_PRIMARY_SUSPECT,Asthma,300,MG,1,Subcutaneous
1028,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,1.3,MG,1,Unknown
1029,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Unknown
1030,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
1031,7632,IS_PRIMARY_SUSPECT,Growth disorder,1.2,MG,1,Unknown
1032,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,75,UG,1,Unknown
1033,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
1034,7853,IS_PRIMARY_SUSPECT,Asthma,600,MG,1,Subcutaneous
1035,7520,IS_PRIMARY_SUSPECT,Breast cancer female,113,MG,1,Intravenous (not otherwise specified)
1036,7996,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,1000,MG/KG,1,Intravenous (not otherwise specified)
1037,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1038,7853,IS_PRIMARY_SUSPECT,Dermatitis atopic,600,MG,1,Subcutaneous
1039,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,7,G,1,Subcutaneous
1040,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,19,G,1,Subcutaneous
1041,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,5,G,1,Subcutaneous
1042,7632,IS_PRIMARY_SUSPECT,Prader-Willi syndrome,3.5,MG,1,Unknown
1043,7930,IS_PRIMARY_SUSPECT,Hypertension,320,MG,1,Unknown
1044,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Intravenous (not otherwise specified)
1045,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1046,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,20,G,1,Subcutaneous
1047,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1048,8234,IS_PRIMARY_SUSPECT,Weight decreased,10,MG,1,Oral
1049,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1050,7734,IS_PRIMARY_SUSPECT,Breast cancer female,120,MG,1,Unknown
1051,8138,IS_PRIMARY_SUSPECT,Cystic fibrosis,1,DF,1,Oral
1052,7536,IS_PRIMARY_SUSPECT,Triple negative breast cancer,1200,MG,1,Intravenous (not otherwise specified)
1053,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,84,MG,1,Unknown
1054,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Subcutaneous
1055,8235,IS_PRIMARY_SUSPECT,HIV wasting syndrome,5,MG,1,Subcutaneous
1056,7178,IS_PRIMARY_SUSPECT,Sciatica,200,MG,1,Oral
1057,7437,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,30,MG,1,Oral
1058,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,90,G,1,Intravenous (not otherwise specified)
1059,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
1060,7520,IS_PRIMARY_SUSPECT,Breast cancer female,185,MG,1,Unknown
1061,7979,IS_PRIMARY_SUSPECT,Immune system disorder,40,G,1,Subcutaneous
1062,8236,IS_PRIMARY_SUSPECT,Hormone receptor positive HER2 negative breast cancer,400,MG,1,Oral
1064,7813,IS_PRIMARY_SUSPECT,Pneumonia,300,MG,1,Oral
1065,8241,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,45,MG,1,Oral
1066,7502,IS_PRIMARY_SUSPECT,Lung adenocarcinoma,60,MG,1,Oral
1067,7901,IS_PRIMARY_SUSPECT,Still's disease,90,MG,1,Subcutaneous
1068,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1070,8243,IS_PRIMARY_SUSPECT,Pain,50,MG,1,Transdermal
1071,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
1073,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.5,MG,1,Unknown
1074,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1075,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
1076,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,1000,MG/KG,1,Intravenous (not otherwise specified)
1077,8248,IS_PRIMARY_SUSPECT,Asthma,100,MG,1,Subcutaneous
1080,7536,IS_PRIMARY_SUSPECT,Mesothelioma malignant,1200,MG,1,Intravenous drip
1081,7332,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,1,Intrathecal
1082,8252,IS_PRIMARY_SUSPECT,Embryonal rhabdomyosarcoma,10,MG/M**2,1,Intravenous (not otherwise specified)
1083,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,7,G,1,Subcutaneous
1084,7280,IS_PRIMARY_SUSPECT,Breast cancer,125,MG,1,Unknown
1086,8253,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,312,MG,1,Intravenous (not otherwise specified)
1088,7218,IS_PRIMARY_SUSPECT,Urge incontinence,25,MG,1,Unknown
1089,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,480,MG,2,Intravenous (not otherwise specified)
1090,8156,IS_PRIMARY_SUSPECT,Muscle spasticity,930,UG,1,Intrathecal
1091,8156,IS_PRIMARY_SUSPECT,Unknown,440,UG,1,Intrathecal
1093,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
1095,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,3788,MG,1,Intravenous (not otherwise specified)
1096,7982,IS_PRIMARY_SUSPECT,Immunodeficiency,30,G,1,Intravenous (not otherwise specified)
1097,8069,IS_PRIMARY_SUSPECT,Non-24-hour sleep-wake disorder,20,MG,1,Oral
1098,7254,IS_PRIMARY_SUSPECT,Diarrhoea,0.325,ML,1,Subcutaneous
1099,7901,IS_PRIMARY_SUSPECT,Still's disease,120,MG,1,Subcutaneous
1100,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Oral
1101,7790,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,12,G,1,Subcutaneous
1102,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
1103,8119,IS_PRIMARY_SUSPECT,Thyroid cancer,300,MG,1,Oral
1104,7632,IS_PRIMARY_SUSPECT,Dwarfism,1.1,MG,1,Subcutaneous
1105,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,28,G,1,Subcutaneous
1106,7996,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,37.5,G,2,Intravenous (not otherwise specified)
1107,8285,IS_PRIMARY_SUSPECT,Liver disorder,550,MG,1,Oral
1108,8290,IS_PRIMARY_SUSPECT,Migraine,140,MG,1,Unknown
1109,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
1110,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1111,8291,IS_PRIMARY_SUSPECT,B precursor type acute leukaemia,26,UG,1,Intravenous (not otherwise specified)
1112,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
1113,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,22,G,1,Subcutaneous
1114,7790,IS_PRIMARY_SUSPECT,Unknown,5,G,1,Subcutaneous
1115,8222,IS_PRIMARY_SUSPECT,Immune system disorder,500,IU,1,Intravenous (not otherwise specified)
1116,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,15,G,1,Intravenous (not otherwise specified)
1117,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
1118,7860,IS_PRIMARY_SUSPECT,Neoplasm,20,MG,1,Oral
1120,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,24,G,1,Subcutaneous
1122,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Subcutaneous
1123,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1124,8298,IS_PRIMARY_SUSPECT,Erectile dysfunction,1,ML,1,INTRACAVITY
1125,8299,IS_PRIMARY_SUSPECT,Hypertension,160,MG,1,Unknown
1126,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,6,G,1,Subcutaneous
1127,7853,IS_PRIMARY_SUSPECT,Dermatitis atopic,200,MG,1,Subcutaneous
1128,8300,IS_PRIMARY_SUSPECT,Precocious puberty,22.5,MG,1,Intramuscular
1129,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1130,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1131,7531,IS_PRIMARY_SUSPECT,Hypothyroidism,25,UG,1,Oral
1132,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
1133,8285,IS_PRIMARY_SUSPECT,Hepatic encephalopathy,550,MG,1,Oral
1134,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,16,G,1,Subcutaneous
1135,7982,IS_PRIMARY_SUSPECT,Stiff person syndrome,35,G,1,Intravenous (not otherwise specified)
1136,7296,IS_PRIMARY_SUSPECT,Alopecia,1,ML,1,Topical
1137,7982,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,10,G,1,Subcutaneous
1138,7905,IS_PRIMARY_SUSPECT,Giant cell arteritis,162,MG,1,Subcutaneous
1139,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,100,UG,1,Subcutaneous
1140,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,24,G,1,Subcutaneous
1141,8312,IS_PRIMARY_SUSPECT,Psychotic disorder,350,MG,1,Oral
1142,7178,IS_PRIMARY_SUSPECT,Back disorder,200,MG,1,Unknown
1143,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Subcutaneous
1144,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,42.5,G,1,Subcutaneous
1145,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1146,7416,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,200,MG,1,Oral
1147,8099,IS_PRIMARY_SUSPECT,Hormone-refractory prostate cancer,40,MG,1,Oral
1148,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Intravenous (not otherwise specified)
1149,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,6000,IU,1,Subcutaneous
1150,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1,MG,1,Unknown
1151,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.3,MG,1,Subcutaneous
1152,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
1153,8323,IS_PRIMARY_SUSPECT,Erectile dysfunction,1,DF,1,Oral
1154,8092,IS_PRIMARY_SUSPECT,Pain,5,MG,1,Unknown
1155,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
1156,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
1157,8234,IS_PRIMARY_SUSPECT,Weight decreased,10,MG,1,Oral
1159,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
1160,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.6,MG,1,Subcutaneous
1161,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
1162,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
1163,7536,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,840,MG,1,Intravenous (not otherwise specified)
1164,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,14,G,1,Subcutaneous
1166,7790,IS_PRIMARY_SUSPECT,Unknown,10,G,1,Subcutaneous
1167,7300,IS_PRIMARY_SUSPECT,Pain,2,MG,1,Oral
1168,7982,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,70,G,1,Intravenous (not otherwise specified)
1169,7536,IS_PRIMARY_SUSPECT,Pleural mesothelioma malignant,1200,MG,1,Intravenous (not otherwise specified)
1170,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1171,8335,IS_PRIMARY_SUSPECT,Unknown,200,MG,1,Oral
1172,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Subcutaneous
1173,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1174,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1175,7466,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,5,MG,1,Oral
1176,7996,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,105,G,1,Intravenous (not otherwise specified)
1179,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1180,7982,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,30,G,1,Intravenous (not otherwise specified)
1181,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,55,G,1,Intravenous (not otherwise specified)
1183,8340,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,150,MG,1,Oral
1184,7893,IS_PRIMARY_SUSPECT,HER2 negative breast cancer,300,MG,1,Oral
1185,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
1186,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
1187,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,600,MG,1,Subcutaneous
1188,7982,IS_PRIMARY_SUSPECT,Coeliac disease,50,G,1,Intravenous (not otherwise specified)
1189,8348,IS_PRIMARY_SUSPECT,Chemotherapy,30,MG/M**2,2,Unknown
1190,7632,IS_PRIMARY_SUSPECT,Hypothalamo-pituitary disorder,2,MG,1,Unknown
1191,7280,IS_PRIMARY_SUSPECT,Neoplasm malignant,100,MG,1,Oral
1192,7632,IS_PRIMARY_SUSPECT,Growth failure,0.4,MG,1,Unknown
1194,7536,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,1200,MG,1,Intravenous drip
1196,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1197,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1198,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,15,G,1,Subcutaneous
1199,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Intravenous (not otherwise specified)
1200,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,12,G,1,Subcutaneous
1201,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Unknown
1202,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,6,G,1,Subcutaneous
1203,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1204,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Subcutaneous
1206,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,16.6,ML,1,Intravenous (not otherwise specified)
1207,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,280,MG,1,Oral
1215,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,27,G,1,Subcutaneous
1216,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,24,G,1,Subcutaneous
1217,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,150,MG,1,Subcutaneous
1218,7790,IS_PRIMARY_SUSPECT,Unknown,21,G,1,Subcutaneous
1219,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
1220,7982,IS_PRIMARY_SUSPECT,Unknown,40,G,1,Intravenous (not otherwise specified)
1221,8099,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,40,MG,1,Oral
1222,7790,IS_PRIMARY_SUSPECT,Immune system disorder,20,G,1,Subcutaneous
1223,7982,IS_PRIMARY_SUSPECT,Encephalitis,30,G,1,Intravenous (not otherwise specified)
1224,7790,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,12,G,1,Subcutaneous
1225,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,15,G,1,Subcutaneous
1226,8352,IS_PRIMARY_SUSPECT,Dizziness,10,MG,1,Unknown
1227,7748,IS_PRIMARY_SUSPECT,Pain,30,MG,1,Unknown
1228,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
1229,8353,IS_PRIMARY_SUSPECT,Benign neoplasm of prostate,267,MG,1,Oral
1230,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
1231,8285,IS_PRIMARY_SUSPECT,Hepatic cirrhosis,550,MG,1,Oral
1232,7632,IS_PRIMARY_SUSPECT,Blood growth hormone,0.4,MG,1,Unknown
1233,8099,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,40,MG,1,Oral
1234,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
1235,8360,IS_PRIMARY_SUSPECT,COVID-19,50,MG,1,Intravenous (not otherwise specified)
1236,7613,IS_PRIMARY_SUSPECT,Prostate cancer,3,MG/KG,1,Intravenous (not otherwise specified)
1237,8367,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,32,IU,1,Subcutaneous
1238,7176,IS_PRIMARY_SUSPECT,5q minus syndrome,5,MG,1,Oral
1239,8099,IS_PRIMARY_SUSPECT,Prostate cancer,40,MG,1,Oral
1240,7334,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,35,G,1,Intravenous (not otherwise specified)
1241,7334,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
1242,7334,IS_PRIMARY_SUSPECT,Myasthenia gravis,75,G,1,Intravenous (not otherwise specified)
1243,7334,IS_PRIMARY_SUSPECT,Stiff person syndrome,40,G,1,Intravenous (not otherwise specified)
1244,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Subcutaneous
1245,8378,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,45,MG,1,Unknown
1246,7334,IS_PRIMARY_SUSPECT,Polymyositis,120,G,1,Intravenous (not otherwise specified)
1247,7476,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,15,ML,1,Intravenous (not otherwise specified)
1249,7458,IS_PRIMARY_SUSPECT,Pain,3,DF,1,Unknown
1250,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1251,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,3.4,MG,1,Unknown
1252,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,17.5,G,1,Subcutaneous
1253,8381,IS_PRIMARY_SUSPECT,Serum ferritin decreased,750,MG,1,Intravenous (not otherwise specified)
1254,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1255,7901,IS_PRIMARY_SUSPECT,Pyrexia,150,MG,1,Subcutaneous
1256,7905,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,200,MG,1,Intravenous (not otherwise specified)
1257,8115,IS_PRIMARY_SUSPECT,Essential thrombocythaemia,500,MG,1,Oral
1258,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,13,G,1,Subcutaneous
1259,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1260,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1261,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,14,G,1,Subcutaneous
1262,8383,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,16,MG,1,Oral
1263,7922,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1264,8387,IS_PRIMARY_SUSPECT,Neurotrophic keratopathy,1,GTT,1,Ophthalmic
1265,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.8,MG,1,Unknown
1266,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
1267,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,4,G,1,Subcutaneous
1268,8143,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,25,MG,1,Unknown
1269,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Intravenous (not otherwise specified)
1270,8388,IS_PRIMARY_SUSPECT,Intestinal haemorrhage,1,PCT,1,Rectal
1271,7334,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,20,G,1,Intravenous (not otherwise specified)
1272,7334,IS_PRIMARY_SUSPECT,Dermatomyositis,60,G,1,Intravenous (not otherwise specified)
1273,7982,IS_PRIMARY_SUSPECT,Immunodeficiency,32,G,1,Intravenous (not otherwise specified)
1274,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1275,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,11,G,1,Subcutaneous
1276,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1278,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.2,MG,1,Unknown
1279,7979,IS_PRIMARY_SUSPECT,Immune system disorder,55,G,1,Subcutaneous
1280,7178,IS_PRIMARY_SUSPECT,Lumbar radiculopathy,75,MG,1,Oral
1281,7982,IS_PRIMARY_SUSPECT,DiGeorge's syndrome,20,G,1,Intravenous (not otherwise specified)
1282,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1283,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1284,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,7,G,1,Subcutaneous
1285,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,5,G,1,Subcutaneous
1287,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,24,G,1,Subcutaneous
1288,7411,IS_PRIMARY_SUSPECT,Psoriasis,30,MG,1,Oral
1289,7536,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,820,MG,1,Intravenous drip
1290,8099,IS_PRIMARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
1291,7982,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,10,G,1,Subcutaneous
1292,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,84,MG,1,Unknown
1293,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,2,DF,1,Unknown
1294,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
1295,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.9,MG,1,Unknown
1296,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
1297,7790,IS_PRIMARY_SUSPECT,Unknown,7,G,1,Unknown
1298,8404,IS_PRIMARY_SUSPECT,Weight decreased,1,DF,1,Oral
1299,7662,IS_PRIMARY_SUSPECT,Renal cell carcinoma,1,MG/KG,2,Intravenous (not otherwise specified)
1301,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1302,7689,IS_PRIMARY_SUSPECT,Prostate cancer,45,MG,1,Subcutaneous
1303,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
1304,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
1305,7982,IS_PRIMARY_SUSPECT,Combined immunodeficiency,20,G,1,Intravenous (not otherwise specified)
1306,8201,IS_PRIMARY_SUSPECT,Cardiac amyloidosis,61,MG,1,Oral
1308,7334,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,40,G,1,Intravenous (not otherwise specified)
1309,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1310,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
1311,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,100,MG,1,Oral
1312,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
1313,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,13,G,1,Subcutaneous
1314,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Oral
1315,7632,IS_PRIMARY_SUSPECT,Autoimmune disorder,2.2,MG,1,Unknown
1316,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
1317,8414,IS_PRIMARY_SUSPECT,Factor VIII deficiency,2400,IU,1,Intravenous (not otherwise specified)
1318,7982,IS_PRIMARY_SUSPECT,Selective IgA immunodeficiency,25,G,1,Intravenous (not otherwise specified)
1319,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,14,G,1,Subcutaneous
1320,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
1321,8415,IS_PRIMARY_SUSPECT,Hypertension,0.1,MG,1,Transdermal
1322,8416,IS_PRIMARY_SUSPECT,Food allergy,0.3,MG,1,Unknown
1323,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1324,7504,IS_PRIMARY_SUSPECT,Arthralgia,10,MG,1,Oral
1325,7187,IS_PRIMARY_SUSPECT,Basal cell carcinoma,150,MG,1,Oral
1326,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1700,MG,1,Intravenous (not otherwise specified)
1327,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1900,MG,1,Intravenous (not otherwise specified)
1328,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,400,MG,1,Intravenous (not otherwise specified)
1329,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,700,MG,1,Intravenous (not otherwise specified)
1330,8419,IS_PRIMARY_SUSPECT,Muscular dystrophy,2300,MG,1,Intravenous (not otherwise specified)
1331,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1300,MG,1,Intravenous (not otherwise specified)
1332,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,800,MG,1,Intravenous (not otherwise specified)
1333,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1000,MG,1,Intravenous (not otherwise specified)
1334,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,2900,MG,1,Intravenous (not otherwise specified)
1335,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,400,MG,1,Intravenous (not otherwise specified)
1336,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,2000,MG,1,Intravenous (not otherwise specified)
1337,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,2200,MG,1,Intravenous (not otherwise specified)
1338,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1500,MG,1,Intravenous (not otherwise specified)
1339,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,9,G,1,Subcutaneous
1340,7536,IS_PRIMARY_SUSPECT,Squamous cell carcinoma of the cervix,1200,MG,1,Intravenous (not otherwise specified)
1341,8427,IS_PRIMARY_SUSPECT,Migraine,50,MG,1,Oral
1342,8400,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
1349,7681,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,20,MG,1,Subcutaneous
1350,7632,IS_PRIMARY_SUSPECT,Unknown,7.2,MG,1,Subcutaneous
1351,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Subcutaneous
1352,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1353,7850,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,180,MG,1,Oral
1354,8432,IS_PRIMARY_SUSPECT,Hypersensitivity,0.3,MG,1,Intramuscular
1355,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Subcutaneous
1357,7179,IS_PRIMARY_SUSPECT,Lipidosis,0.99,MG/KG,1,Intravenous (not otherwise specified)
1358,7982,IS_PRIMARY_SUSPECT,Immune system disorder,25,G,1,Intravenous (not otherwise specified)
1359,7982,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,10,G,1,Intravenous (not otherwise specified)
1360,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,11,G,1,Subcutaneous
1361,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Unknown
1362,7979,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,25,G,1,Subcutaneous
1363,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,100,G,1,Intravenous (not otherwise specified)
1364,7982,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,30,G,1,Intravenous (not otherwise specified)
1366,7982,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,40,G,1,Intravenous (not otherwise specified)
1367,7982,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,400,MG/KG,1,Intravenous (not otherwise specified)
1369,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma in remission,3,MG,1,Oral
1370,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,0.4,MG,1,Unknown
1371,8224,IS_PRIMARY_SUSPECT,Endometriosis,1,DF,1,Oral
1372,8434,IS_PRIMARY_SUSPECT,Infective pulmonary exacerbation of cystic fibrosis,300,MG,1,Unknown
1373,8416,IS_PRIMARY_SUSPECT,Food allergy,1,DF,1,Intramuscular
1374,8175,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,1,MG,1,Intravenous (not otherwise specified)
1375,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,34,G,1,Subcutaneous
1376,7790,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,9,G,1,Subcutaneous
1379,8047,IS_PRIMARY_SUSPECT,Plasma cell myeloma refractory,650,MG,1,Intravenous (not otherwise specified)
1380,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1381,8446,IS_PRIMARY_SUSPECT,Follicular lymphoma,20,MG,1,Oral
1382,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
1383,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Unknown
1384,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1385,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
1386,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1387,8450,IS_PRIMARY_SUSPECT,B-cell lymphoma refractory,1,DF,1,Intravenous (not otherwise specified)
1388,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,15,MG,1,Subcutaneous
1389,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1390,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
1391,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,MG,1,Subcutaneous
1393,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
1395,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,1.6,ML,1,Oral
1396,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
1397,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1398,8468,IS_PRIMARY_SUSPECT,Lung carcinoma cell type unspecified stage IV,90,MG,1,Unknown
1399,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,2,MG,1,Unknown
1401,8471,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
1402,7315,IS_PRIMARY_SUSPECT,Joint injury,200,MG,1,Unknown
1403,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,150,MG,1,Oral
1404,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.5,MG,1,Subcutaneous
1406,7536,IS_PRIMARY_SUSPECT,Renal cell carcinoma,1200,MG,1,Intravenous drip
1407,8040,IS_PRIMARY_SUSPECT,Multiple sclerosis,30,UG,1,Intramuscular
1408,7178,IS_PRIMARY_SUSPECT,Back pain,150,MG,1,Oral
1409,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
1410,8483,IS_PRIMARY_SUSPECT,Unknown,100,MG,1,Other
1411,7733,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,4,DF,1,Oral
1413,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,240,MG,1,Oral
1415,8487,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,60,MG/KG,1,Intravenous (not otherwise specified)
1416,8489,IS_PRIMARY_SUSPECT,Long-chain acyl-coenzyme A dehydrogenase deficiency,4,ML,1,Oral
1417,7280,IS_PRIMARY_SUSPECT,Bone cancer,100,MG,1,Oral
1418,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1419,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
1420,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1421,8139,IS_PRIMARY_SUSPECT,Polyneuropathy,284,MG,1,Subcutaneous
1422,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1423,7613,IS_PRIMARY_SUSPECT,Gastric cancer,480,MG,2,Unknown
1425,7504,IS_PRIMARY_SUSPECT,Unknown,40,MG,1,Oral
1426,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,480,MG,1,Unknown
1427,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1428,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1429,7632,IS_PRIMARY_SUSPECT,Unknown,0.8,MG,1,Unknown
1430,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
1431,8500,IS_PRIMARY_SUSPECT,Hereditary angioedema,30,MG,1,Subcutaneous
1432,8501,IS_PRIMARY_SUSPECT,B-cell type acute leukaemia,68,ML,1,Intravenous (not otherwise specified)
1433,8335,IS_PRIMARY_SUSPECT,Left ventricular failure,1,DF,1,Oral
1434,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,360,MG,1,Intravenous (not otherwise specified)
1435,7291,IS_PRIMARY_SUSPECT,Squamous cell carcinoma of the tongue,150,MG,1,Oral
1436,8156,IS_PRIMARY_SUSPECT,Pain,37.006,UG,1,Intrathecal
1437,8387,IS_PRIMARY_SUSPECT,Keratitis,1,GTT,1,Ophthalmic
1438,7539,IS_PRIMARY_SUSPECT,Cervix carcinoma stage III,220,MG,1,Intravenous (not otherwise specified)
1439,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1440,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,480,MG,1,Intravenous (not otherwise specified)
1441,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,6,G,1,Subcutaneous
1443,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis,12,MG,1,Intravenous (not otherwise specified)
1444,8507,IS_PRIMARY_SUSPECT,Smoking cessation therapy,10,MG,1,Unknown
1445,8508,IS_PRIMARY_SUSPECT,Malignant melanoma,45,MG,1,Oral
1448,7632,IS_PRIMARY_SUSPECT,Short stature,12,MG,1,Unknown
1449,7850,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,180,MG,1,Oral
1450,7504,IS_PRIMARY_SUSPECT,Pain,30,MG,1,Oral
1451,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
1453,8510,IS_PRIMARY_SUSPECT,Unknown,130,MG,1,Intravenous (not otherwise specified)
1454,7504,IS_PRIMARY_SUSPECT,Neck pain,10,MG,1,Oral
1455,8194,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Unknown
1456,8513,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,5,MG,1,Oral
1458,8509,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,450,MG,1,Oral
1459,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1460,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
1461,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
1462,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Subcutaneous
1463,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,5,G,1,Subcutaneous
1464,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,3,MG,1,Unknown
1465,7536,IS_PRIMARY_SUSPECT,Alveolar soft part sarcoma,1200,MG,1,Intravenous (not otherwise specified)
1466,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,18,G,1,Subcutaneous
1467,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Unknown
1468,7790,IS_PRIMARY_SUSPECT,Unknown,11,G,1,Subcutaneous
1469,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,7,G,1,Subcutaneous
1470,7790,IS_PRIMARY_SUSPECT,Immune system disorder,5,MG,1,Subcutaneous
1471,8515,IS_PRIMARY_SUSPECT,Menopausal symptoms,1,DF,1,Transdermal
1472,7537,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,1358,MG,1,Intravenous (not otherwise specified)
1473,8054,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,2000,UG,1,Intravenous (not otherwise specified)
1475,8241,IS_PRIMARY_SUSPECT,Synovial sarcoma,75,MG,1,Oral
1476,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1479,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
1480,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Subcutaneous
1481,8517,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,6,MG,1,Oral
1482,7476,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,19,ML,1,Intravenous (not otherwise specified)
1483,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,15,G,1,Subcutaneous
1484,7982,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,45,G,1,Intravenous (not otherwise specified)
1486,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,5.5,ML,1,Intravenous (not otherwise specified)
1487,7905,IS_PRIMARY_SUSPECT,Giant cell arteritis,162,MG,1,Subcutaneous
1488,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
1489,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,8,G,1,Subcutaneous
1490,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,8,G,1,Subcutaneous
1491,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
1492,7613,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,240,MG,1,Unknown
1493,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,300,MG,1,Unknown
1494,7476,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,16,ML,1,Intravenous (not otherwise specified)
1495,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
1496,7790,IS_PRIMARY_SUSPECT,Asthma,8,G,1,Subcutaneous
1497,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1498,7687,IS_PRIMARY_SUSPECT,Acromegaly,25,MG,1,Subcutaneous
1499,7613,IS_PRIMARY_SUSPECT,Metastatic renal cell carcinoma,360,MG,2,Intravenous (not otherwise specified)
1500,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,1,DF,1,Subcutaneous
1501,8535,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Vaginal
1502,7632,IS_PRIMARY_SUSPECT,Short stature,5,MG,1,Unknown
1504,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,4.437,ML,1,Subcutaneous
1505,7979,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,27.5,G,1,Subcutaneous
1506,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,225,MG,1,Oral
1507,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1508,8538,IS_PRIMARY_SUSPECT,Immune thrombocytopenia,75,MG,1,Oral
1509,7979,IS_PRIMARY_SUSPECT,Unknown,45,G,1,Subcutaneous
1510,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,45,G,1,Intravenous (not otherwise specified)
1512,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
1514,7201,IS_PRIMARY_SUSPECT,Diabetes mellitus,500,MG,1,Oral
1515,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.65,MG,1,Other
1516,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1517,8388,IS_PRIMARY_SUSPECT,Haemorrhoids,1,PCT,1,Rectal
1518,7979,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,50,G,1,Unknown
1519,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
1521,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.24,ML,1,Unknown
1522,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,80,G,1,Intravenous (not otherwise specified)
1523,8381,IS_PRIMARY_SUSPECT,Iron deficiency anaemia,750,MG,1,Intravenous (not otherwise specified)
1524,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis II,24,MG,1,Intravenous (not otherwise specified)
1525,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,179.4,MG,1,Unknown
1526,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.492,ML,1,Unknown
1528,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1529,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
1530,8547,IS_PRIMARY_SUSPECT,Contraception,0.35,MG,1,Oral
1531,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,10,G,1,Subcutaneous
1532,7982,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,30,G,1,Intravenous (not otherwise specified)
1533,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
1534,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
1535,7504,IS_PRIMARY_SUSPECT,Pain,40,MG,1,Oral
1536,7632,IS_PRIMARY_SUSPECT,Renal transplant,1.8,MG,1,Unknown
1538,8335,IS_PRIMARY_SUSPECT,Cardiac failure,100,MG,1,Oral
1539,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
1540,7832,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
1541,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.6,MG,1,Subcutaneous
1542,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Subcutaneous
1543,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
1544,7982,IS_PRIMARY_SUSPECT,Polymyositis,50,MG,1,Unknown
1545,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,4.5,MG,1,Unknown
1546,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.24,ML,1,Subcutaneous
1547,8201,IS_PRIMARY_SUSPECT,Amyloidosis,61,MG,1,Unknown
1549,8240,IS_PRIMARY_SUSPECT,Primary amyloidosis,20,MG,1,Oral
1550,8551,IS_PRIMARY_SUSPECT,COVID-19,700,MG,1,Unknown
1552,8552,IS_PRIMARY_SUSPECT,Depression,80,MG,1,Oral
1553,8553,IS_PRIMARY_SUSPECT,Toxic goitre,1200,MG,1,Intravenous (not otherwise specified)
1554,8554,IS_PRIMARY_SUSPECT,Peripheral T-cell lymphoma unspecified,1790,MG,1,Intravenous (not otherwise specified)
1555,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Unknown
1556,8553,IS_PRIMARY_SUSPECT,Basedow's disease,800,MG,1,Intravenous (not otherwise specified)
1557,7280,IS_PRIMARY_SUSPECT,Breast cancer female,100,MG,1,Oral
1558,7993,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,400,MG,1,Oral
1559,7234,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,0.5,MG,1,Oral
1560,7790,IS_PRIMARY_SUSPECT,Combined immunodeficiency,30,G,1,Subcutaneous
1561,8118,IS_PRIMARY_SUSPECT,Multiple sclerosis relapse,2,MG,1,Oral
1562,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
1563,8558,IS_PRIMARY_SUSPECT,Type 1 diabetes mellitus,0.5,MG,1,Subcutaneous
1564,7632,IS_PRIMARY_SUSPECT,Short stature,1,MG,1,Unknown
1565,8559,IS_PRIMARY_SUSPECT,Autoimmune thyroiditis,200,UG,1,Oral
1566,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
1567,8560,IS_PRIMARY_SUSPECT,HIV infection,1,DF,1,Transplacental
1568,8510,IS_PRIMARY_SUSPECT,Unknown,134.4,MG,1,Intravenous (not otherwise specified)
1569,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,2.6,MG,1,Unknown
1570,8487,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,4200,MG,1,Intravenous (not otherwise specified)
1571,8222,IS_PRIMARY_SUSPECT,Immune system disorder,1000,IU,1,Intravenous (not otherwise specified)
1572,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.13,ML,1,Subcutaneous
1573,7354,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,85,MG,1,Oral
1574,8471,IS_PRIMARY_SUSPECT,Axial spondyloarthritis,15,MG,1,Oral
1575,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Unknown
1576,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
1577,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
1578,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
1579,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
1580,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1581,7472,IS_PRIMARY_SUSPECT,Malignant melanoma,300,MG,1,Oral
1582,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.05,MG/KG,1,Unknown
1583,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1584,8253,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
1587,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
1588,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
1589,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis,36,MG,1,Intravenous (not otherwise specified)
1594,7860,IS_PRIMARY_SUSPECT,Metastatic renal cell carcinoma,14,MG,1,Oral
1595,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
1596,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,2,DF,1,Unknown
1597,7536,IS_PRIMARY_SUSPECT,Cervix carcinoma,1200,MG,1,Intravenous drip
1598,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
1599,7979,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,50,G,1,Subcutaneous
1601,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
1602,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1603,8586,IS_PRIMARY_SUSPECT,Crohn's disease,300,MG,1,Intravenous (not otherwise specified)
1604,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.05,MG/KG,1,Unknown
1605,7850,IS_PRIMARY_SUSPECT,Metastasis,120,MG,1,Oral
1606,8587,IS_PRIMARY_SUSPECT,Factor VIII deficiency,2000,IU,1,Intravenous (not otherwise specified)
1612,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,35,G,1,Intravenous (not otherwise specified)
1613,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Unknown
1614,8253,IS_PRIMARY_SUSPECT,Multiple sclerosis,1200,MG,1,Subcutaneous
1615,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,12,G,1,Subcutaneous
1616,7338,IS_PRIMARY_SUSPECT,Crohn's disease,10,MG,1,Oral
1617,8500,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
1618,7850,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,180,MG,1,Oral
1619,8224,IS_PRIMARY_SUSPECT,Uterine leiomyoma,1,DF,1,Oral
1620,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1622,8299,IS_PRIMARY_SUSPECT,Hypertension,320,MG,1,Unknown
1626,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
1627,7536,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,840,MG,1,Intravenous drip
1628,7662,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,201.9,MG,2,Intravenous (not otherwise specified)
1629,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Subcutaneous
1630,7790,IS_PRIMARY_SUSPECT,Immunoglobulins abnormal,20,G,1,Subcutaneous
1631,7982,IS_PRIMARY_SUSPECT,Multifocal motor neuropathy,100,G,1,Intravenous (not otherwise specified)
1632,8603,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,4,ML,1,IRRIGATION
1633,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
1634,8004,IS_PRIMARY_SUSPECT,Major depression,84,MG,1,Unknown
1635,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,120,MG/KG,1,Intravenous (not otherwise specified)
1637,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,4,G,1,Subcutaneous
1638,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Subcutaneous
1639,8299,IS_PRIMARY_SUSPECT,Hypertension,302,MG,1,Unknown
1640,8606,IS_PRIMARY_SUSPECT,Unknown,60,MG,1,Oral
1641,8513,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,2.7,MG,1,Oral
1642,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.54,MG,1,Subcutaneous
1644,8388,IS_PRIMARY_SUSPECT,Haemorrhoids,1,PCT,1,Unknown
1645,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
1646,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Unknown
1648,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
1649,8610,IS_PRIMARY_SUSPECT,Dermatomyositis,125,MG,1,Subcutaneous
1650,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.25,ML,1,Subcutaneous
1651,8236,IS_PRIMARY_SUSPECT,HER2 negative breast cancer,400,MG,1,Oral
1652,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1653,7280,IS_PRIMARY_SUSPECT,Breast cancer stage IV,100,MG,1,Unknown
1654,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,24,G,1,Subcutaneous
1655,8299,IS_PRIMARY_SUSPECT,Hypertension,320,MG,1,Unknown
1656,8476,IS_PRIMARY_SUSPECT,Hypertension,320,MG,1,Unknown
1657,7767,IS_PRIMARY_SUSPECT,Multiple sclerosis,40,MG,1,Subcutaneous
1658,8553,IS_PRIMARY_SUSPECT,Toxic goitre,1614,MG,1,Intravenous (not otherwise specified)
1659,8577,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,150,MG,12,Oral
1661,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
1662,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
1663,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Subcutaneous
1664,8619,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,300,MG,1,Oral
1665,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,1.86,MG,1,Subcutaneous
1667,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,110,G,1,Intravenous (not otherwise specified)
1668,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
1669,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
1670,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
1675,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,22,ML,1,Intravenous (not otherwise specified)
1676,7982,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,8,G,1,Subcutaneous
1677,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,1.4,ML,1,Oral
1678,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,0.8,ML,1,Oral
1679,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,3,ML,1,Oral
1680,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,5.9,ML,1,Oral
1681,8623,IS_PRIMARY_SUSPECT,Fallopian tube cancer stage III,600,MG,1,Oral
1682,7437,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,15,MG,1,Oral
1683,8468,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,180,MG,1,Oral
1685,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
1686,8222,IS_PRIMARY_SUSPECT,Immune system disorder,1000,IU,1,Intravenous (not otherwise specified)
1687,7790,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,6,G,1,Subcutaneous
1688,7437,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,15,MG,1,Oral
1689,8468,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,30,MG,1,Oral
1690,7613,IS_PRIMARY_SUSPECT,Fallopian tube cancer stage III,480,MG,1,Intravenous (not otherwise specified)
1691,8222,IS_PRIMARY_SUSPECT,Immune system disorder,1000,IU,1,Intravenous (not otherwise specified)
1692,7248,IS_PRIMARY_SUSPECT,Gait disturbance,10,MG,1,Oral
1693,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1232,MG,1,Subcutaneous
1694,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Unknown
1695,8636,IS_PRIMARY_SUSPECT,HER2 positive breast cancer,5.4,MG/KG,1,Intravenous (not otherwise specified)
1696,7662,IS_PRIMARY_SUSPECT,Renal cell carcinoma,1,MG/KG,3,Intravenous (not otherwise specified)
1697,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1698,7502,IS_PRIMARY_SUSPECT,Rectal cancer,40,MG,1,Oral
1699,8154,IS_PRIMARY_SUSPECT,Diabetes mellitus,5,MG,1,Oral
1700,7632,IS_PRIMARY_SUSPECT,Unknown,0.4,MG,1,Unknown
1701,8640,IS_PRIMARY_SUSPECT,Lung cancer metastatic,100,MG,1,Unknown
1702,7504,IS_PRIMARY_SUSPECT,Pain,20,MG,1,Oral
1703,7993,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,400,MG,1,Oral
1704,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Unknown
1705,8645,IS_PRIMARY_SUSPECT,Antiviral prophylaxis,450,MG,1,Oral
1706,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
1707,8646,IS_PRIMARY_SUSPECT,Colorectal cancer metastatic,300,MG,1,Oral
1708,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Unknown
1709,7613,IS_PRIMARY_SUSPECT,Squamous cell carcinoma of head and neck,480,MG,1,Intravenous (not otherwise specified)
1712,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
1713,7496,IS_PRIMARY_SUSPECT,Primary progressive multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
1714,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
1715,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Oral
1716,7178,IS_PRIMARY_SUSPECT,Fall,75,MG,1,Unknown
1717,8483,IS_PRIMARY_SUSPECT,Parkinson's disease,100,ML,1,Other
1718,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
1719,7280,IS_PRIMARY_SUSPECT,Oestrogen receptor assay positive,200,MG,1,Unknown
1721,8649,IS_PRIMARY_SUSPECT,Colorectal adenocarcinoma,150,MG,1,Oral
1722,7539,IS_PRIMARY_SUSPECT,B-cell lymphoma,750,MG,5,Unknown
1723,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
1724,7234,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.5,MG,1,Oral
1725,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1726,8247,IS_PRIMARY_SUSPECT,Depression,50,MG,1,Oral
1727,8651,IS_PRIMARY_SUSPECT,Benign prostatic hyperplasia,5,MG,1,Oral
1728,8224,IS_PRIMARY_SUSPECT,Uterine fibrosis,1,DF,1,Oral
1729,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,190,G,1,Intravenous (not otherwise specified)
1730,7280,IS_PRIMARY_SUSPECT,Neoplasm malignant,75,MG,1,Unknown
1731,8174,IS_PRIMARY_SUSPECT,Sickle cell anaemia with crisis,190,MG,1,Unknown
1733,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Intravenous (not otherwise specified)
1735,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,15,G,1,Subcutaneous
1736,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
1737,8654,IS_PRIMARY_SUSPECT,Pituitary tumour,40,MG,1,Oral
1739,8416,IS_PRIMARY_SUSPECT,Hypersensitivity,0.3,MG,1,Intramuscular
1744,8401,IS_PRIMARY_SUSPECT,Unknown,2,DF,1,Unknown
1745,8655,IS_PRIMARY_SUSPECT,Magnetic resonance imaging,11,ML,1,Intravenous (not otherwise specified)
1747,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
1748,8551,IS_PRIMARY_SUSPECT,COVID-19,700,MG,1,Intravenous (not otherwise specified)
1749,8621,IS_PRIMARY_SUSPECT,Asthma,30,MG,1,Subcutaneous
1750,8660,IS_PRIMARY_SUSPECT,Haemophilia A without inhibitors,102,MG,1,Unknown
1751,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,16,MG/KG,1,Intravenous drip
1752,7502,IS_PRIMARY_SUSPECT,Rectal cancer,40,MG,1,Oral
1753,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis II,0.5,MG/KG,1,Intravenous (not otherwise specified)
1754,7993,IS_PRIMARY_SUSPECT,Plasma cell myeloma,800,MG,1,Oral
1756,7188,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.8,MG,1,Oral
1757,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
1758,7613,IS_PRIMARY_SUSPECT,Colorectal cancer,480,MG,1,Intravenous (not otherwise specified)
1759,7179,IS_PRIMARY_SUSPECT,Fabry's disease,65,MG,1,Intravenous bolus
1760,8670,IS_PRIMARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
1761,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,300,MG,1,Subcutaneous
1762,8671,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
1763,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
1764,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,200,MG,1,Subcutaneous
1765,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
1766,8557,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,100,MG,1,Subcutaneous
1767,8672,IS_PRIMARY_SUSPECT,Hormone receptor positive HER2 negative breast cancer,1250,MG,1,Oral
1768,7901,IS_PRIMARY_SUSPECT,Juvenile idiopathic arthritis,150,MG,1,Subcutaneous
1769,8173,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,300,MG,1,Unknown
1770,8054,IS_PRIMARY_SUSPECT,Polyneuropathy,110,G,1,Intravenous (not otherwise specified)
1771,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
1772,7862,IS_PRIMARY_SUSPECT,Asthma,300,MG,1,Subcutaneous
1773,8194,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
1774,8099,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,40,MG,1,Oral
1775,7993,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Oral
1776,7452,IS_PRIMARY_SUSPECT,Hyperkalaemia,8.4,G,1,Oral
1777,8680,IS_PRIMARY_SUSPECT,Skin wrinkling,50,IU,1,Intramuscular
1778,8681,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,0.75,MG,1,Subcutaneous
1779,8335,IS_PRIMARY_SUSPECT,Unknown,100,MG,1,Oral
1782,7352,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,2,MG,1,Intravenous (not otherwise specified)
1783,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
1784,8500,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
1785,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1786,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1787,8407,IS_PRIMARY_SUSPECT,Drug dependence,380,MG,1,Intramuscular
1789,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
1790,8691,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,3,MG,1,Intravenous (not otherwise specified)
1791,7536,IS_PRIMARY_SUSPECT,Adenocarcinoma of colon,840,MG,1,Intravenous (not otherwise specified)
1793,7437,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia recurrent,30,MG,1,Unknown
1794,7782,IS_PRIMARY_SUSPECT,Atrial fibrillation,20,MG,1,Oral
1796,8544,IS_PRIMARY_SUSPECT,Cardiac failure,100,MG,1,Oral
1797,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,1000,MG,1,Intravenous (not otherwise specified)
1799,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,12,G,1,Subcutaneous
1800,8381,IS_PRIMARY_SUSPECT,Iron deficiency anaemia,750,MG,1,Intravenous (not otherwise specified)
1802,7965,IS_PRIMARY_SUSPECT,Psoriasis,45,MG,1,Subcutaneous
1803,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1804,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
1805,7862,IS_PRIMARY_SUSPECT,Asthma,300,MG,1,Subcutaneous
1807,7982,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,40,G,1,Intravenous (not otherwise specified)
1809,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,5,MG,1,Subcutaneous
1810,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
1812,8241,IS_PRIMARY_SUSPECT,Colon cancer metastatic,45,MG,1,Oral
1813,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1814,8727,IS_PRIMARY_SUSPECT,Post-traumatic stress disorder,37.5,MG,1,Intramuscular
1815,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
1816,7170,IS_PRIMARY_SUSPECT,Systemic lupus erythematosus,80,MG,1,Intravenous (not otherwise specified)
1818,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Subcutaneous
1819,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,5000,IU,1,Subcutaneous
1820,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,120,MG,1,Oral
1821,8735,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Unknown
1823,7437,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,45,MG,1,Oral
1824,7496,IS_PRIMARY_SUSPECT,Secondary progressive multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
1825,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1826,7790,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,5,G,1,Subcutaneous
1827,8055,IS_PRIMARY_SUSPECT,Bipolar disorder,225,MG,1,Unknown
1828,8368,IS_PRIMARY_SUSPECT,Anaemia of malignant disease,1,MG/KG,1,Subcutaneous
1829,7234,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.5,MG,1,Oral
1830,7882,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
1831,7681,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,20,MG,1,Subcutaneous
1832,7905,IS_PRIMARY_SUSPECT,Giant cell arteritis,162,MG,1,Subcutaneous
1833,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Intravenous (not otherwise specified)
1834,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
1835,7613,IS_PRIMARY_SUSPECT,Haematological malignancy,240,MG,1,Intravenous (not otherwise specified)
1837,7979,IS_PRIMARY_SUSPECT,Immunodeficiency,30,G,1,Subcutaneous
1838,8739,IS_PRIMARY_SUSPECT,Angioimmunoblastic T-cell lymphoma,25,MG,1,Oral
1839,8737,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,125,MG,1,Subcutaneous
1840,7365,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
1841,8748,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,800,MG,1,Oral
1842,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Intravenous (not otherwise specified)
1843,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
1844,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1845,8143,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,10,MG,1,Unknown
1846,7539,IS_PRIMARY_SUSPECT,B-cell lymphoma,384.5,MG,1,Intravenous (not otherwise specified)
1847,7321,IS_PRIMARY_SUSPECT,Renal transplant,750,MG,2,Oral
1849,8173,IS_PRIMARY_SUSPECT,Unknown,150,MG,1,Unknown
1850,7536,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,1200,MG,1,Intravenous drip
1852,8174,IS_PRIMARY_SUSPECT,Sickle cell anaemia with crisis,5,MG/KG,1,Intravenous (not otherwise specified)
1853,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
1854,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1855,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1856,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
1857,7213,IS_PRIMARY_SUSPECT,Hypertension,5,MG,1,Unknown
1858,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Unknown
1859,8655,IS_PRIMARY_SUSPECT,Pruritus,10,ML,1,Unknown
1860,8670,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,40,MG,1,Oral
1861,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
1862,8762,IS_PRIMARY_SUSPECT,Contraception,68,MG,1,Subdermal
1863,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Unknown
1864,8610,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
1865,8764,IS_PRIMARY_SUSPECT,Seizure,100,MG,1,Oral
1866,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.2,MG,1,Subcutaneous
1867,7982,IS_PRIMARY_SUSPECT,White blood cell disorder,25,G,1,Intravenous (not otherwise specified)
1868,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.23,MG,1,Oral
1869,8098,IS_PRIMARY_SUSPECT,Atrophic vulvovaginitis,1,DF,1,Vaginal
1870,8388,IS_PRIMARY_SUSPECT,Haemorrhoids,1,PCT,1,Rectal
1871,7632,IS_PRIMARY_SUSPECT,Body height abnormal,1.8,MG,1,Unknown
1877,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
1878,8768,IS_PRIMARY_SUSPECT,Primary biliary cholangitis,5,MG,1,Oral
1879,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
1880,7333,IS_PRIMARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,150,MG,1,Intravenous (not otherwise specified)
1881,8353,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,267,MG,1,Oral
1882,7333,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,170,MG,1,Intravenous (not otherwise specified)
1883,7181,IS_PRIMARY_SUSPECT,Unknown,100,MG,1,Oral
1884,8236,IS_PRIMARY_SUSPECT,HER2 negative breast cancer,400,MG,1,Oral
1885,8387,IS_PRIMARY_SUSPECT,Neurotrophic keratopathy,1,GTT,1,Ophthalmic
1886,8610,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
1887,8774,IS_PRIMARY_SUSPECT,Contraception,150,MG,1,Unknown
1888,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis II,16,IU,1,Intravenous (not otherwise specified)
1889,8775,IS_PRIMARY_SUSPECT,Pulmonary hypertension,200,UG,1,Oral
1890,7899,IS_PRIMARY_SUSPECT,Adrenocortical carcinoma,290,MG,1,Intravenous (not otherwise specified)
1891,8551,IS_PRIMARY_SUSPECT,COVID-19,700,MG,1,Intravenous (not otherwise specified)
1893,8577,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,150,MG,1,Oral
1894,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.23,MG,1,Oral
1895,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
1896,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,1,Oral
1897,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
1898,7982,IS_PRIMARY_SUSPECT,Immune system disorder,32,G,1,Intravenous (not otherwise specified)
1899,7662,IS_PRIMARY_SUSPECT,Leiomyosarcoma,1,MG/KG,2,Intravenous (not otherwise specified)
1900,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
1902,8785,IS_PRIMARY_SUSPECT,Infection prophylaxis,480,MG,1,Oral
1903,8786,IS_PRIMARY_SUSPECT,HIV infection,500,MG,1,Transplacental
1904,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
1905,7901,IS_PRIMARY_SUSPECT,Still's disease,245,MG,1,Subcutaneous
1906,7478,IS_PRIMARY_SUSPECT,Neuroendocrine tumour,25,MG,1,Oral
1908,8671,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
1910,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
1911,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
1912,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,18,G,1,Subcutaneous
1913,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
1914,8473,IS_PRIMARY_SUSPECT,Diabetes mellitus,3,IU,1,Subcutaneous
1915,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
1917,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
1918,8335,IS_PRIMARY_SUSPECT,Cardiac failure congestive,50,MG,1,Oral
1919,8500,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
1920,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
1921,7897,IS_PRIMARY_SUSPECT,Parkinson's disease,84,MG,1,Unknown
1922,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
1923,8577,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,150,MG,1,Oral
1924,8790,IS_PRIMARY_SUSPECT,Brain neoplasm malignant,150,MG,1,Oral
1925,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Unknown
1926,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
1927,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.8,MG,1,Unknown
1928,7536,IS_PRIMARY_SUSPECT,Colorectal cancer metastatic,840,MG,1,Intravenous drip
1930,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1931,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
1933,8335,IS_PRIMARY_SUSPECT,Cardiac failure,1,DF,1,Oral
1934,7982,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,30,G,1,Intravenous (not otherwise specified)
1935,8794,IS_PRIMARY_SUSPECT,Osteoporosis,1,DF,1,Oral
1936,8312,IS_PRIMARY_SUSPECT,Schizoaffective disorder,325,MG,1,Oral
1937,8610,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
1938,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1939,7613,IS_PRIMARY_SUSPECT,Colorectal cancer,480,MG,2,Intravenous (not otherwise specified)
1940,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,3.5,MG,1,Subcutaneous
1941,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.05,MG/KG,1,Unknown
1942,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
1944,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Unknown
1945,8801,IS_PRIMARY_SUSPECT,Hereditary angioedema,150,MG,1,Oral
1946,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
1947,8803,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,2,MG/KG,1,Intravenous (not otherwise specified)
1948,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.5,MG,1,Subcutaneous
1949,8806,IS_PRIMARY_SUSPECT,Factor IX deficiency,7000,IU,1,Intravenous (not otherwise specified)
1950,7536,IS_PRIMARY_SUSPECT,Colon cancer stage III,840,MG,1,Intravenous (not otherwise specified)
1951,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
1952,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
1953,8807,IS_PRIMARY_SUSPECT,Multiple sclerosis,14,MG,1,Oral
1954,8218,IS_PRIMARY_SUSPECT,Connective tissue disorder,1000,MG,1,Intravenous (not otherwise specified)
1955,7920,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
1956,8577,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,200,MG,1,Oral
1957,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,1.6,MG,1,Unknown
1958,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.45,MG,1,Subcutaneous
1959,7922,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
1960,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
1962,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
1963,8810,IS_PRIMARY_SUSPECT,Contraception,17.5,UG,1,Intra-uterine
1964,8811,IS_PRIMARY_SUSPECT,Liposarcoma metastatic,800,MG,1,Oral
1965,8812,IS_PRIMARY_SUSPECT,Breast cancer,125,MG,1,Oral
1966,8814,IS_PRIMARY_SUSPECT,Contraception,14,UG,1,Intra-uterine
1968,8143,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,10,MG,1,Oral
1969,7790,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,10,G,1,Subcutaneous
1970,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
1971,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.272,ML,1,Subcutaneous
1972,7893,IS_PRIMARY_SUSPECT,PIK3CA related overgrowth spectrum,50,MG,1,Oral
1973,7993,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Oral
1974,7922,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
1975,7233,IS_PRIMARY_SUSPECT,Unknown,150,UG,1,Intravenous bolus
1976,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,32,G,1,Subcutaneous
1978,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
1979,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
1980,8118,IS_PRIMARY_SUSPECT,Clinically isolated syndrome,2,MG,1,Oral
1981,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
1983,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
1984,8823,IS_PRIMARY_SUSPECT,Epilepsy,0.5,MG,1,Oral
1985,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
1986,8551,IS_PRIMARY_SUSPECT,COVID-19,700,MG,1,Intravenous (not otherwise specified)
1987,8825,IS_PRIMARY_SUSPECT,Invasive breast carcinoma,300,MG,1,Oral
1988,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
1989,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
1990,8830,IS_PRIMARY_SUSPECT,Chronic hepatitis C,1,DF,1,Oral
1991,8500,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
1993,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
1994,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
1995,7965,IS_PRIMARY_SUSPECT,Psoriasis,45,MG,1,Subcutaneous
1996,7899,IS_PRIMARY_SUSPECT,Colon cancer,181.5,MG,1,Unknown
1997,8551,IS_PRIMARY_SUSPECT,COVID-19,700,MG,1,Intravenous (not otherwise specified)
1998,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Unknown
1999,7365,IS_PRIMARY_SUSPECT,Thrombosis prophylaxis,5,MG,1,Oral
2000,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2001,8838,IS_PRIMARY_SUSPECT,Psoriasis,400,MG,1,Subcutaneous
2002,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,30,MG,1,Subcutaneous
2003,8845,IS_PRIMARY_SUSPECT,Prostate cancer metastatic,1000,MG,1,Oral
2004,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Oral
2008,7850,IS_PRIMARY_SUSPECT,Neurofibromatosis,180,MG,1,Unknown
2009,7632,IS_PRIMARY_SUSPECT,Turner's syndrome,2,MG,1,Unknown
2010,8846,IS_PRIMARY_SUSPECT,Carcinoid tumour of the duodenum,202.47,MCI,1,Unknown
2011,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2012,8064,IS_PRIMARY_SUSPECT,Seizure,20,MG,1,Oral
2013,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2014,7333,IS_PRIMARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,150,MG,1,Intravenous (not otherwise specified)
2015,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
2016,7536,IS_PRIMARY_SUSPECT,K-ras gene mutation,1200,MG,1,Intravenous drip
2017,7899,IS_PRIMARY_SUSPECT,Renal cell carcinoma,480,MG,1,Intravenous (not otherwise specified)
2018,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
2019,7536,IS_PRIMARY_SUSPECT,Adenocarcinoma of colon,840,MG,1,Intravenous drip
2020,7790,IS_PRIMARY_SUSPECT,Unknown,14,G,1,Subcutaneous
2021,8748,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,800,MG,2,Unknown
2022,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,1,DF,1,Unknown
2023,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
2024,7788,IS_PRIMARY_SUSPECT,Chemotherapy,750,MG,1,Intravenous (not otherwise specified)
2025,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2026,7536,IS_PRIMARY_SUSPECT,Skin cancer,1200,MG,1,Intravenous drip
2027,7850,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,90,MG,1,Unknown
2028,7905,IS_PRIMARY_SUSPECT,Giant cell arteritis,162,MG,1,Subcutaneous
2029,8855,IS_PRIMARY_SUSPECT,Crohn's disease,10,MG/KG,1,Intravenous (not otherwise specified)
2030,7338,IS_PRIMARY_SUSPECT,Seronegative arthritis,5,MG,1,Oral
2031,8691,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,3,MG,1,Intravenous (not otherwise specified)
2032,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,5,MG,1,Intravenous (not otherwise specified)
2033,7335,IS_PRIMARY_SUSPECT,Deep vein thrombosis,5,MG,1,Oral
2034,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,40,MG,1,Subcutaneous
2035,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
2036,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
2037,8810,IS_PRIMARY_SUSPECT,Contraception,17.5,UG,1,Intra-uterine
2038,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.45,ML,1,Other
2039,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2041,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2042,8858,IS_PRIMARY_SUSPECT,Schizophrenia,42,MG,1,Oral
2043,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
2044,8859,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2045,7893,IS_PRIMARY_SUSPECT,Breast cancer metastatic,150,MG,1,Oral
2046,7681,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,20,MG,1,Subcutaneous
2047,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,400,UG,1,Oral
2048,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2049,7901,IS_PRIMARY_SUSPECT,Familial mediterranean fever,32,MG,1,Subcutaneous
2050,8862,IS_PRIMARY_SUSPECT,Neuralgia,165,MG,1,Unknown
2051,8236,IS_PRIMARY_SUSPECT,Breast cancer,400,MG,1,Oral
2053,8577,IS_PRIMARY_SUSPECT,Pulmonary fibrosis,150,MG,1,Oral
2054,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2055,7613,IS_PRIMARY_SUSPECT,Squamous cell carcinoma,240,MG,1,Intravenous (not otherwise specified)
2056,8099,IS_PRIMARY_SUSPECT,Hormone-refractory prostate cancer,40,MG,1,Oral
2057,8870,IS_PRIMARY_SUSPECT,Migraine,675,MG,1,Unknown
2058,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,1200,MG,1,Intravenous (not otherwise specified)
2059,7899,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,120,MG,1,Intravenous (not otherwise specified)
2061,8399,IS_PRIMARY_SUSPECT,Pulmonary hypertension,1600,UG,1,Oral
2062,8872,IS_PRIMARY_SUSPECT,Renal transplant,500,MG,1,Intravenous (not otherwise specified)
2063,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
2064,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
2065,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
2066,8764,IS_PRIMARY_SUSPECT,Seizure,150,MG,1,Oral
2067,8335,IS_PRIMARY_SUSPECT,Cardiac failure,50,MG,1,Oral
2068,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2069,8873,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,14,MG,1,Oral
2070,7536,IS_PRIMARY_SUSPECT,Adenocarcinoma of colon,840,MG,1,Intravenous drip
2071,8489,IS_PRIMARY_SUSPECT,Carnitine palmitoyltransferase deficiency,10,ML,1,Unknown
2073,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2074,7394,IS_PRIMARY_SUSPECT,Parkinson's disease,34,MG,1,Oral
2075,8118,IS_PRIMARY_SUSPECT,Multiple sclerosis,1,MG,1,Oral
2076,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
2077,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2078,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
2079,7961,IS_PRIMARY_SUSPECT,Hypothyroidism,100,UG,1,Unknown
2080,8817,IS_PRIMARY_SUSPECT,Iron deficiency,100,MG,1,Unknown
2081,7965,IS_PRIMARY_SUSPECT,Psoriasis,45,MG,1,Subcutaneous
2082,7939,IS_PRIMARY_SUSPECT,Breast cancer metastatic,3.6,MG/KG,1,Intravenous (not otherwise specified)
2083,8880,IS_PRIMARY_SUSPECT,Gastrointestinal carcinoma,50,MG,1,Oral
2084,7965,IS_PRIMARY_SUSPECT,Crohn's disease,520,MG,1,Intravenous (not otherwise specified)
2085,7278,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,40,MG,1,Subcutaneous
2086,7536,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,840,MG,1,Intravenous drip
2087,7536,IS_PRIMARY_SUSPECT,Metastatic neoplasm,1200,MG,1,Intravenous (not otherwise specified)
2088,7502,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,40,MG,1,Oral
2090,8884,IS_PRIMARY_SUSPECT,Skin ulcer,300,MG,1,Oral
2091,8885,IS_PRIMARY_SUSPECT,Unknown,1000,MG,1,Oral
2092,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
2093,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,6,ML,1,Oral
2094,8465,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,4.9,ML,1,Oral
2095,8465,IS_PRIMARY_SUSPECT,Lennox-Gastaut syndrome,2.7,ML,1,Oral
2096,8201,IS_PRIMARY_SUSPECT,Amyloidosis,1,DF,1,Oral
2097,8886,IS_PRIMARY_SUSPECT,Lupus nephritis,23.7,MG,1,Oral
2099,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2100,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2101,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,100,UG,1,Unknown
2102,7994,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,560,MG,1,Oral
2103,8099,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,60,MG,1,Oral
2104,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
2105,8889,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Oral
2106,8892,IS_PRIMARY_SUSPECT,Hypertension,1,DF,1,Unknown
2107,7502,IS_PRIMARY_SUSPECT,Colorectal cancer,40,MG,1,Oral
2109,8896,IS_PRIMARY_SUSPECT,Multiple sclerosis,44,UG,1,Subcutaneous
2110,8681,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,1.5,MG,1,Subcutaneous
2111,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Oral
2112,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2113,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2114,8900,IS_PRIMARY_SUSPECT,Muscular weakness,2,DF,1,Unknown
2115,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2116,7536,IS_PRIMARY_SUSPECT,Colon cancer stage III,840,MG,1,Intravenous (not otherwise specified)
2117,8748,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,800,MG,2,Oral
2118,8902,IS_PRIMARY_SUSPECT,Triple negative breast cancer,300,MG,1,Oral
2119,8904,IS_PRIMARY_SUSPECT,Endometriosis,150,MG,1,Oral
2120,8905,IS_PRIMARY_SUSPECT,Trisomy 21,15,MG/KG,1,Intramuscular
2121,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2122,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
2123,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
2124,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,100,MG,1,Unknown
2125,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2126,8119,IS_PRIMARY_SUSPECT,Thyroid cancer,200,MG,1,Oral
2127,8907,IS_PRIMARY_SUSPECT,Fabry's disease,123,MG,1,Oral
2128,7478,IS_PRIMARY_SUSPECT,Renal cancer,50,MG,1,Oral
2130,8908,IS_PRIMARY_SUSPECT,Blepharitis,1,GTT,1,Ophthalmic
2131,7278,IS_PRIMARY_SUSPECT,Ankylosing spondylitis,40,MG,1,Subcutaneous
2132,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Unknown
2133,7850,IS_PRIMARY_SUSPECT,Lung squamous cell carcinoma metastatic,90,MG,1,Unknown
2134,8173,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2135,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
2144,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
2145,8858,IS_PRIMARY_SUSPECT,Bipolar disorder,42,MG,1,Oral
2147,7536,IS_PRIMARY_SUSPECT,Bladder cancer,1200,MG,1,Intravenous drip
2148,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,280,MG,1,Oral
2149,8911,IS_PRIMARY_SUSPECT,Psoriasis,80,MG,1,Subcutaneous
2150,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
2152,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Unknown
2154,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
2155,8383,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,125,MG,1,Oral
2156,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2157,8173,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Unknown
2158,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,800,MG,1,Intravenous drip
2159,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
2160,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma recurrent,10,MG,1,Oral
2161,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2162,8489,IS_PRIMARY_SUSPECT,Long-chain acyl-coenzyme A dehydrogenase deficiency,20,ML,1,Oral
2163,8917,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subcutaneous
2164,7899,IS_PRIMARY_SUSPECT,Epithelioid mesothelioma,196,MG,1,Intravenous (not otherwise specified)
2165,7940,IS_PRIMARY_SUSPECT,Malignant melanoma,375,MG/M**2,1,Intravenous drip
2166,8918,IS_PRIMARY_SUSPECT,Plasma cell myeloma,60,MG,1,Oral
2167,8921,IS_PRIMARY_SUSPECT,Unknown,45,MG,1,Unknown
2168,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,100,ML,1,Intravenous (not otherwise specified)
2169,8681,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,0.75,MG,1,Subcutaneous
2170,8034,IS_PRIMARY_SUSPECT,Dyskinesia,137,MG,1,Oral
2171,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2172,8926,IS_PRIMARY_SUSPECT,Urinary tract infection,1,DF,1,Oral
2173,8174,IS_PRIMARY_SUSPECT,Sickle cell anaemia,275,MG,1,Intravenous (not otherwise specified)
2174,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2175,8810,IS_PRIMARY_SUSPECT,Contraception,17.5,UG,1,Intra-uterine
2176,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.7,MG,1,Unknown
2177,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
2178,7416,IS_PRIMARY_SUSPECT,Malignant peritoneal neoplasm,200,MG,1,Unknown
2179,7170,IS_PRIMARY_SUSPECT,Systemic lupus erythematosus,10,MG/KG,1,Transplacental
2180,8928,IS_PRIMARY_SUSPECT,Hypophosphatasia,120,MG,1,Subcutaneous
2181,8929,IS_PRIMARY_SUSPECT,Magnetic resonance imaging abdominal,20,ML,1,Intravenous (not otherwise specified)
2182,7354,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,75,MG,1,Oral
2183,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,75,MG,1,Oral
2184,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2185,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Subcutaneous
2186,8500,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
2187,7632,IS_PRIMARY_SUSPECT,Short stature,1.8,MG,1,Unknown
2188,8407,IS_PRIMARY_SUSPECT,Drug dependence,380,MG,1,Intramuscular
2189,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
2190,7411,IS_PRIMARY_SUSPECT,Psoriasis,30,MG,1,Oral
2191,8934,IS_PRIMARY_SUSPECT,Soft tissue neoplasm,200,MG,1,Oral
2192,8204,IS_PRIMARY_SUSPECT,Breast cancer,500,MG,1,Intravenous (not otherwise specified)
2193,8941,IS_PRIMARY_SUSPECT,Papillary thyroid cancer,100,MG,1,Oral
2194,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2195,8173,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Unknown
2196,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2197,7899,IS_PRIMARY_SUSPECT,Chordoma,41,MG,1,Intravenous (not otherwise specified)
2198,7176,IS_PRIMARY_SUSPECT,Carcinoid tumour,20,MG,1,Oral
2199,8558,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,0.25,MG,1,Subcutaneous
2200,7790,IS_PRIMARY_SUSPECT,Chronic kidney disease,6,G,1,Subcutaneous
2201,8404,IS_PRIMARY_SUSPECT,Weight decreased,1,DF,1,Oral
2202,8671,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
2203,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
2204,8175,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,5,MG,1,Subcutaneous
2205,7505,IS_PRIMARY_SUSPECT,Nerve compression,100,MG,1,Oral
2206,8367,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,10,IU,1,Subcutaneous
2207,8812,IS_PRIMARY_SUSPECT,Nephroblastoma,75,MG/M**2,1,Oral
2209,8948,IS_PRIMARY_SUSPECT,Lysosomal acid lipase deficiency,40,MG,1,Intravenous (not otherwise specified)
2210,8500,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,1,Subcutaneous
2211,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2212,7613,IS_PRIMARY_SUSPECT,Leiomyosarcoma,208,MG,1,Intravenous (not otherwise specified)
2213,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2214,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,20,MG,1,Subcutaneous
2215,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2216,8950,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,62.5,MG,1,Oral
2218,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2219,7918,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Subcutaneous
2220,8958,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,40,MG,1,Oral
2221,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
2222,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
2223,7993,IS_PRIMARY_SUSPECT,Recurrent cancer,170,MG,1,Oral
2224,8964,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,200,MG,1,Intravenous (not otherwise specified)
2225,7782,IS_PRIMARY_SUSPECT,Atrial fibrillation,15,MG,1,Oral
2226,8098,IS_PRIMARY_SUSPECT,Menopausal symptoms,2,MG,1,Unknown
2227,7334,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,10,G,1,Intravenous (not otherwise specified)
2228,8965,IS_PRIMARY_SUSPECT,Unknown,1,DF,4,Unknown
2230,7183,IS_PRIMARY_SUSPECT,Unknown,6.25,MG,1,Oral
2231,8335,IS_PRIMARY_SUSPECT,Cardiac failure,50,MG,1,Oral
2232,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
2233,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2234,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,1000,MG,1,Intravenous (not otherwise specified)
2235,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,889.2,MG,1,Intravenous (not otherwise specified)
2236,8381,IS_PRIMARY_SUSPECT,Iron deficiency anaemia,750,MG,1,Intravenous (not otherwise specified)
2237,7613,IS_PRIMARY_SUSPECT,Prostate cancer metastatic,3,MG/KG,1,Intravenous (not otherwise specified)
2238,8967,IS_PRIMARY_SUSPECT,Malignant melanoma,100,ML,1,Unknown
2239,8552,IS_PRIMARY_SUSPECT,Psychotic disorder,60,MG,1,Unknown
2240,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
2241,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2242,8970,IS_PRIMARY_SUSPECT,Seizure,200,MG,1,Oral
2243,8143,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,10,MG,1,Unknown
2244,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.3,MG,1,Oral
2245,7965,IS_PRIMARY_SUSPECT,Crohn's disease,520,MG,1,Intravenous (not otherwise specified)
2246,8838,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,200,MG,1,Unknown
2247,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2248,8737,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,125,MG,1,Subcutaneous
2250,8976,IS_PRIMARY_SUSPECT,Haematological malignancy,1297.5,MG,1,Intravenous (not otherwise specified)
2251,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2253,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2254,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
2255,7536,IS_PRIMARY_SUSPECT,Malignant melanoma,1200,MG,1,Intravenous drip
2257,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2258,8762,IS_PRIMARY_SUSPECT,Contraception,68,MG,1,Subdermal
2259,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2260,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
2261,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,120,MG,1,Oral
2262,7536,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,1200,MG,1,Intravenous drip
2263,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Intravenous drip
2264,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2265,8838,IS_PRIMARY_SUSPECT,Ankylosing spondylitis,400,MG,1,Subcutaneous
2266,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
2267,7536,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,1680,MG,1,Intravenous drip
2268,8660,IS_PRIMARY_SUSPECT,Factor VIII deficiency,175.8,MG,1,Subcutaneous
2269,8291,IS_PRIMARY_SUSPECT,B precursor type acute leukaemia,15,UG/M**2,1,Intravenous (not otherwise specified)
2270,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
2271,7278,IS_PRIMARY_SUSPECT,Psoriasis,40,MG,1,Subcutaneous
2278,8985,IS_PRIMARY_SUSPECT,Myelosuppression,465,MG,1,Intravenous (not otherwise specified)
2281,8991,IS_PRIMARY_SUSPECT,Skin swelling,0.5,MG,1,Cutaneous
2282,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Unknown
2283,7278,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,40,MG,1,Subcutaneous
2284,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Subcutaneous
2285,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2286,7922,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2287,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2288,9003,IS_PRIMARY_SUSPECT,Immunosuppression,0.92,MG,1,Other
2289,8174,IS_PRIMARY_SUSPECT,Sickle cell disease,5,MG/KG,1,Intravenous (not otherwise specified)
2290,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2291,7536,IS_PRIMARY_SUSPECT,Transitional cell carcinoma metastatic,1200,MG,1,Unknown
2292,8291,IS_PRIMARY_SUSPECT,B precursor type acute leukaemia,28,UG,1,Intravenous (not otherwise specified)
2293,9005,IS_PRIMARY_SUSPECT,Breast cancer metastatic,4.4,MG/KG,1,Intravenous (not otherwise specified)
2294,7411,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,30,MG,1,Oral
2295,8670,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,60,MG,1,Oral
2296,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2297,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2298,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2299,8004,IS_PRIMARY_SUSPECT,Depression,56,MG,1,Unknown
2300,9008,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis,52.2,MG,1,Intravenous (not otherwise specified)
2301,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2302,9009,IS_PRIMARY_SUSPECT,Tendonitis,2,ML,1,Intramuscular
2303,9009,IS_PRIMARY_SUSPECT,Tendon disorder,1,ML,1,Intramuscular
2304,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2305,9011,IS_PRIMARY_SUSPECT,T-cell type acute leukaemia,20,MG/KG,1,Intravenous (not otherwise specified)
2306,9013,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,5,UG,1,Subcutaneous
2307,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,150,UG,1,Intravenous bolus
2308,9014,IS_PRIMARY_SUSPECT,Hepatitis C,1,DF,1,Oral
2309,9009,IS_PRIMARY_SUSPECT,Posterior tibial nerve injury,1,ML,1,Intramuscular
2311,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG/KG,1,Subcutaneous
2312,8918,IS_PRIMARY_SUSPECT,Plasma cell myeloma,60,MG,1,Oral
2314,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
2315,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.33,ML,1,Subcutaneous
2316,7363,IS_PRIMARY_SUSPECT,Hormone replacement therapy,1,MG,1,Oral
2317,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2318,8241,IS_PRIMARY_SUSPECT,Colon cancer metastatic,15,MG,1,Oral
2319,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2320,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2321,7993,IS_PRIMARY_SUSPECT,Recurrent cancer,100,MG,1,Oral
2322,8557,IS_PRIMARY_SUSPECT,Unknown,100,MG,1,Subcutaneous
2323,8846,IS_PRIMARY_SUSPECT,Neuroendocrine tumour,7400,MBQ,1,Intravenous (not otherwise specified)
2324,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2325,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
2326,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,5800,IU,1,Subcutaneous
2327,8970,IS_PRIMARY_SUSPECT,Seizure,200,MG,1,Oral
2328,8872,IS_PRIMARY_SUSPECT,Transplant rejection,5,MG/KG,1,Intravenous (not otherwise specified)
2329,9019,IS_PRIMARY_SUSPECT,Diabetes mellitus,3,MG,1,Oral
2330,7502,IS_PRIMARY_SUSPECT,Ovarian cancer recurrent,60,MG,1,Oral
2331,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2332,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
2333,8004,IS_PRIMARY_SUSPECT,Depression,56,MG,1,Unknown
2334,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2335,8312,IS_PRIMARY_SUSPECT,Bipolar disorder,25,MG,1,Unknown
2336,8748,IS_PRIMARY_SUSPECT,Marginal zone lymphoma,800,MG,1,Oral
2340,7321,IS_PRIMARY_SUSPECT,Liver transplant,750,MG,2,Oral
2341,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
2342,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
2343,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
2344,9027,IS_PRIMARY_SUSPECT,Neuromyelitis optica spectrum disorder,300,MG,1,Intravenous (not otherwise specified)
2345,8197,IS_PRIMARY_SUSPECT,Migraine,240,MG,1,Subcutaneous
2346,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
2347,8671,IS_PRIMARY_SUSPECT,Pulmonary hypertension,10,MG,1,Oral
2348,8253,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2349,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,1,Oral
2350,7365,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
2351,7321,IS_PRIMARY_SUSPECT,Lupus nephritis,1500,MG,1,Oral
2352,7703,IS_PRIMARY_SUSPECT,Adenocarcinoma of colon,535.2,MG,1,Unknown
2354,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
2355,8872,IS_PRIMARY_SUSPECT,Renal transplant,312.5,MG,1,Intravenous (not otherwise specified)
2356,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2357,8838,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Subcutaneous
2358,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2359,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2360,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2362,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
2364,7496,IS_PRIMARY_SUSPECT,Primary progressive multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2365,9038,IS_PRIMARY_SUSPECT,Haemochromatosis,1500,MG,1,Oral
2366,8814,IS_PRIMARY_SUSPECT,Contraception,14,UG,1,Intra-uterine
2367,8950,IS_PRIMARY_SUSPECT,Pulmonary hypertension,125,MG,1,Oral
2368,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
2370,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2371,7613,IS_PRIMARY_SUSPECT,Pancreatic carcinoma,240,MG,1,Intravenous (not otherwise specified)
2372,7984,IS_PRIMARY_SUSPECT,Asthma,300,MG,1,Subcutaneous
2373,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2374,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Subcutaneous
2375,8253,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
2376,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
2377,8241,IS_PRIMARY_SUSPECT,Unknown,30,MG,1,Oral
2378,8737,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
2379,7646,IS_PRIMARY_SUSPECT,Dyslipidaemia,1,ML,1,Subcutaneous
2380,7278,IS_PRIMARY_SUSPECT,Crohn's disease,20,MG,1,Subcutaneous
2381,8508,IS_PRIMARY_SUSPECT,Hairy cell leukaemia,450,MG,1,Oral
2382,8748,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,600,MG,2,Oral
2383,7416,IS_PRIMARY_SUSPECT,Adenocarcinoma,100,MG,2,Oral
2384,9043,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,400,MG,2,Oral
2385,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2386,9044,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.5,MG/KG,1,Intravenous (not otherwise specified)
2387,8681,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,0.75,MG,1,Subcutaneous
2388,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
2389,7456,IS_PRIMARY_SUSPECT,Weight decreased,10,MG,1,Oral
2390,7335,IS_PRIMARY_SUSPECT,Pulmonary embolism,10,MG,1,Oral
2391,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2392,7613,IS_PRIMARY_SUSPECT,Leiomyosarcoma metastatic,158,MG,1,Intravenous (not otherwise specified)
2393,7536,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,1200,MG,1,Intravenous drip
2394,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2395,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Subcutaneous
2396,9048,IS_PRIMARY_SUSPECT,Migraine prophylaxis,75,MG,1,Oral
2397,8174,IS_PRIMARY_SUSPECT,Sickle cell disease,300,MG,1,Intravenous (not otherwise specified)
2398,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,15,G,1,Subcutaneous
2399,7416,IS_PRIMARY_SUSPECT,Pancreatic carcinoma,200,MG,1,Oral
2400,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
2401,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2402,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
2403,8970,IS_PRIMARY_SUSPECT,Seizure,200,MG,1,Oral
2404,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Intravenous (not otherwise specified)
2405,8513,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,5,MG,1,Oral
2411,7335,IS_PRIMARY_SUSPECT,Unknown,5,MG,1,Oral
2412,7333,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,132,MG,1,Intravenous (not otherwise specified)
2413,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2414,8884,IS_PRIMARY_SUSPECT,Mycobacterial infection,300,MG,1,Oral
2415,7930,IS_PRIMARY_SUSPECT,Hypertension,160,MG,1,Unknown
2416,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
2417,9061,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,50,MG,1,Subcutaneous
2418,8118,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.25,MG,1,Oral
2419,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2421,7940,IS_PRIMARY_SUSPECT,Mantle cell lymphoma,720,MG,1,Intravenous (not otherwise specified)
2422,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2423,9065,IS_PRIMARY_SUSPECT,Unknown,80,MG,1,Unknown
2424,7790,IS_PRIMARY_SUSPECT,Immunodeficiency,18,G,1,Subcutaneous
2425,8489,IS_PRIMARY_SUSPECT,Gene mutation,1.5,ML,1,Unknown
2426,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,36,MG,1,Subcutaneous
2427,8538,IS_PRIMARY_SUSPECT,Unknown,150,MG,1,Oral
2429,9078,IS_PRIMARY_SUSPECT,Nausea,300,MG,1,Oral
2430,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2431,8762,IS_PRIMARY_SUSPECT,Unknown,68,MG,1,Subdermal
2432,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,400,UG,1,Oral
2433,7918,IS_PRIMARY_SUSPECT,Ankylosing spondylitis,200,MG,1,Subcutaneous
2434,9079,IS_PRIMARY_SUSPECT,Multiple sclerosis,462,MG,1,Oral
2435,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2436,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2437,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,30,G,1,Intravenous (not otherwise specified)
2438,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2439,7782,IS_PRIMARY_SUSPECT,Pulmonary embolism,15,MG,1,Oral
2440,8335,IS_PRIMARY_SUSPECT,Unknown,50,MG,1,Oral
2441,8154,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,5,MG,1,Oral
2443,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,16000,MG,1,Intravenous (not otherwise specified)
2444,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1800,MG,1,Subcutaneous
2445,8646,IS_PRIMARY_SUSPECT,HER2 positive breast cancer,300,MG,1,Oral
2446,7995,IS_PRIMARY_SUSPECT,Follicular lymphoma,1000,MG,1,Intravenous (not otherwise specified)
2448,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2449,8204,IS_PRIMARY_SUSPECT,Endometrial cancer,500,MG,1,Unknown
2450,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,16,MG/KG,1,Intravenous (not otherwise specified)
2451,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2452,7314,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,2,DF,1,Oral
2453,7901,IS_PRIMARY_SUSPECT,Still's disease,300,MG,1,Subcutaneous
2454,8970,IS_PRIMARY_SUSPECT,Seizure,150,MG,1,Unknown
2455,9084,IS_PRIMARY_SUSPECT,Age-related macular degeneration,6,MG,1,Other
2456,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2457,7836,IS_PRIMARY_SUSPECT,Attention deficit hyperactivity disorder,60,MG,1,Unknown
2459,9087,IS_PRIMARY_SUSPECT,Colorectal cancer metastatic,80,MG,1,Unknown
2460,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2461,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
2462,7585,IS_PRIMARY_SUSPECT,Hypertension,10,MG,2,Oral
2463,7334,IS_PRIMARY_SUSPECT,Selective IgA immunodeficiency,70,G,1,Unknown
2464,7283,IS_PRIMARY_SUSPECT,Kaposi's sarcoma,4,MG,1,Oral
2465,8004,IS_PRIMARY_SUSPECT,Depression,56,MG,1,Unknown
2467,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
2468,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2469,8123,IS_PRIMARY_SUSPECT,Glycogen storage disease type II,1200,MG,1,Intravenous (not otherwise specified)
2470,8883,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,400,MG,2,Oral
2471,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2472,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.8,MG,1,Unknown
2473,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
2474,8069,IS_PRIMARY_SUSPECT,Non-24-hour sleep-wake disorder,20,MG,1,Oral
2475,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2476,9091,IS_PRIMARY_SUSPECT,Gallbladder cancer,2400,MG/M**2,1,Intravenous (not otherwise specified)
2477,7536,IS_PRIMARY_SUSPECT,Non-small cell lung cancer metastatic,1200,MG,1,Intravenous drip
2478,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
2479,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2480,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2481,7225,IS_PRIMARY_SUSPECT,30,AMPHETAMINE ASPARTATE\AMPHETAMINE SULFATE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE SULFATE,Oral,1, DEXTROAMPHET SULFATE AND AMPHET SULFAT
2482,7965,IS_PRIMARY_SUSPECT,Colitis ulcerative,90,MG,1,Subcutaneous
2483,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Intravenous drip
2484,8557,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,100,MG,1,Subcutaneous
2485,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2487,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2488,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
2490,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
2492,9095,IS_PRIMARY_SUSPECT,Renal cell carcinoma,5,MG,1,Oral
2493,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2494,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Subcutaneous
2496,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2498,7899,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,480,MG,1,Intravenous (not otherwise specified)
2499,9102,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,100,MG,1,Oral
2500,8735,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
2501,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2502,8004,IS_PRIMARY_SUSPECT,Depression,84,MG,1,Unknown
2503,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2504,7978,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,180,MG,4,Intravenous (not otherwise specified)
2505,7335,IS_PRIMARY_SUSPECT,Unknown,5,MG,1,Oral
2506,8204,IS_PRIMARY_SUSPECT,Neoplasm,500,MG,1,Intravenous (not otherwise specified)
2507,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
2508,7715,IS_PRIMARY_SUSPECT,Mycobacterium abscessus infection,100,MG,1,Oral
2509,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,201.6,MG,1,Intravenous (not otherwise specified)
2510,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
2512,7361,IS_PRIMARY_SUSPECT,Arthralgia,11,MG,1,Oral
2513,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,960,MG,1,Intravenous (not otherwise specified)
2514,7613,IS_PRIMARY_SUSPECT,Pancreatic carcinoma,240,MG,1,Intravenous (not otherwise specified)
2515,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2516,9112,IS_PRIMARY_SUSPECT,Sickle cell anaemia,400,MG,1,Intravenous (not otherwise specified)
2517,7920,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2518,8004,IS_PRIMARY_SUSPECT,Depression,84,MG,1,Unknown
2519,7335,IS_PRIMARY_SUSPECT,Deep vein thrombosis,5,MG,1,Oral
2520,7899,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,480,MG,1,Intravenous (not otherwise specified)
2521,7536,IS_PRIMARY_SUSPECT,Fallopian tube cancer,800,MG,1,Intravenous drip
2522,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
2523,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2524,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2525,9116,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,500,MG,1,Unknown
2526,7613,IS_PRIMARY_SUSPECT,B-cell lymphoma,3,MG/KG,1,Intravenous (not otherwise specified)
2527,9118,IS_PRIMARY_SUSPECT,Colon cancer,1500,MG,1,Oral
2528,8004,IS_PRIMARY_SUSPECT,Depression,56,MG,1,Unknown
2529,9011,IS_PRIMARY_SUSPECT,Plasma cell myeloma refractory,900,MG,1,Intravenous (not otherwise specified)
2530,8099,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,40,MG,1,Oral
2531,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2532,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2533,7502,IS_PRIMARY_SUSPECT,Plasma cell myeloma,60,MG,1,Unknown
2534,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2535,8796,IS_PRIMARY_SUSPECT,Psychiatric symptom,117,MG,1,Intramuscular
2536,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2538,9121,IS_PRIMARY_SUSPECT,Prophylaxis against transplant rejection,3,MG,1,Oral
2543,8681,IS_PRIMARY_SUSPECT,Glycosylated haemoglobin increased,0.75,MG,1,Unknown
2544,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
2545,7613,IS_PRIMARY_SUSPECT,Glioblastoma,3,MG/KG,1,Intravenous (not otherwise specified)
2546,7940,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,679,MG,3,Intravenous (not otherwise specified)
2547,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2548,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
2549,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
2550,9127,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,100,MG,1,Oral
2551,8365,IS_PRIMARY_SUSPECT,Prostate cancer,45,MG,1,Intramuscular
2552,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2553,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2554,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
2557,8517,IS_PRIMARY_SUSPECT,Breast cancer metastatic,8,MG,1,Oral
2558,8204,IS_PRIMARY_SUSPECT,Ovarian cancer,500,MG,1,Unknown
2559,9044,IS_PRIMARY_SUSPECT,Unknown,200,MG,1,Unknown
2561,8389,IS_PRIMARY_SUSPECT,Colonoscopy,24,DF,1,Oral
2562,8340,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,150,MG,1,Oral
2563,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2564,9134,IS_PRIMARY_SUSPECT,Prostate cancer,240,MG,1,Oral
2565,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,960,MG,1,Oral
2566,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
2567,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2568,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2569,8578,IS_PRIMARY_SUSPECT,Psoriasis,75,MG,1,Subcutaneous
2570,7862,IS_PRIMARY_SUSPECT,Asthma,600,MG,1,Subcutaneous
2572,7233,IS_PRIMARY_SUSPECT,Haemoglobin decreased,100,UG,1,Subcutaneous
2573,9139,IS_PRIMARY_SUSPECT,Oesophageal carcinoma,150,MG,1,Unknown
2574,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Subcutaneous
2575,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2576,7787,IS_PRIMARY_SUSPECT,Major depression,225,MG,1,Oral
2578,7632,IS_PRIMARY_SUSPECT,Blood glucose abnormal,1.6,MG,1,Unknown
2579,9141,IS_PRIMARY_SUSPECT,COVID-19,1400,MG,1,Intravenous (not otherwise specified)
2580,9143,IS_PRIMARY_SUSPECT,Blood potassium decreased,160,MG,1,Unknown
2581,9146,IS_PRIMARY_SUSPECT,Narcolepsy,8.9,MG,1,Oral
2582,8308,IS_PRIMARY_SUSPECT,Dyspnoea,180,Unknown,1,Respiratory (inhalation)
2583,9141,IS_PRIMARY_SUSPECT,COVID-19,1400,MG,1,Intravenous (not otherwise specified)
2584,7613,IS_PRIMARY_SUSPECT,Ovarian cancer,480,MG,1,Intravenous (not otherwise specified)
2585,7188,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1.3,MG/M**2,1,Intravenous (not otherwise specified)
2586,8468,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,90,MG,1,Oral
2587,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2588,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,5000,IU,1,Subcutaneous
2589,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2590,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
2591,8312,IS_PRIMARY_SUSPECT,Affective disorder,50,MG,1,Unknown
2593,8618,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,40,UG,1,Unknown
2594,8762,IS_PRIMARY_SUSPECT,Contraception,68,MG,1,Subdermal
2595,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
2596,8838,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Unknown
2597,7862,IS_PRIMARY_SUSPECT,Crohn's disease,300,MG,1,Subcutaneous
2598,7613,IS_PRIMARY_SUSPECT,Metastatic renal cell carcinoma,480,MG,1,Intravenous (not otherwise specified)
2599,7384,IS_PRIMARY_SUSPECT,Astrocytoma,0.025,MG/KG,1,Oral
2600,7278,IS_PRIMARY_SUSPECT,Crohn's disease,160,MG,1,Subcutaneous
2601,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2602,9148,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2603,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma recurrent,4,MG,1,Oral
2604,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2605,7994,IS_PRIMARY_SUSPECT,Chronic graft versus host disease,420,MG,1,Oral
2606,8729,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,60,G,1,Unknown
2609,9127,IS_PRIMARY_SUSPECT,Philadelphia positive chronic myeloid leukaemia,100,MG,1,Oral
2610,9009,IS_PRIMARY_SUSPECT,Arthralgia,1,ML,1,Intra-articular
2611,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
2612,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2613,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
2614,9154,IS_PRIMARY_SUSPECT,Erectile dysfunction,20,UG,1,Unknown
2616,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,2.2,MG,1,Unknown
2617,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2618,9155,IS_PRIMARY_SUSPECT,Computerised tomogram abdomen,110,ML,1,Intravenous (not otherwise specified)
2619,9155,IS_PRIMARY_SUSPECT,Computerised tomogram abdomen,110,ML,1,Intravenous (not otherwise specified)
2620,8076,IS_PRIMARY_SUSPECT,Heavy menstrual bleeding,20,UG,1,Intra-uterine
2622,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2623,9156,IS_PRIMARY_SUSPECT,Colorectal cancer metastatic,15,MG,1,Oral
2624,8189,IS_PRIMARY_SUSPECT,Unknown,140,MG,1,Unknown
2625,7863,IS_PRIMARY_SUSPECT,Hormone replacement therapy,0.1,MG,1,Transdermal
2626,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2627,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Unknown
2628,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2629,7790,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,24,G,1,Subcutaneous
2630,7613,IS_PRIMARY_SUSPECT,Ovarian clear cell carcinoma,480,MG,1,Intravenous (not otherwise specified)
2631,8240,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Oral
2633,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2634,7965,IS_PRIMARY_SUSPECT,Colitis,390,MG,1,Intravenous (not otherwise specified)
2635,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Unknown
2636,7536,IS_PRIMARY_SUSPECT,Ovarian cancer,800,MG,1,Intravenous drip
2637,7278,IS_PRIMARY_SUSPECT,Crohn's disease,80,MG,1,Subcutaneous
2638,8132,IS_PRIMARY_SUSPECT,Cerebrovascular accident,100,MG,1,Intravenous (not otherwise specified)
2639,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2642,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2644,7965,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,90,MG,1,Subcutaneous
2645,9141,IS_PRIMARY_SUSPECT,COVID-19,1400,MG,1,Intravenous (not otherwise specified)
2646,9161,IS_PRIMARY_SUSPECT,Insomnia,5,MG,1,Oral
2647,9162,IS_PRIMARY_SUSPECT,Ewing's sarcoma,800,MG,1,Oral
2649,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
2650,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2651,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2652,7437,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia recurrent,45,MG,1,Unknown
2653,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2654,7536,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,1200,MG,1,Intravenous (not otherwise specified)
2655,8099,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,60,MG,1,Oral
2656,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2657,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
2658,7883,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,70,MG,1,Intravenous (not otherwise specified)
2659,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,2.6,MG,1,Unknown
2662,8848,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,960,MG,1,Oral
2663,8592,IS_PRIMARY_SUSPECT,Computerised tomogram abdomen,500,ML,1,Oral
2664,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,3,MG/KG,2,Intravenous (not otherwise specified)
2665,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.8,MG,1,Unknown
2666,9061,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,50,MG,1,Subcutaneous
2667,7993,IS_PRIMARY_SUSPECT,B-cell lymphoma refractory,400,MG,1,Oral
2668,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,138,MG,1,Intravenous drip
2674,9169,IS_PRIMARY_SUSPECT,Unknown,250,MG,1,Unknown
2675,8228,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,1,DF,1,Intravenous (not otherwise specified)
2676,8557,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,100,MG,1,Unknown
2677,7882,IS_PRIMARY_SUSPECT,Immune system disorder,30,MG,21,Subcutaneous
2678,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2679,7685,IS_PRIMARY_SUSPECT,Neutropenia,6000,UG,1,Unknown
2680,7862,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,300,MG,1,Subcutaneous
2681,8855,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,300,MG,1,Intravenous (not otherwise specified)
2683,8541,IS_PRIMARY_SUSPECT,Lipodystrophy acquired,2.5,MG,1,Subcutaneous
2684,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2685,8670,IS_PRIMARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
2686,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,2,Intravenous (not otherwise specified)
2687,7536,IS_PRIMARY_SUSPECT,Endometrial cancer,1200,MG,1,Intravenous drip
2688,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2689,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,100,UG,1,Intravenous bolus
2690,7901,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,250,MG,1,Subcutaneous
2691,8848,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,120,MG,1,Oral
2692,7632,IS_PRIMARY_SUSPECT,Unknown,0.9,MG,1,Unknown
2693,7613,IS_PRIMARY_SUSPECT,Endometrial cancer stage IV,480,MG,1,Intravenous (not otherwise specified)
2695,7613,IS_PRIMARY_SUSPECT,Gastric cancer,240,MG,1,Intravenous (not otherwise specified)
2696,8847,IS_PRIMARY_SUSPECT,Diabetes mellitus,2,MG,1,Subcutaneous
2697,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2698,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2699,9134,IS_PRIMARY_SUSPECT,Hormone-dependent prostate cancer,240,MG,1,Oral
2700,8291,IS_PRIMARY_SUSPECT,B precursor type acute leukaemia,15,UG/M**2,1,Intravenous (not otherwise specified)
2702,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2703,7536,IS_PRIMARY_SUSPECT,Bile duct cancer,1200,MG,1,Intravenous (not otherwise specified)
2704,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
2705,7982,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,11,G,1,Subcutaneous
2706,8290,IS_PRIMARY_SUSPECT,Migraine,140,MG,1,Unknown
2707,8621,IS_PRIMARY_SUSPECT,Asthma,30,MG,1,Subcutaneous
2708,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
2709,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,200,UG,1,Intravenous bolus
2710,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,200,UG,1,Intravenous (not otherwise specified)
2711,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
2712,8174,IS_PRIMARY_SUSPECT,Sickle cell disease,5,MG/KG,1,Intravenous (not otherwise specified)
2713,9174,IS_PRIMARY_SUSPECT,Sickle cell anaemia with crisis,1500,MG,1,Oral
2714,8884,IS_PRIMARY_SUSPECT,Mycobacterial infection,300,MG,1,Oral
2715,8618,IS_PRIMARY_SUSPECT,Anaemia,500,UG,1,Unknown
2716,8918,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,60,MG,1,Oral
2717,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2718,8557,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,100,MG,1,Unknown
2720,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
2721,7734,IS_PRIMARY_SUSPECT,Triple positive breast cancer,150,MG,1,Unknown
2722,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2723,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2724,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
2725,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2726,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
2727,8399,IS_PRIMARY_SUSPECT,Unknown,1600,UG,1,Oral
2728,8565,IS_PRIMARY_SUSPECT,Depression,20,MG,1,Oral
2729,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2730,8558,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,1,MG,1,Subcutaneous
2731,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,20,MG,1,Oral
2732,8509,IS_PRIMARY_SUSPECT,Hairy cell leukaemia,300,MG,1,Oral
2733,8619,IS_PRIMARY_SUSPECT,Philadelphia positive chronic myeloid leukaemia,300,MG,1,Oral
2736,7278,IS_PRIMARY_SUSPECT,Psoriasis,40,MG,1,Subcutaneous
2737,7899,IS_PRIMARY_SUSPECT,Malignant melanoma,100,MG,1,Intravenous (not otherwise specified)
2738,8577,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,150,MG,1,Oral
2739,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2740,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
2741,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
2742,7782,IS_PRIMARY_SUSPECT,Atrial fibrillation,20,MG,1,Oral
2743,7178,IS_PRIMARY_SUSPECT,Trigeminal neuralgia,150,MG,1,Unknown
2744,7632,IS_PRIMARY_SUSPECT,Growth disorder,12,MG,1,Unknown
2745,7268,IS_PRIMARY_SUSPECT,Unknown,10,MG,1,Unknown
2746,8509,IS_PRIMARY_SUSPECT,Hairy cell leukaemia,450,MG,1,Oral
2747,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2748,7334,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
2749,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2750,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2751,7918,IS_PRIMARY_SUSPECT,Unknown,200,MG,1,Subcutaneous
2752,7278,IS_PRIMARY_SUSPECT,Ankylosing spondylitis,40,MG,1,Subcutaneous
2753,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2754,8240,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Oral
2755,8762,IS_PRIMARY_SUSPECT,Contraception,68,MG,1,Subdermal
2756,8451,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.7,MG,1,Subcutaneous
2757,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2758,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.4,MG,1,Unknown
2759,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2761,7993,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Oral
2762,7918,IS_PRIMARY_SUSPECT,Unknown,400,MG,1,Subcutaneous
2763,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2764,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.2,IU,1,Unknown
2765,7502,IS_PRIMARY_SUSPECT,Ovarian cancer recurrent,60,MG,1,Oral
2766,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
2767,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
2768,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
2769,8312,IS_PRIMARY_SUSPECT,Schizophrenia,100,MG,1,Oral
2770,8735,IS_PRIMARY_SUSPECT,Unknown,300,MG,1,Unknown
2771,8810,IS_PRIMARY_SUSPECT,Contraception,17.5,UG,1,Intra-uterine
2772,7335,IS_PRIMARY_SUSPECT,Unknown,5,MG,1,Oral
2773,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,160,MG,1,Subcutaneous
2775,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
2776,7496,IS_PRIMARY_SUSPECT,Multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2777,7176,IS_PRIMARY_SUSPECT,Bone marrow transplant,25,MG,1,Oral
2778,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1200,UG,1,Oral
2779,7965,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,45,MG,1,Subcutaneous
2780,8794,IS_PRIMARY_SUSPECT,Osteopenia,1,DF,1,Oral
2781,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
2782,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2783,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,960,MG,1,Oral
2784,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2785,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
2786,8848,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,960,MG,1,Oral
2787,8636,IS_PRIMARY_SUSPECT,Osteosarcoma,320,MG,1,Intravenous (not otherwise specified)
2788,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
2789,7278,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,40,MG,1,Subcutaneous
2790,8901,IS_PRIMARY_SUSPECT,Myasthenic syndrome,10,MG,1,Oral
2792,8901,IS_PRIMARY_SUSPECT,Myasthenic syndrome,10,MG,1,Oral
2795,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2796,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,240,MG,2,Intravenous (not otherwise specified)
2797,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,3,MG/KG,1,Intravenous (not otherwise specified)
2799,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
2800,8681,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,0.75,MG,1,Unknown
2801,8290,IS_PRIMARY_SUSPECT,Migraine,140,MG,1,Unknown
2805,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,600,MG,1,Subcutaneous
2806,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,480,MG,1,Unknown
2807,7685,IS_PRIMARY_SUSPECT,Neutropenia,6000,UG,1,Unknown
2808,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,420,MG,1,Unknown
2809,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,6000,IU,1,Subcutaneous
2810,7384,IS_PRIMARY_SUSPECT,Ovarian epithelial cancer,2,MG,1,Oral
2811,7233,IS_PRIMARY_SUSPECT,Nephrogenic anaemia,200,UG,1,Intravenous bolus
2812,9187,IS_PRIMARY_SUSPECT,Chronic obstructive pulmonary disease,1,DF,1,Respiratory (inhalation)
2813,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2814,7901,IS_PRIMARY_SUSPECT,Juvenile idiopathic arthritis,150,MG,1,Subcutaneous
2815,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,229.5,MG,1,Unknown
2816,7335,IS_PRIMARY_SUSPECT,Thrombosis prophylaxis,2.5,MG,1,Oral
2817,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2818,8817,IS_PRIMARY_SUSPECT,Iron deficiency,100,MG,1,Unknown
2820,8670,IS_PRIMARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
2821,9048,IS_PRIMARY_SUSPECT,Migraine without aura,75,MG,1,Unknown
2822,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
2824,7590,IS_PRIMARY_SUSPECT,Depression,300,MG,1,Oral
2825,7188,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.625,MG,1,Subcutaneous
2827,8004,IS_PRIMARY_SUSPECT,Depression,56,MG,1,Unknown
2828,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Unknown
2829,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
2830,8014,IS_PRIMARY_SUSPECT,Unknown,140,MG,1,Oral
2832,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,750,MG,1,Intravenous (not otherwise specified)
2835,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
2836,8249,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
2837,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
2838,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2839,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
2840,9205,IS_PRIMARY_SUSPECT,Diabetes mellitus,500,MG,1,Oral
2841,9206,IS_PRIMARY_SUSPECT,Obesity,2.4,MG,1,Subcutaneous
2842,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
2843,9207,IS_PRIMARY_SUSPECT,Ovarian cancer metastatic,600,MG/M**2,1,Intravenous (not otherwise specified)
2844,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2845,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2846,7678,IS_PRIMARY_SUSPECT,Seizure,500,MG,1,Unknown
2847,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
2848,7531,IS_PRIMARY_SUSPECT,Hypothyroidism,88,UG,1,Oral
2849,9212,IS_PRIMARY_SUSPECT,Irritable bowel syndrome,2,MG,1,Oral
2850,7284,IS_PRIMARY_SUSPECT,Analgesic therapy,30,UG/KG,1,Intravenous (not otherwise specified)
2851,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
2852,7965,IS_PRIMARY_SUSPECT,Psoriasis,45,MG,1,Subcutaneous
2853,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
2854,7920,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2855,7365,IS_PRIMARY_SUSPECT,Pulmonary embolism,5,MG,1,Oral
2858,9220,IS_PRIMARY_SUSPECT,Drug withdrawal syndrome,0.18,MG,48,Oral
2859,7944,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
2860,7360,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2862,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
2863,7944,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
2864,9226,IS_PRIMARY_SUSPECT,Pancreatic failure,36000,IU,1,Oral
2865,8174,IS_PRIMARY_SUSPECT,Sickle cell anaemia with crisis,5,MG/KG,1,Intravenous (not otherwise specified)
2866,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,20,MG,1,Subcutaneous
2867,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
2868,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
2869,9227,IS_PRIMARY_SUSPECT,Glioblastoma multiforme,15,MG/KG,1,Intravenous (not otherwise specified)
2870,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2871,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2872,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2873,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
2874,7944,IS_PRIMARY_SUSPECT,Pulmonary hypertension,10,MG,1,Oral
2876,8407,IS_PRIMARY_SUSPECT,Drug use disorder,380,MG,1,Intramuscular
2877,7247,IS_PRIMARY_SUSPECT,Unknown,800,MG,1,Unknown
2878,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
2879,7536,IS_PRIMARY_SUSPECT,Skin cancer,1200,MG,1,Intravenous (not otherwise specified)
2880,7613,IS_PRIMARY_SUSPECT,Central nervous system lymphoma,240,MG,1,Intravenous (not otherwise specified)
2881,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,2.4,MG,1,Unknown
2882,7176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,20,MG,1,Oral
2883,9141,IS_PRIMARY_SUSPECT,COVID-19,1400,MG,1,Intravenous (not otherwise specified)
2884,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
2887,9112,IS_PRIMARY_SUSPECT,Sickle cell disease,5,MG/KG,1,Intravenous (not otherwise specified)
2888,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2889,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2890,8174,IS_PRIMARY_SUSPECT,Sickle cell anaemia with crisis,5,MG/KG,1,Intravenous (not otherwise specified)
2891,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,420,MG,1,Unknown
2892,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
2893,7262,IS_PRIMARY_SUSPECT,Herpes zoster,100,MG,1,Unknown
2894,8557,IS_PRIMARY_SUSPECT,Unknown,100,MG,1,Unknown
2895,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
2896,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2897,8848,IS_PRIMARY_SUSPECT,Colorectal adenocarcinoma,960,MG,1,Oral
2898,8883,IS_PRIMARY_SUSPECT,Lung carcinoma cell type unspecified stage IV,200,MG,1,Oral
2899,7519,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,166,MG,1,Intravenous drip
2901,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
2902,8896,IS_PRIMARY_SUSPECT,Multiple sclerosis,44,UG,1,Subcutaneous
2903,9236,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,600000,IU/KG,1,Intravenous (not otherwise specified)
2904,7683,IS_PRIMARY_SUSPECT,Plasma cell myeloma,16,MG/KG,1,Intravenous (not otherwise specified)
2905,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis II,0.5,MG,1,Intravenous (not otherwise specified)
2906,7965,IS_PRIMARY_SUSPECT,Colitis ulcerative,520,MG,1,Intravenous (not otherwise specified)
2908,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2909,8236,IS_PRIMARY_SUSPECT,Ovarian cancer metastatic,200,MG,1,Oral
2910,9239,IS_PRIMARY_SUSPECT,Arthralgia,5,PCT,1,Cutaneous
2912,7361,IS_PRIMARY_SUSPECT,Arthritis,11,MG,1,Unknown
2913,8173,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,300,MG,1,Subcutaneous
2914,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.2,MG,1,Unknown
2915,7860,IS_PRIMARY_SUSPECT,Non-small cell lung cancer metastatic,20,MG,1,Oral
2917,8350,IS_PRIMARY_SUSPECT,Unknown,85,MG,1,Intravenous drip
2918,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
2919,8670,IS_PRIMARY_SUSPECT,Renal cancer,40,MG,1,Oral
2920,7613,IS_PRIMARY_SUSPECT,Bladder cancer,360,MG,2,Intravenous (not otherwise specified)
2921,7982,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,10,G,1,Subcutaneous
2922,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,5.1,MG,1,Unknown
2925,7611,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis IV,100,MG,1,Intravenous (not otherwise specified)
2926,9156,IS_PRIMARY_SUSPECT,Colon cancer,60,MG,1,Oral
2927,8812,IS_PRIMARY_SUSPECT,Hormone receptor positive HER2 negative breast cancer,125,MG,1,Oral
2928,8201,IS_PRIMARY_SUSPECT,Amyloidosis,61,MG,1,Oral
2929,7920,IS_PRIMARY_SUSPECT,Follicular lymphoma,20,MG,1,Oral
2930,9252,IS_PRIMARY_SUSPECT,Unknown,840,MG,1,Intravenous (not otherwise specified)
2931,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2932,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
2935,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
2937,8189,IS_PRIMARY_SUSPECT,Unknown,140,MG,1,Unknown
2938,7646,IS_PRIMARY_SUSPECT,Dyslipidaemia,140,MG,1,Subcutaneous
2939,7278,IS_PRIMARY_SUSPECT,Crohn's disease,20,MG,1,Subcutaneous
2940,8773,IS_PRIMARY_SUSPECT,Unknown,60,MG,1,Unknown
2943,7539,IS_PRIMARY_SUSPECT,B-cell lymphoma,575,MG,5,Unknown
2944,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
2945,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
2946,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2947,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
2948,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Subcutaneous
2950,8335,IS_PRIMARY_SUSPECT,Cardiomyopathy,50,MG,1,Oral
2951,7632,IS_PRIMARY_SUSPECT,Septo-optic dysplasia,5,MG,1,Unknown
2952,8917,IS_PRIMARY_SUSPECT,Unknown,104,MG,1,Unknown
2953,8917,IS_PRIMARY_SUSPECT,Contraception,104,MG,1,Subcutaneous
2954,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,2.4,MG,1,Unknown
2955,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2956,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2957,8224,IS_PRIMARY_SUSPECT,Endometriosis,1,DF,1,Oral
2958,8222,IS_PRIMARY_SUSPECT,Angioedema,2500,IU,1,Unknown
2959,8766,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,0.92,MG,1,Oral
2960,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
2961,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.2,ML,1,Unknown
2962,8253,IS_PRIMARY_SUSPECT,Primary progressive multiple sclerosis,260,ML,2,Intravenous (not otherwise specified)
2964,7662,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,990,MG,1,Intravenous (not otherwise specified)
2966,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
2967,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.25,ML,1,Subcutaneous
2968,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2969,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2971,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
2972,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
2973,7632,IS_PRIMARY_SUSPECT,Turner's syndrome,3,MG,1,Unknown
2977,9261,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Sublingual
2978,7613,IS_PRIMARY_SUSPECT,Squamous cell carcinoma of head and neck,480,MG,1,Intravenous (not otherwise specified)
2979,8917,IS_PRIMARY_SUSPECT,Contraception,104,MG,1,Subcutaneous
2980,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
2982,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
2983,7994,IS_PRIMARY_SUSPECT,Central nervous system lymphoma,560,MG,1,Oral
2984,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Intravenous drip
2985,9265,IS_PRIMARY_SUSPECT,Unknown,400,MG,1,Intramuscular
2986,7918,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Subcutaneous
2987,8118,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.25,MG,1,Oral
2988,8531,IS_PRIMARY_SUSPECT,Endometrial cancer metastatic,5,MG,2,Oral
2990,9148,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
2991,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
2993,9267,IS_PRIMARY_SUSPECT,Malignant atrophic papulosis,1200,MG,1,Intravenous (not otherwise specified)
2995,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
2996,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
2997,9268,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,10,MG/KG,1,Intravenous (not otherwise specified)
2998,7476,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,14,ML,1,Intravenous (not otherwise specified)
2999,8747,IS_PRIMARY_SUSPECT,Pain,160,MG,1,Topical
3000,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3001,7401,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG/M**2,1,Intravenous (not otherwise specified)
3002,8762,IS_PRIMARY_SUSPECT,Menstrual cycle management,68,MG,1,Subdermal
3003,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
3005,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3006,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
3007,9268,IS_PRIMARY_SUSPECT,Neoplasm,67.1,MG,1,Intravenous (not otherwise specified)
3008,8378,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,45,MG,1,Unknown
3009,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
3010,7176,IS_PRIMARY_SUSPECT,Neoplasm malignant,25,MG,1,Oral
3011,8189,IS_PRIMARY_SUSPECT,Unknown,140,MG,1,Unknown
3012,8240,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Oral
3013,7945,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,12,MG,1,Intrathecal
3014,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
3015,8990,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,120,MG,1,Subcutaneous
3016,9269,IS_PRIMARY_SUSPECT,Osteoporosis postmenopausal,210,MG,1,Subcutaneous
3017,8468,IS_PRIMARY_SUSPECT,Lung cancer metastatic,180,MG,1,Unknown
3018,7733,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,600,MG,1,Oral
3019,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3020,9270,IS_PRIMARY_SUSPECT,Schizophrenia,819,MG,1,Intramuscular
3021,8858,IS_PRIMARY_SUSPECT,Schizophrenia,42,MG,1,Oral
3023,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
3024,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,480,MG,1,Oral
3026,7876,IS_PRIMARY_SUSPECT,Plasma cell myeloma,16,MG/KG,1,Intravenous (not otherwise specified)
3027,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3028,9275,IS_PRIMARY_SUSPECT,Seizure,500,MG,1,Oral
3029,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
3030,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,400,UG,1,Oral
3031,8838,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Subcutaneous
3032,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
3033,9276,IS_PRIMARY_SUSPECT,Unknown,1800,MG,1,Intravenous (not otherwise specified)
3034,7401,IS_PRIMARY_SUSPECT,Plasma cell myeloma,27,MG/M**2,1,Intravenous (not otherwise specified)
3035,8848,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,960,MG,1,Oral
3036,7502,IS_PRIMARY_SUSPECT,Chronic myelomonocytic leukaemia,60,MG,1,Oral
3037,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3039,9279,IS_PRIMARY_SUSPECT,Osteoporosis,20,UG,1,Subcutaneous
3040,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3041,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
3043,9141,IS_PRIMARY_SUSPECT,COVID-19,1400,MG,1,Intravenous (not otherwise specified)
3044,9141,IS_PRIMARY_SUSPECT,COVID-19,1400,MG,1,Intravenous (not otherwise specified)
3045,8290,IS_PRIMARY_SUSPECT,Migraine prophylaxis,70,MG,1,Unknown
3046,9061,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,50,MG,1,Subcutaneous
3047,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,5,MG,1,Intravenous (not otherwise specified)
3048,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3049,8812,IS_PRIMARY_SUSPECT,Hormone receptor negative HER2 positive breast cancer,125,MG,1,Oral
3050,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1200,UG,1,Oral
3051,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3052,8848,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,960,MG,1,Oral
3053,8610,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
3054,9293,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,40,MG,1,Unknown
3055,7632,IS_PRIMARY_SUSPECT,Blood growth hormone abnormal,0.2,MG,1,Unknown
3059,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3063,8228,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma unspecified histology indolent,68,ML,1,Intravenous (not otherwise specified)
3065,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Intravenous (not otherwise specified)
3066,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3067,7334,IS_PRIMARY_SUSPECT,Myasthenia gravis,10,G,1,Intravenous (not otherwise specified)
3068,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3069,8848,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,960,MG,1,Oral
3071,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3072,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3073,8671,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
3074,7452,IS_PRIMARY_SUSPECT,Hyperkalaemia,8.4,G,1,Oral
3075,7685,IS_PRIMARY_SUSPECT,Prophylaxis,6,MG,1,Unknown
3076,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
3077,9299,IS_PRIMARY_SUSPECT,Breast cancer,3.6,MG/KG,1,Intravenous (not otherwise specified)
3078,8650,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,9800,MG,1,Intravenous (not otherwise specified)
3079,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
3080,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3081,9300,IS_PRIMARY_SUSPECT,Unknown,4,G,1,Oral
3082,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Unknown
3083,9148,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3084,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3085,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3086,7883,IS_PRIMARY_SUSPECT,Plasma cell myeloma,60,MG,1,Intravenous (not otherwise specified)
3087,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
3088,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
3089,9301,IS_PRIMARY_SUSPECT,Non-small cell lung cancer metastatic,350,MG,1,Intravenous (not otherwise specified)
3090,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
3091,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome unclassifiable,5,MG,1,Oral
3093,7685,IS_PRIMARY_SUSPECT,Prophylaxis,6,UG,1,Unknown
3094,9239,IS_PRIMARY_SUSPECT,Back pain,5,PCT,1,Cutaneous
3095,7176,IS_PRIMARY_SUSPECT,Mantle cell lymphoma,20,MG,1,Oral
3096,8189,IS_PRIMARY_SUSPECT,Hypercholesterolaemia,140,MG,1,Unknown
3097,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3099,7179,IS_PRIMARY_SUSPECT,Fabry's disease,65,MG,1,Intravenous (not otherwise specified)
3100,7254,IS_PRIMARY_SUSPECT,Unknown,0.279,ML,1,Other
3101,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1,MG,1,Oral
3102,7613,IS_PRIMARY_SUSPECT,Oropharyngeal cancer,240,MG,1,Intravenous (not otherwise specified)
3103,8290,IS_PRIMARY_SUSPECT,Unknown,140,MG,1,Unknown
3104,8348,IS_PRIMARY_SUSPECT,Plasma cell myeloma,60,MG,1,Intravenous (not otherwise specified)
3105,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,40,MG,1,Subcutaneous
3106,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
3107,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1100,MG,1,Unknown
3109,8830,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Oral
3110,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
3111,9304,IS_PRIMARY_SUSPECT,Renal disorder,500,MG,1,Oral
3112,7995,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,1000,MG,1,Intravenous (not otherwise specified)
3113,8870,IS_PRIMARY_SUSPECT,Migraine,225,MG,1,Unknown
3114,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
3115,8622,IS_PRIMARY_SUSPECT,Myasthenia gravis,20,G,1,Subcutaneous
3116,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
3117,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Subcutaneous
3118,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
3119,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3120,8004,IS_PRIMARY_SUSPECT,Depression,84,MG,1,Unknown
3121,7818,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,1075,MG,1,Intravenous (not otherwise specified)
3122,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
3123,9044,IS_PRIMARY_SUSPECT,Plasma cell myeloma,193.25,MG,1,Intravenous (not otherwise specified)
3124,8218,IS_PRIMARY_SUSPECT,Immune thrombocytopenia,900,MG,1,Intravenous (not otherwise specified)
3125,9305,IS_PRIMARY_SUSPECT,Rhesus antigen negative,300,UG,1,Unknown
3126,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3128,7176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,20,MG,1,Oral
3129,8766,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,0.92,MG,1,Oral
3130,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.5,MG,1,Oral
3131,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3132,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
3133,9306,IS_PRIMARY_SUSPECT,Ovarian cancer,600,MG,1,Unknown
3134,7536,IS_PRIMARY_SUSPECT,K-ras gene mutation,1200,MG,1,Intravenous drip
3135,8859,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3136,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3139,8621,IS_PRIMARY_SUSPECT,Asthma,30,MG,1,Subcutaneous
3140,7334,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,50,G,1,Intravenous (not otherwise specified)
3142,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subcutaneous
3143,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3144,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3145,8670,IS_PRIMARY_SUSPECT,Renal cell carcinoma,40,MG,1,Unknown
3146,7537,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,631,MG,1,Intravenous (not otherwise specified)
3147,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,20,MG,1,Subcutaneous
3148,7440,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,40,MG,1,Oral
3149,8247,IS_PRIMARY_SUSPECT,Depression,50,MG,1,Oral
3151,7365,IS_PRIMARY_SUSPECT,Deep vein thrombosis,5,MG,1,Oral
3152,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3153,7162,IS_PRIMARY_SUSPECT,Unknown,0.5,DF,1,Unknown
3154,7883,IS_PRIMARY_SUSPECT,B-cell lymphoma,52.5,MG,1,Intravenous (not otherwise specified)
3155,7955,IS_PRIMARY_SUSPECT,Insomnia,0.25,MG,1,Oral
3156,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,1440,MG,1,Unknown
3157,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
3158,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3159,7176,IS_PRIMARY_SUSPECT,Lymphoma,10,MG,1,Oral
3160,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3161,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3162,8557,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,100,MG,1,Subcutaneous
3163,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3165,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3166,8416,IS_PRIMARY_SUSPECT,Allergy to arthropod sting,0.3,MG,1,Unknown
3168,7243,IS_PRIMARY_SUSPECT,Hodgkin's disease,1.8,MG/KG,1,Intravenous (not otherwise specified)
3169,9314,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma recurrent,68,ML,1,Intravenous (not otherwise specified)
3170,9315,IS_PRIMARY_SUSPECT,Peripheral arterial occlusive disease,0.1,MG,1,Unknown
3171,7918,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,400,MG,1,Subcutaneous
3172,7782,IS_PRIMARY_SUSPECT,Embolism venous,20,MG,1,Oral
3173,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
3176,7176,IS_PRIMARY_SUSPECT,Monoclonal gammopathy,10,MG,1,Oral
3181,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
3182,9061,IS_PRIMARY_SUSPECT,Colitis ulcerative,100,MG,1,Subcutaneous
3183,8353,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,80,MG,1,Oral
3185,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3186,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3187,7918,IS_PRIMARY_SUSPECT,Ankylosing spondylitis,200,MG,1,Unknown
3188,7993,IS_PRIMARY_SUSPECT,Follicular lymphoma,800,MG,1,Oral
3190,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
3195,9156,IS_PRIMARY_SUSPECT,Colon cancer,60,MG,1,Oral
3196,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Unknown
3197,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Unknown
3198,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
3199,9297,IS_PRIMARY_SUSPECT,Thrombocytopenia,20,MG,1,Oral
3201,7255,IS_PRIMARY_SUSPECT,Crohn's disease,300,MG,1,Intravenous (not otherwise specified)
3202,8172,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
3203,8240,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,400,MG,1,Oral
3204,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3205,8773,IS_PRIMARY_SUSPECT,Osteoporosis postmenopausal,60,MG,1,Subcutaneous
3206,8247,IS_PRIMARY_SUSPECT,Major depression,100,MG,1,Oral
3208,7176,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,10,MG,1,Oral
3209,9031,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,0.5,MG,1,Oral
3210,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
3211,7993,IS_PRIMARY_SUSPECT,Follicular lymphoma,800,MG,1,Oral
3212,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
3213,7334,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,60,G,1,Intravenous (not otherwise specified)
3214,7334,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
3215,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3216,7498,IS_PRIMARY_SUSPECT,Pain,75,UG,1,Buccal
3217,9322,IS_PRIMARY_SUSPECT,Eye infection toxoplasmal,200,MG,1,Oral
3218,9322,IS_PRIMARY_SUSPECT,Cerebral toxoplasmosis,75,MG,1,Oral
3219,7883,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,64.5,MG,1,Intravenous (not otherwise specified)
3220,8004,IS_PRIMARY_SUSPECT,Depression,84,MG,1,Unknown
3222,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3223,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,0.2,MG,1,Unknown
3224,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
3225,9327,IS_PRIMARY_SUSPECT,Myalgia,5,PCT,1,Topical
3226,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
3227,8917,IS_PRIMARY_SUSPECT,Contraception,150,MG,1,Intramuscular
3228,8917,IS_PRIMARY_SUSPECT,Contraception,150,MG,1,Intramuscular
3229,8917,IS_PRIMARY_SUSPECT,Contraception,150,MG,1,Intramuscular
3230,8610,IS_PRIMARY_SUSPECT,Unknown,125,MG,1,Subcutaneous
3232,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3233,7498,IS_PRIMARY_SUSPECT,Pain,75,UG,1,Buccal
3234,9329,IS_PRIMARY_SUSPECT,Schizophrenia,882,MG,1,Intramuscular
3235,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3236,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
3237,9333,IS_PRIMARY_SUSPECT,Adenomatous polyposis coli,1,ML,1,Subcutaneous
3238,8911,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,80,MG,1,Subcutaneous
3240,9297,IS_PRIMARY_SUSPECT,Thrombocytopenia,20,MG,1,Oral
3241,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3242,7996,IS_PRIMARY_SUSPECT,Polyneuropathy,50,G,1,Unknown
3243,8801,IS_PRIMARY_SUSPECT,Hereditary angioedema,150,MG,1,Oral
3244,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3246,7498,IS_PRIMARY_SUSPECT,Pain,300,UG,1,Buccal
3247,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
3248,8636,IS_PRIMARY_SUSPECT,Neoplasm,118.2,ML,1,Intravenous (not otherwise specified)
3250,8917,IS_PRIMARY_SUSPECT,Contraception,150,MG,1,Intramuscular
3253,8838,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Unknown
3254,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3255,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
3256,7280,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,125,MG,1,Oral
3257,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3258,7352,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia recurrent,0.4,MG/M**2,1,Intravenous (not otherwise specified)
3259,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3260,8660,IS_PRIMARY_SUSPECT,Factor VIII deficiency,330,MG,1,Subcutaneous
3261,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
3262,7918,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,200,MG,1,Subcutaneous
3265,8796,IS_PRIMARY_SUSPECT,Schizophrenia,234,MG,1,Intramuscular
3266,7613,IS_PRIMARY_SUSPECT,Uveal melanoma,240,MG,1,Intravenous (not otherwise specified)
3267,7662,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,930,MG,1,Unknown
3269,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3271,9134,IS_PRIMARY_SUSPECT,Prostate cancer,240,MG,1,Oral
3273,8870,IS_PRIMARY_SUSPECT,Migraine,225,MG,1,Unknown
3274,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3276,8518,IS_PRIMARY_SUSPECT,Bone density decreased,5,MG,1,Unknown
3277,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
3278,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3279,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Unknown
3281,7394,IS_PRIMARY_SUSPECT,Dementia,10,MG,1,Oral
3282,7176,IS_PRIMARY_SUSPECT,Pseudolymphoma,25,MG,1,Oral
3283,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
3284,7411,IS_PRIMARY_SUSPECT,Unknown,30,MG,1,Oral
3285,9127,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,100,MG,1,Oral
3286,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3287,9340,IS_PRIMARY_SUSPECT,Clostridium difficile infection,875,MG,1,Intravenous (not otherwise specified)
3288,7171,IS_PRIMARY_SUSPECT,Chronic graft versus host disease,70,MG,1,Oral
3289,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3290,7298,IS_PRIMARY_SUSPECT,Pyrexia,1,DF,1,Unknown
3291,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3292,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3293,8184,IS_PRIMARY_SUSPECT,Cystic fibrosis,1,MG,1,Unknown
3294,9343,IS_PRIMARY_SUSPECT,Nasal congestion,2400,MG,1,Oral
3295,7432,IS_PRIMARY_SUSPECT,Renal transplant,250,MG,1,Oral
3296,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
3297,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3298,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3299,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3300,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3302,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
3303,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3304,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3305,8917,IS_PRIMARY_SUSPECT,Contraception,150,MG,1,Intramuscular
3306,7685,IS_PRIMARY_SUSPECT,Unknown,6,MG,1,Unknown
3307,7176,IS_PRIMARY_SUSPECT,Mantle cell lymphoma,15,MG,1,Oral
3308,7190,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.8,MG,1,Subcutaneous
3309,7853,IS_PRIMARY_SUSPECT,Eczema,600,MG,1,Subcutaneous
3310,7496,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
3312,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
3313,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3314,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3315,7832,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,35,G,1,Intravenous (not otherwise specified)
3316,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3317,8353,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,801,MG,1,Oral
3318,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3319,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
3320,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3321,7586,IS_PRIMARY_SUSPECT,Atrial fibrillation,0.25,MG,1,Unknown
3322,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,960,MG,1,Oral
3326,8451,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.57,MG,1,Subcutaneous
3327,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,480,MG,1,Intravenous (not otherwise specified)
3328,7365,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
3329,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
3330,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
3331,7632,IS_PRIMARY_SUSPECT,Blood growth hormone abnormal,0.5,MG,1,Unknown
3332,7632,IS_PRIMARY_SUSPECT,Unknown,0.2,MG,1,Unknown
3333,7632,IS_PRIMARY_SUSPECT,Hypothalamo-pituitary disorder,0.4,MG,1,Unknown
3334,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3335,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
3336,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3337,7230,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Unknown
3338,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
3339,7862,IS_PRIMARY_SUSPECT,Eczema,300,MG,1,Subcutaneous
3340,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
3342,7613,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,204,MG,1,Intravenous (not otherwise specified)
3343,8483,IS_PRIMARY_SUSPECT,Parkinson's disease,100,ML,1,Other
3344,8557,IS_PRIMARY_SUSPECT,Unknown,100,MG,1,Subcutaneous
3347,7255,IS_PRIMARY_SUSPECT,Colitis ulcerative,300,MG,1,Intravenous (not otherwise specified)
3348,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3349,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3350,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
3351,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3352,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
3353,7411,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,30,MG,1,Oral
3354,7685,IS_PRIMARY_SUSPECT,Neutropenia,6000,UG,1,Unknown
3355,9127,IS_PRIMARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,140,MG,1,Oral
3356,9297,IS_PRIMARY_SUSPECT,Thrombocytopenia,20,MG,1,Oral
3357,9352,IS_PRIMARY_SUSPECT,Iron deficiency anaemia,1000,MG,1,Intravenous (not otherwise specified)
3358,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3359,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3360,8290,IS_PRIMARY_SUSPECT,Migraine prophylaxis,70,MG,1,Unknown
3361,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
3362,8773,IS_PRIMARY_SUSPECT,Osteoporosis postmenopausal,60,MG,1,Subcutaneous
3363,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3365,9353,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Unknown
3366,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
3368,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3369,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,5,MG,1,Oral
3371,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3372,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
3373,7918,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,400,MG,1,Subcutaneous
3374,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
3375,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3376,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3377,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,2.5,MG,1,Oral
3378,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3379,8932,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,20,IU,1,Unknown
3380,8224,IS_PRIMARY_SUSPECT,Uterine leiomyoma,1,DF,1,Oral
3381,9356,IS_PRIMARY_SUSPECT,Depression,150,MG,1,Oral
3383,8846,IS_PRIMARY_SUSPECT,Phaeochromocytoma,200,MCI,1,Intravenous (not otherwise specified)
3384,7335,IS_PRIMARY_SUSPECT,Thrombosis,5,MG,1,Oral
3386,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3387,7632,IS_PRIMARY_SUSPECT,Short stature,0.2,MG,1,Unknown
3388,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,0.6,MG,1,Unknown
3389,7613,IS_PRIMARY_SUSPECT,Prostate cancer,3,MG/KG,1,Intravenous (not otherwise specified)
3390,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3391,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3392,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,1472,MG,1,Unknown
3393,7498,IS_PRIMARY_SUSPECT,Pain,150,UG,1,Buccal
3394,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,200,UG,1,Oral
3395,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
3396,8775,IS_PRIMARY_SUSPECT,Pulmonary hypertension,1600,UG,1,Oral
3397,7498,IS_PRIMARY_SUSPECT,Pain,300,UG,1,Buccal
3398,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3399,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3400,9329,IS_PRIMARY_SUSPECT,Schizoaffective disorder bipolar type,1064,MG,1,Intramuscular
3401,9329,IS_PRIMARY_SUSPECT,Schizoaffective disorder depressive type,662,MG,1,Intramuscular
3402,7553,IS_PRIMARY_SUSPECT,Barrett's oesophagus,15,MG,1,Unknown
3403,7955,IS_PRIMARY_SUSPECT,Unknown,5,MG,1,Unknown
3404,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3405,8762,IS_PRIMARY_SUSPECT,Unknown,68,MG,1,Subdermal
3406,7196,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Oral
3407,7498,IS_PRIMARY_SUSPECT,Pain,300,UG,1,Buccal
3408,7498,IS_PRIMARY_SUSPECT,Pain,900,UG,1,Buccal
3409,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3410,7393,IS_PRIMARY_SUSPECT,Constipation,17,G,1,Oral
3411,8004,IS_PRIMARY_SUSPECT,Depression,56,MG,1,Unknown
3412,8929,IS_PRIMARY_SUSPECT,Magnetic resonance imaging head,15,ML,1,Unknown
3413,8929,IS_PRIMARY_SUSPECT,Magnetic resonance imaging head,15,ML,1,Intravenous (not otherwise specified)
3415,7176,IS_PRIMARY_SUSPECT,Monoclonal gammopathy,15,MG,1,Oral
3416,8446,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3417,8762,IS_PRIMARY_SUSPECT,Unknown,68,MG,1,Unknown
3418,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,122,MG,1,Intravenous drip
3419,8350,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,75,MG/M**2,1,Intravenous drip
3420,8929,IS_PRIMARY_SUSPECT,Magnetic resonance imaging,11,ML,1,Intravenous (not otherwise specified)
3421,7613,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,84,MG,1,Intravenous (not otherwise specified)
3422,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3423,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3424,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3425,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3426,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3427,8335,IS_PRIMARY_SUSPECT,Cardiac failure,50,MG,1,Oral
3428,8189,IS_PRIMARY_SUSPECT,Unknown,420,MG,1,Unknown
3429,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3430,8335,IS_PRIMARY_SUSPECT,Cardiomyopathy,1,DF,1,Unknown
3431,8964,IS_PRIMARY_SUSPECT,Cervix cancer metastatic,200,MG,1,Intravenous (not otherwise specified)
3432,8929,IS_PRIMARY_SUSPECT,Magnetic resonance imaging head,10,ML,1,Intravenous (not otherwise specified)
3435,8389,IS_PRIMARY_SUSPECT,Colonoscopy,22,DF,1,Oral
3436,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
3437,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
3438,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3439,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3440,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,240,MG,1,Oral
3441,9156,IS_PRIMARY_SUSPECT,Colon cancer,70,MG,1,Oral
3442,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3443,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
3445,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,960,MG,1,Oral
3446,8838,IS_PRIMARY_SUSPECT,Crohn's disease,200,MG,1,Subcutaneous
3447,8565,IS_PRIMARY_SUSPECT,Bipolar disorder,20,MG,1,Oral
3449,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
3450,7613,IS_PRIMARY_SUSPECT,Small cell lung cancer,480,MG,1,Intravenous (not otherwise specified)
3451,8290,IS_PRIMARY_SUSPECT,Migraine,140,MG,1,Unknown
3452,7220,IS_PRIMARY_SUSPECT,Anticoagulant therapy,75,MG,1,Unknown
3453,9366,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,16,MG,1,Intravenous (not otherwise specified)
3457,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3459,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3461,9368,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis,36,MG,1,Intravenous (not otherwise specified)
3462,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3463,7280,IS_PRIMARY_SUSPECT,Breast cancer female,100,MG,1,Oral
3464,7359,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,500,MG,1,Oral
3465,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3466,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3467,7356,IS_PRIMARY_SUSPECT,Hypertonic bladder,4,MG,1,Oral
3470,7632,IS_PRIMARY_SUSPECT,Short stature,0.6,MG,1,Unknown
3471,7469,IS_PRIMARY_SUSPECT,Juvenile idiopathic arthritis,162,MG,1,Subcutaneous
3472,7613,IS_PRIMARY_SUSPECT,Malignant melanoma,3,MG/KG,1,Intravenous (not otherwise specified)
3473,8353,IS_PRIMARY_SUSPECT,Idiopathic pulmonary fibrosis,267,MG,1,Oral
3474,9031,IS_PRIMARY_SUSPECT,Pulmonary hypertension,2.5,MG,1,Unknown
3476,8655,IS_PRIMARY_SUSPECT,Chronic tonsillitis,7.5,ML,1,Intravenous (not otherwise specified)
3479,7335,IS_PRIMARY_SUSPECT,Unknown,2.5,MG,1,Oral
3480,9183,IS_PRIMARY_SUSPECT,Irritable bowel syndrome,3,MG,1,Oral
3481,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,200,UG,1,Oral
3483,7432,IS_PRIMARY_SUSPECT,Strabismus,250,MG,1,Oral
3484,7432,IS_PRIMARY_SUSPECT,Immunosuppression,500,MG,1,Oral
3485,7432,IS_PRIMARY_SUSPECT,Unknown,500,MG,1,Oral
3486,8622,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,0.2,KG,1,Subcutaneous
3487,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,0.35,ML,1,Subcutaneous
3488,7767,IS_PRIMARY_SUSPECT,Multiple sclerosis,40,MG,1,Subcutaneous
3489,7498,IS_PRIMARY_SUSPECT,Pain,600,UG,1,Buccal
3490,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3492,7278,IS_PRIMARY_SUSPECT,Colitis ulcerative,40,MG,1,Subcutaneous
3493,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3494,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.4,MG,1,Unknown
3495,9374,IS_PRIMARY_SUSPECT,Endometrial cancer recurrent,14,MG,1,Oral
3496,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
3497,7718,IS_PRIMARY_SUSPECT,Hereditary angioedema,300,MG,1,Unknown
3499,9375,IS_PRIMARY_SUSPECT,Psoriasis,200,MG,1,Subcutaneous
3500,9300,IS_PRIMARY_SUSPECT,Diarrhoea,4,G,1,Oral
3502,9156,IS_PRIMARY_SUSPECT,Gastric cancer,75,MG,1,Oral
3504,8766,IS_PRIMARY_SUSPECT,Colitis ulcerative,0.46,MG,1,Oral
3505,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
3506,8290,IS_PRIMARY_SUSPECT,Migraine prophylaxis,70,MG,1,Unknown
3507,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3508,8189,IS_PRIMARY_SUSPECT,Hypercholesterolaemia,140,MG,1,Unknown
3509,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3510,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3511,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
3512,8189,IS_PRIMARY_SUSPECT,Blood cholesterol abnormal,140,MG,1,Subcutaneous
3513,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3514,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3515,9061,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,50,MG,1,Subcutaneous
3516,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3517,7545,IS_PRIMARY_SUSPECT,Unknown,300,MG,1,Unknown
3522,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3523,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
3525,9383,IS_PRIMARY_SUSPECT,Invasive breast carcinoma,1200,MG,1,Oral
3526,9384,IS_PRIMARY_SUSPECT,Osteoporosis,150,MG,1,Unknown
3527,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3528,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
3529,7206,IS_PRIMARY_SUSPECT,Brain neoplasm malignant,150,MG,1,Oral
3530,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3531,9162,IS_PRIMARY_SUSPECT,Clear cell renal cell carcinoma,800,MG,1,Oral
3533,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3534,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3535,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3536,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3537,7506,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3538,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3539,7506,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3540,9156,IS_PRIMARY_SUSPECT,Colon cancer,60,MG,1,Oral
3541,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3542,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Intradermal
3543,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3544,7506,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3545,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3546,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3547,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3548,7862,IS_PRIMARY_SUSPECT,Asthma,300,MG,1,Subcutaneous
3549,7545,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3550,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3551,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,300,MG,1,Unknown
3552,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3553,7359,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,400,MG,1,Oral
3554,7506,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3555,7545,IS_PRIMARY_SUSPECT,Abdominal pain upper,75,MG,1,Unknown
3556,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3557,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3558,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3559,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3560,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
3561,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3562,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,600,UG,1,Oral
3563,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3564,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1200,UG,1,Oral
3565,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
3566,8399,IS_PRIMARY_SUSPECT,Pulmonary hypertension,1600,UG,1,Oral
3567,7335,IS_PRIMARY_SUSPECT,Unknown,5,MG,1,Oral
3569,7506,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3570,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3571,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1400,UG,1,Oral
3572,8076,IS_PRIMARY_SUSPECT,Unknown,20,UG,1,Intra-uterine
3573,7545,IS_PRIMARY_SUSPECT,Gastritis,150,MG,1,Unknown
3574,8004,IS_PRIMARY_SUSPECT,Unknown,84,MG,1,Nasal
3575,7176,IS_PRIMARY_SUSPECT,Follicular lymphoma,20,MG,1,Oral
3576,7632,IS_PRIMARY_SUSPECT,Short stature,0.8,MG,1,Unknown
3577,9387,IS_PRIMARY_SUSPECT,Skin cosmetic procedure,33,IU,1,Intramuscular
3579,7545,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3580,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3581,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
3582,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3583,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3584,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3587,9390,IS_PRIMARY_SUSPECT,Myeloproliferative neoplasm,200,MG,1,Oral
3588,7160,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Oral
3589,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3590,7681,IS_PRIMARY_SUSPECT,Multiple sclerosis,20,MG,1,Subcutaneous
3591,7176,IS_PRIMARY_SUSPECT,Lymphoma,20,MG,1,Oral
3592,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
3594,7251,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,52.9,UG,1,Intravenous (not otherwise specified)
3595,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3596,7613,IS_PRIMARY_SUSPECT,Bladder cancer,360,MG,5,Unknown
3597,8189,IS_PRIMARY_SUSPECT,Blood cholesterol abnormal,140,MG,1,Unknown
3598,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
3599,7945,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,12,MG,1,Unknown
3600,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3601,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3602,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3603,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3604,7545,IS_PRIMARY_SUSPECT,Dyspepsia,120,MG,1,Unknown
3605,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3606,8622,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,20,G,1,Subcutaneous
3607,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3608,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3609,7162,IS_PRIMARY_SUSPECT,Drug withdrawal syndrome,0.5,MG,1,Oral
3610,7165,IS_PRIMARY_SUSPECT,Blood pressure abnormal,5,MG,1,Oral
3611,7165,IS_PRIMARY_SUSPECT,Blood pressure abnormal,10,MG,1,Oral
3612,7165,IS_PRIMARY_SUSPECT,Hypertension,10,MG,1,Oral
3614,7545,IS_PRIMARY_SUSPECT,Unknown,150,MG,1,Unknown
3615,7545,IS_PRIMARY_SUSPECT,Diverticulitis,150,MG,1,Unknown
3616,8970,IS_PRIMARY_SUSPECT,Seizure,200,MG,1,Unknown
3617,9394,IS_PRIMARY_SUSPECT,Hypertension,10,MG,1,Oral
3618,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3619,8858,IS_PRIMARY_SUSPECT,Schizophrenia,42,MG,1,Oral
3620,8858,IS_PRIMARY_SUSPECT,Schizophrenia,42,MG,1,Oral
3621,8139,IS_PRIMARY_SUSPECT,Hereditary neuropathic amyloidosis,284,MG,1,Subcutaneous
3622,7611,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis IV,65,MG,1,Intravenous (not otherwise specified)
3623,7997,IS_PRIMARY_SUSPECT,Hyperphenylalaninaemia,10,MG,1,Subcutaneous
3624,9268,IS_PRIMARY_SUSPECT,Transitional cell cancer of the renal pelvis and ureter,10,MG/KG,1,Intravenous (not otherwise specified)
3625,7997,IS_PRIMARY_SUSPECT,Phenylketonuria,10,MG,1,Subcutaneous
3626,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3627,7506,IS_PRIMARY_SUSPECT,Throat clearing,150,MG,1,Unknown
3628,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3629,8774,IS_PRIMARY_SUSPECT,Contraception,1,ML,1,Parenteral
3630,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3631,7460,IS_PRIMARY_SUSPECT,Unknown,40,MG,1,Intravenous (not otherwise specified)
3632,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3633,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3634,8189,IS_PRIMARY_SUSPECT,Unknown,420,MG,1,Unknown
3635,9399,IS_PRIMARY_SUSPECT,Seizure,750,MG,1,Oral
3636,9400,IS_PRIMARY_SUSPECT,Neoplasm,600000,IU/KG,1,Intravenous (not otherwise specified)
3637,8189,IS_PRIMARY_SUSPECT,Vascular graft,140,MG,1,Unknown
3638,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3639,7536,IS_PRIMARY_SUSPECT,Endometrial cancer,1200,MG,1,Intravenous drip
3640,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3641,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3644,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Oral
3645,7545,IS_PRIMARY_SUSPECT,Hyperchlorhydria,75,MG,1,Unknown
3646,7506,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3647,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3648,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3649,7545,IS_PRIMARY_SUSPECT,Duodenal ulcer,75,MG,1,Unknown
3650,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3651,7745,IS_PRIMARY_SUSPECT,Unknown,10,MG,1,Oral
3652,7361,IS_PRIMARY_SUSPECT,Immunodeficiency,11,MG,1,Oral
3653,9401,IS_PRIMARY_SUSPECT,Transitional cell carcinoma,1.25,MG/KG,1,Intravenous (not otherwise specified)
3654,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3655,9174,IS_PRIMARY_SUSPECT,Sickle cell disease,1000,MG,1,Oral
3656,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3657,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3658,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3659,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3660,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3661,7545,IS_PRIMARY_SUSPECT,Abdominal pain upper,150,MG,1,Unknown
3662,7545,IS_PRIMARY_SUSPECT,Barrett's oesophagus,300,MG,1,Unknown
3663,7545,IS_PRIMARY_SUSPECT,Gastrointestinal disorder,150,MG,1,Unknown
3664,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3665,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3666,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3667,7506,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3668,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3669,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,300,MG,1,Oral
3670,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3671,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3672,7506,IS_PRIMARY_SUSPECT,Unknown,75,MG,1,Unknown
3673,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3674,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3675,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3678,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
3679,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3680,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3681,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
3682,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
3684,8655,IS_PRIMARY_SUSPECT,Headache,9,ML,1,Intravenous (not otherwise specified)
3685,8243,IS_PRIMARY_SUSPECT,Procedural pain,37.5,UG,1,Transdermal
3686,9374,IS_PRIMARY_SUSPECT,Endometrial cancer,20,MG,1,Oral
3687,9399,IS_PRIMARY_SUSPECT,Seizure,500,MG,1,Oral
3688,9404,IS_PRIMARY_SUSPECT,Still's disease,70,MG,2,Unknown
3689,9091,IS_PRIMARY_SUSPECT,Gallbladder cancer metastatic,2400,MG/M**2,1,Intravenous (not otherwise specified)
3690,9038,IS_PRIMARY_SUSPECT,Anaemia,2500,MG,1,Oral
3691,8389,IS_PRIMARY_SUSPECT,Colonoscopy,12,DF,1,Oral
3694,9091,IS_PRIMARY_SUSPECT,Cholangiocarcinoma,4490,MG,1,Intravenous (not otherwise specified)
3696,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3697,7278,IS_PRIMARY_SUSPECT,Ankylosing spondylitis,40,MG,1,Subcutaneous
3698,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3699,8565,IS_PRIMARY_SUSPECT,Bipolar disorder,60,MG,1,Oral
3700,9390,IS_PRIMARY_SUSPECT,Myelofibrosis,300,MG,1,Oral
3702,7611,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis IV,50,MG,1,Intravenous (not otherwise specified)
3703,9407,IS_PRIMARY_SUSPECT,Phenylketonuria,1100,MG,1,Oral
3704,9407,IS_PRIMARY_SUSPECT,Phenylketonuria,1900,MG,1,Oral
3705,7197,IS_PRIMARY_SUSPECT,Blood cholesterol increased,20,MG,1,Oral
3707,7197,IS_PRIMARY_SUSPECT,Unknown,40,MG,1,Unknown
3708,8240,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,400,MG,1,Oral
3709,7197,IS_PRIMARY_SUSPECT,Blood cholesterol increased,10,MG,1,Oral
3711,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3712,7613,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,100,ML,1,Intravenous (not otherwise specified)
3713,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3714,7545,IS_PRIMARY_SUSPECT,Abdominal pain upper,75,MG,1,Unknown
3719,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3720,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3721,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3722,7545,IS_PRIMARY_SUSPECT,Abdominal pain upper,150,MG,1,Unknown
3723,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,300,MG,1,Unknown
3724,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3725,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3726,7545,IS_PRIMARY_SUSPECT,Unknown,75,MG,1,Unknown
3727,8154,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,10,MG,1,Oral
3728,7176,IS_PRIMARY_SUSPECT,Follicular lymphoma,15,MG,1,Oral
3729,7951,IS_PRIMARY_SUSPECT,Ewing's sarcoma,500,UG,1,Unknown
3730,8630,IS_PRIMARY_SUSPECT,Pollakiuria,60,MG,1,Oral
3731,8630,IS_PRIMARY_SUSPECT,Pollakiuria,60,MG,1,Oral
3732,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3733,7176,IS_PRIMARY_SUSPECT,B-cell lymphoma,20,MG,1,Oral
3734,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,240,MG,1,Intravenous (not otherwise specified)
3735,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,200,UG,1,Oral
3737,8340,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,150,MG,1,Oral
3738,8247,IS_PRIMARY_SUSPECT,Persistent depressive disorder,100,MG,1,Oral
3739,7613,IS_PRIMARY_SUSPECT,Glioblastoma,980.1,MG,1,Unknown
3740,8592,IS_PRIMARY_SUSPECT,Computerised tomogram thorax,120,ML,1,Intravenous (not otherwise specified)
3741,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3742,7545,IS_PRIMARY_SUSPECT,Hyperchlorhydria,150,MG,1,Unknown
3743,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3744,7850,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,180,MG,1,Oral
3745,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3746,7993,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,100,MG,1,Oral
3747,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3749,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3750,7243,IS_PRIMARY_SUSPECT,Hodgkin's disease,549.9,MG,1,Unknown
3752,7176,IS_PRIMARY_SUSPECT,Follicular lymphoma,10,MG,1,Oral
3753,7681,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Subcutaneous
3754,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
3755,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3756,7218,IS_PRIMARY_SUSPECT,Hypertonic bladder,25,MG,1,Oral
3757,7965,IS_PRIMARY_SUSPECT,Colitis ulcerative,90,MG,1,Subcutaneous
3758,8047,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,700,MG,1,Intravenous (not otherwise specified)
3759,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3760,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3761,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
3762,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
3763,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
3764,9425,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,50,MG,1,Unknown
3765,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3766,9426,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,100,MG,1,Oral
3768,8483,IS_PRIMARY_SUSPECT,Parkinson's disease,100,ML,1,Other
3769,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,3,MG/KG,1,Intravenous (not otherwise specified)
3770,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
3771,7788,IS_PRIMARY_SUSPECT,Hepatobiliary cancer,400,MG/M**2,1,Unknown
3772,7545,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3773,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3774,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,450,MG,1,Unknown
3775,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3776,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3777,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3778,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
3779,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3780,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3781,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3782,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3783,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3784,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3785,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3786,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
3787,7545,IS_PRIMARY_SUSPECT,Unknown,300,MG,1,Unknown
3788,7545,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3789,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
3790,7394,IS_PRIMARY_SUSPECT,Parkinson's disease psychosis,34,MG,1,Unknown
3791,7332,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,12.5,MG,1,Oral
3792,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3793,8619,IS_PRIMARY_SUSPECT,Inappropriate schedule of product administration,300,MG,1,Oral
3794,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3795,8291,IS_PRIMARY_SUSPECT,B precursor type acute leukaemia,28,UG,1,Intravenous (not otherwise specified)
3796,9430,IS_PRIMARY_SUSPECT,Immunodeficiency,40,G,1,Unknown
3797,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3798,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3799,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Oral
3800,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3801,9038,IS_PRIMARY_SUSPECT,Haemochromatosis,2000,MG,1,Oral
3802,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3803,8401,IS_PRIMARY_SUSPECT,Unknown,20,MG,1,Unknown
3804,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3805,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3806,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3807,7782,IS_PRIMARY_SUSPECT,Thrombosis,10,MG,1,Oral
3808,7767,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,40,MG,1,Subcutaneous
3809,9431,IS_PRIMARY_SUSPECT,Diarrhoea,5,MG,1,Unknown
3810,8906,IS_PRIMARY_SUSPECT,Unknown,16.5,ML,1,Oral
3811,8164,IS_PRIMARY_SUSPECT,Pain,650,MG,1,Oral
3812,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3813,9432,IS_PRIMARY_SUSPECT,Anaphylactic reaction,0.3,MG,1,Unknown
3814,8855,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,650,MG,1,Intravenous (not otherwise specified)
3816,7883,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,50,MG,1,Intravenous (not otherwise specified)
3817,9148,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Unknown
3818,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3819,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3820,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3822,9434,IS_PRIMARY_SUSPECT,Neurofibromatosis,35,MG,1,Oral
3823,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3824,7678,IS_PRIMARY_SUSPECT,Epilepsy,750,MG,1,Unknown
3825,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3826,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3827,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3828,8197,IS_PRIMARY_SUSPECT,Migraine,240,MG,1,Unknown
3829,8224,IS_PRIMARY_SUSPECT,Uterine leiomyoma,1,DF,1,Oral
3830,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
3831,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3832,7545,IS_PRIMARY_SUSPECT,Gastrointestinal disorder,75,MG,1,Unknown
3833,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3834,9435,IS_PRIMARY_SUSPECT,Cystic fibrosis,112,MG,1,Unknown
3835,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
3836,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3837,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3838,7853,IS_PRIMARY_SUSPECT,Dermatitis atopic,600,MG,1,Subcutaneous
3839,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3840,8803,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,143,MG,1,Intravenous (not otherwise specified)
3842,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
3843,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,200,UG,1,Oral
3844,8838,IS_PRIMARY_SUSPECT,Psoriasis,400,MG,1,Subcutaneous
3845,9437,IS_PRIMARY_SUSPECT,Erectile dysfunction,500,UG,1,Urethral
3846,8610,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
3847,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3848,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3849,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3850,7456,IS_PRIMARY_SUSPECT,Seizure,300,MG,1,Oral
3851,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
3852,7899,IS_PRIMARY_SUSPECT,Metastatic malignant melanoma,100,MG,1,Unknown
3853,9095,IS_PRIMARY_SUSPECT,Renal cancer,5,MG,1,Unknown
3854,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3855,9438,IS_PRIMARY_SUSPECT,Schizoaffective disorder,1,DF,1,Unknown
3856,7334,IS_PRIMARY_SUSPECT,Myasthenia gravis,50,G,1,Intravenous (not otherwise specified)
3857,7545,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3858,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,300,MG,1,Unknown
3859,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3860,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,300,MG,1,Unknown
3861,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
3862,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3863,7545,IS_PRIMARY_SUSPECT,Abdominal pain upper,150,MG,1,Unknown
3864,7545,IS_PRIMARY_SUSPECT,Abdominal pain upper,75,MG,1,Unknown
3865,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3866,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3867,8848,IS_PRIMARY_SUSPECT,K-ras gene mutation,360,MG,1,Oral
3868,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3869,8399,IS_PRIMARY_SUSPECT,Pulmonary hypertension,800,UG,1,Oral
3871,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
3872,7993,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,400,MG,1,Oral
3873,9442,IS_PRIMARY_SUSPECT,Hormone replacement therapy,25,UG,1,Oral
3874,8775,IS_PRIMARY_SUSPECT,Pulmonary hypertension,1600,UG,1,Oral
3875,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,240,MG,1,Oral
3876,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
3877,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
3878,8646,IS_PRIMARY_SUSPECT,HER2 positive breast cancer,300,MG,1,Oral
3879,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3880,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,2000,IU,1,Subcutaneous
3881,7171,IS_PRIMARY_SUSPECT,Graft versus host disease,30,MG,1,Oral
3882,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3885,7924,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,26,IU,1,Subcutaneous
3886,8681,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,0.75,MG,1,Subcutaneous
3887,7335,IS_PRIMARY_SUSPECT,Deep vein thrombosis,10,MG,1,Oral
3889,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
3890,8686,IS_PRIMARY_SUSPECT,Asthma,2,DF,1,Unknown
3892,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
3893,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3894,7506,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3895,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,200,UG,1,Oral
3896,7506,IS_PRIMARY_SUSPECT,Dyspepsia,300,MG,1,Unknown
3897,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
3898,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3899,7545,IS_PRIMARY_SUSPECT,Hyperchlorhydria,75,MG,1,Unknown
3900,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3901,7611,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis IV,50,MG,1,Intravenous (not otherwise specified)
3902,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
3904,7863,IS_PRIMARY_SUSPECT,Hormone replacement therapy,0.075,MG,1,Transdermal
3905,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3906,9101,IS_PRIMARY_SUSPECT,Prostate cancer,120,MG,1,Oral
3907,7278,IS_PRIMARY_SUSPECT,Psoriasis,40,MG,1,Subcutaneous
3908,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3909,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
3912,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3914,8167,IS_PRIMARY_SUSPECT,HIV infection,50,MG,1,Oral
3916,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3917,8189,IS_PRIMARY_SUSPECT,Hypercholesterolaemia,140,MG,1,Unknown
3918,7365,IS_PRIMARY_SUSPECT,Deep vein thrombosis,2.5,MG,1,Oral
3919,9447,IS_PRIMARY_SUSPECT,Infertility female,10000,DF,1,Subcutaneous
3921,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3922,7545,IS_PRIMARY_SUSPECT,Unknown,300,MG,1,Unknown
3923,9450,IS_PRIMARY_SUSPECT,Parkinson's disease,6,MG,1,Unknown
3925,7613,IS_PRIMARY_SUSPECT,Hodgkin's disease,240,MG,1,Intravenous (not otherwise specified)
3927,9155,IS_PRIMARY_SUSPECT,Computerised tomogram abdomen,100,ML,1,Intravenous (not otherwise specified)
3929,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3930,7545,IS_PRIMARY_SUSPECT,Gastric ulcer,150,MG,1,Unknown
3931,7545,IS_PRIMARY_SUSPECT,Unknown,150,MG,1,Unknown
3932,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3933,7536,IS_PRIMARY_SUSPECT,Bladder cancer,1200,MG,1,Intravenous (not otherwise specified)
3934,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,1.4,MG,1,Unknown
3937,7176,IS_PRIMARY_SUSPECT,Follicular lymphoma,15,MG,1,Oral
3938,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
3939,7503,IS_PRIMARY_SUSPECT,Thrombosis,120,MG,1,Subcutaneous
3940,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
3941,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3943,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3944,7545,IS_PRIMARY_SUSPECT,Gastric disorder,75,MG,1,Unknown
3945,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,300,MG,1,Unknown
3946,7545,IS_PRIMARY_SUSPECT,Dyspepsia,75,MG,1,Unknown
3947,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3948,7545,IS_PRIMARY_SUSPECT,Gastrointestinal disorder,75,MG,1,Unknown
3949,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3950,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3951,7506,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
3952,9300,IS_PRIMARY_SUSPECT,Diarrhoea,4,G,1,Oral
3953,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
3954,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,75,MG,1,Unknown
3955,9454,IS_PRIMARY_SUSPECT,Genital herpes,1,DF,1,Oral
3956,8737,IS_PRIMARY_SUSPECT,Juvenile idiopathic arthritis,125,MG,1,Subcutaneous
3957,9455,IS_PRIMARY_SUSPECT,Metastatic carcinoma of the bladder,8,MG,1,Oral
3958,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3960,7613,IS_PRIMARY_SUSPECT,Pleural mesothelioma malignant,240,MG,1,Intravenous (not otherwise specified)
3961,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
3962,9456,IS_PRIMARY_SUSPECT,Anxiety,25,MG,1,Oral
3963,8906,IS_PRIMARY_SUSPECT,Seizure,800,MG,1,Oral
3964,9187,IS_PRIMARY_SUSPECT,Chronic obstructive pulmonary disease,1,DF,1,Respiratory (inhalation)
3965,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3966,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3967,8218,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,1000,MG,1,Intravenous drip
3968,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
3969,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,2.6,MG,1,Unknown
3970,7632,IS_PRIMARY_SUSPECT,Hormone therapy,1.5,MG,1,Unknown
3971,9459,IS_PRIMARY_SUSPECT,Hepatitis C,1,DF,1,Oral
3972,8189,IS_PRIMARY_SUSPECT,Blood cholesterol increased,140,MG,1,Unknown
3973,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
3977,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
3978,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
3979,9460,IS_PRIMARY_SUSPECT,Sarcoma,1.4,MG/M**2,1,Intravenous (not otherwise specified)
3981,7613,IS_PRIMARY_SUSPECT,Glioblastoma multiforme,315,MG,1,Unknown
3982,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1200,UG,1,Oral
3983,9461,IS_PRIMARY_SUSPECT,Orthostatic hypotension,100,MG,1,Oral
3984,7965,IS_PRIMARY_SUSPECT,Crohn's disease,90,MG,1,Subcutaneous
3986,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Subcutaneous
3987,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
3988,9471,IS_PRIMARY_SUSPECT,Major depression,75,MG,1,Unknown
3989,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
3990,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
3992,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
3995,8399,IS_PRIMARY_SUSPECT,Pulmonary hypertension,400,UG,1,Oral
3997,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
4000,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1,MG,1,Oral
4001,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,10,MG,1,Oral
4002,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,800,UG,1,Oral
4003,7782,IS_PRIMARY_SUSPECT,Blood cholesterol increased,20,MG,1,Oral
4004,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4007,7536,IS_PRIMARY_SUSPECT,Prostate cancer metastatic,1200,MG,1,Intravenous drip
4008,9475,IS_PRIMARY_SUSPECT,Thrombolysis,19.25,MG,1,Intravenous (not otherwise specified)
4009,8737,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,250,MG,1,Unknown
4010,8399,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,400,UG,1,Oral
4011,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,300,MG,1,Subcutaneous
4012,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,200,UG,1,Oral
4013,8671,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
4014,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
4015,8622,IS_PRIMARY_SUSPECT,Hypogammaglobulinaemia,8,G,1,Subcutaneous
4016,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
4017,7291,IS_PRIMARY_SUSPECT,Basal cell carcinoma,150,MG,1,Oral
4018,7176,IS_PRIMARY_SUSPECT,5q minus syndrome,10,MG,1,Oral
4019,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4021,9437,IS_PRIMARY_SUSPECT,Erectile dysfunction,250,UG,1,Urethral
4022,7984,IS_PRIMARY_SUSPECT,Chronic spontaneous urticaria,300,MG,1,Subcutaneous
4023,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
4024,7683,IS_PRIMARY_SUSPECT,Plasma cell myeloma,1400,MG,1,Intravenous (not otherwise specified)
4026,7176,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,25,MG,1,Oral
4027,8950,IS_PRIMARY_SUSPECT,Pulmonary hypertension,125,MG,1,Oral
4028,9479,IS_PRIMARY_SUSPECT,Acute myeloid leukaemia,300,MG,1,Oral
4030,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
4031,9156,IS_PRIMARY_SUSPECT,Colon cancer,20,MG,1,Oral
4032,8578,IS_PRIMARY_SUSPECT,Psoriasis,150,MG,1,Subcutaneous
4034,9374,IS_PRIMARY_SUSPECT,Renal cancer,18,MG,1,Oral
4036,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
4037,8557,IS_PRIMARY_SUSPECT,Psoriasis,100,MG,1,Subcutaneous
4038,8173,IS_PRIMARY_SUSPECT,Psoriasis,300,MG,1,Subcutaneous
4039,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4040,8335,IS_PRIMARY_SUSPECT,Cardiac failure,1,DF,1,Oral
4041,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,5,MG,1,Oral
4042,9148,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
4043,8321,IS_PRIMARY_SUSPECT,Prophylaxis,6000,IU,1,Subcutaneous
4045,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
4046,7536,IS_PRIMARY_SUSPECT,Endometrial cancer,1200,MG,1,Intravenous (not otherwise specified)
4048,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
4049,7416,IS_PRIMARY_SUSPECT,Breast cancer,200,MG,1,Oral
4050,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1600,UG,1,Oral
4051,8222,IS_PRIMARY_SUSPECT,Immune system disorder,1000,IU,1,Intravenous (not otherwise specified)
4052,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1400,UG,1,Oral
4053,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4054,8407,IS_PRIMARY_SUSPECT,Alcoholism,380,MG,1,Intramuscular
4055,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4056,9148,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Unknown
4057,7176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,10,MG,1,Oral
4058,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
4059,7571,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,15,MG,1,Oral
4061,8076,IS_PRIMARY_SUSPECT,Contraception,20,UG,1,Intra-uterine
4062,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Unknown
4063,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
4064,7862,IS_PRIMARY_SUSPECT,Dermatitis atopic,600,MG,1,Subcutaneous
4066,8335,IS_PRIMARY_SUSPECT,Unknown,25,MG,1,Oral
4067,9485,IS_PRIMARY_SUSPECT,Multiple sclerosis,30,UG,1,Unknown
4068,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4072,7335,IS_PRIMARY_SUSPECT,Pulmonary embolism,5,MG,1,Oral
4073,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
4074,7335,IS_PRIMARY_SUSPECT,Cerebrovascular accident prophylaxis,5,MG,1,Oral
4075,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4077,8548,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,15,MG,1,Oral
4078,9091,IS_PRIMARY_SUSPECT,Cholangiocarcinoma,4040,MG,1,Intravenous (not otherwise specified)
4079,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4080,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4081,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4082,9487,IS_PRIMARY_SUSPECT,Pancreatic carcinoma,11,MG/KG,1,Intravenous (not otherwise specified)
4083,7536,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,840,MG,1,Intravenous (not otherwise specified)
4084,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,UG,1,Unknown
4085,8557,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,100,MG,1,Subcutaneous
4086,9489,IS_PRIMARY_SUSPECT,B-cell lymphoma,2.5,MG,1,Unknown
4087,9239,IS_PRIMARY_SUSPECT,Fracture pain,5,PCT,1,Cutaneous
4088,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,600,UG,1,Oral
4090,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
4091,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
4092,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
4093,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
4094,9490,IS_PRIMARY_SUSPECT,Unknown,4,DF,1,Unknown
4095,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
4096,8737,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,125,MG,1,Subcutaneous
4097,8766,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,0.92,MG,1,Oral
4098,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4099,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4100,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4101,7685,IS_PRIMARY_SUSPECT,Prophylaxis,6,MG,1,Unknown
4102,7994,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
4103,9491,IS_PRIMARY_SUSPECT,Gastric cancer,600,MG,1,Subcutaneous
4104,9492,IS_PRIMARY_SUSPECT,Schizophrenia,405,MG,1,Intramuscular
4107,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
4108,8838,IS_PRIMARY_SUSPECT,Psoriatic arthropathy,400,MG,1,Unknown
4109,7944,IS_PRIMARY_SUSPECT,Pulmonary hypertension,10,MG,1,Oral
4111,7384,IS_PRIMARY_SUSPECT,Noonan syndrome,0.012,MG/KG,1,Unknown
4112,7334,IS_PRIMARY_SUSPECT,Dermatomyositis,35,G,1,Intravenous (not otherwise specified)
4113,7176,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,25,MG,1,Oral
4114,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4115,7901,IS_PRIMARY_SUSPECT,Still's disease,300,MG,1,Unknown
4116,7536,IS_PRIMARY_SUSPECT,Neoplasm malignant,1200,MG,1,Intravenous drip
4117,7176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,25,MG,1,Oral
4118,7668,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Oral
4119,7863,IS_PRIMARY_SUSPECT,Unknown,0.025,MG,1,Transdermal
4120,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1400,UG,1,Oral
4122,8766,IS_PRIMARY_SUSPECT,Multiple sclerosis,0.92,MG,1,Oral
4123,9300,IS_PRIMARY_SUSPECT,Irritable bowel syndrome,4,G,1,Oral
4124,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4125,9156,IS_PRIMARY_SUSPECT,Colon cancer,15,MG,1,Oral
4126,7278,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,40,MG,1,Subcutaneous
4127,7477,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2.3,MG,1,Oral
4128,7685,IS_PRIMARY_SUSPECT,Neutropenia,6,MG,1,Unknown
4129,7632,IS_PRIMARY_SUSPECT,Failure to thrive,1.4,MG,1,Unknown
4130,7632,IS_PRIMARY_SUSPECT,Failure to thrive,1.4,MG,1,Unknown
4131,9131,IS_PRIMARY_SUSPECT,Acute lymphocytic leukaemia,0.3,MG/M**2,1,Intravenous (not otherwise specified)
4133,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
4134,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,2,MG,1,Oral
4135,7176,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,25,MG,1,Oral
4136,8671,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,10,MG,1,Oral
4137,7392,IS_PRIMARY_SUSPECT,Hypereosinophilic syndrome,4,MG,1,Unknown
4138,8950,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,31.25,MG,1,Oral
4140,9494,IS_PRIMARY_SUSPECT,Lung cancer metastatic,40,MG,1,Oral
4141,7613,IS_PRIMARY_SUSPECT,Renal cell carcinoma,413,MG,1,Unknown
4142,7613,IS_PRIMARY_SUSPECT,Ovarian cancer,240,MG,1,Intravenous (not otherwise specified)
4143,9329,IS_PRIMARY_SUSPECT,Bipolar disorder,1064,MG,1,Intramuscular
4144,8172,IS_PRIMARY_SUSPECT,Asthma,1,DF,1,Oral
4145,7863,IS_PRIMARY_SUSPECT,Hormone replacement therapy,0.037,MG,1,Transdermal
4146,7782,IS_PRIMARY_SUSPECT,Pulmonary embolism,20,MG,1,Oral
4147,9497,IS_PRIMARY_SUSPECT,Motion sickness,1,MG,1,Transdermal
4148,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4149,8660,IS_PRIMARY_SUSPECT,Factor VIII deficiency,285,MG,1,Subcutaneous
4150,7984,IS_PRIMARY_SUSPECT,Idiopathic urticaria,300,MG,1,Subcutaneous
4151,9498,IS_PRIMARY_SUSPECT,Endometriosis,200,MG,1,Oral
4152,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
4153,7545,IS_PRIMARY_SUSPECT,Dyspepsia,150,MG,1,Unknown
4154,7545,IS_PRIMARY_SUSPECT,Gastrooesophageal reflux disease,150,MG,1,Unknown
4155,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,20,MG,1,Oral
4156,9499,IS_PRIMARY_SUSPECT,HIV infection,1,DF,1,Transplacental
4157,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4158,8762,IS_PRIMARY_SUSPECT,Unknown,1,DF,1,Subdermal
4159,8847,IS_PRIMARY_SUSPECT,Type 2 diabetes mellitus,2,MG,1,Subcutaneous
4160,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4162,9500,IS_PRIMARY_SUSPECT,Unknown,2,DF,1,Dental
4163,9019,IS_PRIMARY_SUSPECT,Unknown,7,MG,1,Oral
4164,7883,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,59,MG,1,Intravenous (not otherwise specified)
4165,7632,IS_PRIMARY_SUSPECT,Growth disorder,2.8,MG,1,Unknown
4166,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,15,MG,1,Oral
4167,7734,IS_PRIMARY_SUSPECT,Non-small cell lung cancer metastatic,55,MG/M**2,1,Intravenous (not otherwise specified)
4168,8766,IS_PRIMARY_SUSPECT,Colitis ulcerative,0.46,MG,1,Oral
4169,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,4,MG,1,Oral
4170,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,2.2,MG,1,Unknown
4172,8099,IS_PRIMARY_SUSPECT,Colorectal cancer,40,MG,1,Oral
4174,7254,IS_PRIMARY_SUSPECT,Short-bowel syndrome,2.5,MG,1,Unknown
4175,8964,IS_PRIMARY_SUSPECT,Prostate cancer,200,MG,1,Intravenous (not otherwise specified)
4176,7332,IS_PRIMARY_SUSPECT,Philadelphia positive acute lymphocytic leukaemia,35,MG,1,Oral
4177,7176,IS_PRIMARY_SUSPECT,5q minus syndrome,20,MG,1,Oral
4178,8312,IS_PRIMARY_SUSPECT,Hallucination,25,MG,1,Unknown
4179,8762,IS_PRIMARY_SUSPECT,Contraception,1,DF,1,Subdermal
4180,7176,IS_PRIMARY_SUSPECT,Lymphoma,20,MG,1,Oral
4182,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1000,UG,1,Oral
4183,8478,IS_PRIMARY_SUSPECT,Renal cell carcinoma,40,MG,1,Oral
4184,7860,IS_PRIMARY_SUSPECT,Nephroblastoma,8,MG,1,Oral
4185,7164,IS_PRIMARY_SUSPECT,Tremor,250,MG,1,Oral
4186,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4187,7283,IS_PRIMARY_SUSPECT,Plasma cell myeloma,3,MG,1,Oral
4188,7278,IS_PRIMARY_SUSPECT,Crohn's disease,40,MG,1,Subcutaneous
4189,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,10,MG,1,Oral
4190,8335,IS_PRIMARY_SUSPECT,Cardiomyopathy,1,DF,1,Oral
4191,9061,IS_PRIMARY_SUSPECT,Psoriasis,50,MG,1,Subcutaneous
4192,7356,IS_PRIMARY_SUSPECT,Hypertonic bladder,8,MG,1,Unknown
4194,7262,IS_PRIMARY_SUSPECT,Seizure,800,MG,1,Oral
4195,7178,IS_PRIMARY_SUSPECT,Trigeminal neuralgia,75,MG,1,Oral
4196,7687,IS_PRIMARY_SUSPECT,Acromegaly,20,MG,1,Subcutaneous
4197,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,3,DF,1,Oral
4198,8506,IS_PRIMARY_SUSPECT,Mucopolysaccharidosis II,0.33,MG,1,Intravenous drip
4199,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,100,MG,1,Oral
4200,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Oral
4201,9095,IS_PRIMARY_SUSPECT,Renal cancer metastatic,4,MG,1,Oral
4202,7178,IS_PRIMARY_SUSPECT,Back disorder,200,MG,1,Oral
4203,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,100,MG,1,Oral
4204,7191,IS_PRIMARY_SUSPECT,Narcolepsy,2.25,G,1,Oral
4205,7178,IS_PRIMARY_SUSPECT,Pain,150,MG,1,Oral
4206,7178,IS_PRIMARY_SUSPECT,Neuralgia,300,MG,1,Oral
4207,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
4208,7178,IS_PRIMARY_SUSPECT,Migraine,500,MG,1,Oral
4210,7315,IS_PRIMARY_SUSPECT,Arthritis,100,MG,1,Unknown
4211,7178,IS_PRIMARY_SUSPECT,Post herpetic neuralgia,75,MG,1,Oral
4212,7305,IS_PRIMARY_SUSPECT,Cardiac hypertrophy,1,MG,1,Unknown
4213,9527,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,250,MG,1,Oral
4214,7178,IS_PRIMARY_SUSPECT,Pain,75,MG,1,Oral
4215,7178,IS_PRIMARY_SUSPECT,Pain,100,MG,1,Oral
4216,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,300,MG,1,Oral
4217,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
4218,7178,IS_PRIMARY_SUSPECT,Neuralgia,400,MG,1,Oral
4219,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Unknown
4220,7160,IS_PRIMARY_SUSPECT,"Astrocytoma, low grade",10,MG,1,Oral
4221,7536,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,1200,MG,1,Intravenous drip
4222,7178,IS_PRIMARY_SUSPECT,Spinal osteoarthritis,225,MG,1,Oral
4223,7206,IS_PRIMARY_SUSPECT,Plasma cell myeloma,100,MG,1,Oral
4224,7178,IS_PRIMARY_SUSPECT,Pain,150,MG,1,Oral
4226,7280,IS_PRIMARY_SUSPECT,Breast cancer stage IV,125,MG,1,Oral
4227,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
4228,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Oral
4229,7280,IS_PRIMARY_SUSPECT,Breast cancer female,125,MG,1,Oral
4230,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
4231,9538,IS_PRIMARY_SUSPECT,Factor IX deficiency,6500,IU,1,Intravenous (not otherwise specified)
4233,7525,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,12,MG,1,Intravenous drip
4234,7452,IS_PRIMARY_SUSPECT,Hyperkalaemia,16.8,G,1,Oral
4237,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
4238,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
4239,7478,IS_PRIMARY_SUSPECT,Gastrointestinal stromal tumour,50,MG,1,Unknown
4240,7496,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,600,MG,1,Intravenous (not otherwise specified)
4241,7338,IS_PRIMARY_SUSPECT,Alopecia,5,MG,1,Oral
4242,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,100,MG,1,Oral
4243,8194,IS_PRIMARY_SUSPECT,Multiple sclerosis,300,MG,1,Other
4244,7178,IS_PRIMARY_SUSPECT,Pain,300,MG,1,Oral
4245,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,100,MG,1,Oral
4246,7178,IS_PRIMARY_SUSPECT,Neuralgia,150,MG,1,Oral
4247,7874,IS_PRIMARY_SUSPECT,Factor VIII deficiency,3000,IU,1,Intravenous (not otherwise specified)
4248,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Unknown
4249,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,100,MG,1,Oral
4250,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,75,MG,1,Oral
4251,7191,IS_PRIMARY_SUSPECT,Narcolepsy,4,G,1,Oral
4252,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1,MG,1,Subcutaneous
4253,7178,IS_PRIMARY_SUSPECT,Polyneuropathy,200,MG,1,Oral
4254,7632,IS_PRIMARY_SUSPECT,Septo-optic dysplasia,0.8,MG,1,Unknown
4255,7178,IS_PRIMARY_SUSPECT,Pain in extremity,300,MG,1,Oral
4256,7178,IS_PRIMARY_SUSPECT,Radiculopathy,75,MG,1,Unknown
4257,7178,IS_PRIMARY_SUSPECT,Back disorder,150,MG,1,Oral
4258,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,300,MG,1,Oral
4259,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
4260,7178,IS_PRIMARY_SUSPECT,Nerve injury,150,MG,1,Oral
4261,7437,IS_PRIMARY_SUSPECT,Chronic myeloid leukaemia,45,MG,1,Oral
4262,7681,IS_PRIMARY_SUSPECT,Relapsing multiple sclerosis,20,MG,1,Subcutaneous
4263,8066,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,16,MG,1,Subcutaneous
4264,8176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,149,MG,2,Intravenous (not otherwise specified)
4265,7576,IS_PRIMARY_SUSPECT,Hypertension,10,MG,1,Oral
4266,7178,IS_PRIMARY_SUSPECT,Post herpetic neuralgia,50,MG,1,Oral
4267,7178,IS_PRIMARY_SUSPECT,Seizure,200,MG,1,Oral
4268,7249,IS_PRIMARY_SUSPECT,Multiple sclerosis,120,MG,1,Other
4269,7178,IS_PRIMARY_SUSPECT,Diabetic neuropathy,300,MG,1,Unknown
4270,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,300,MG,1,Oral
4271,8066,IS_PRIMARY_SUSPECT,Pancreatic carcinoma metastatic,16,MG,1,Subcutaneous
4272,7178,IS_PRIMARY_SUSPECT,Neuralgia,75,MG,1,Oral
4273,7452,IS_PRIMARY_SUSPECT,Hyperkalaemia,8.4,G,1,Oral
4274,7338,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,5,MG,1,Unknown
4275,7384,IS_PRIMARY_SUSPECT,Lymphangioma,0.5,MG,1,Oral
4276,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,75,MG,1,Oral
4277,7178,IS_PRIMARY_SUSPECT,Complex regional pain syndrome,150,MG,1,Oral
4278,7178,IS_PRIMARY_SUSPECT,Pain,75,MG,1,Oral
4279,7235,IS_PRIMARY_SUSPECT,Atrophic vulvovaginitis,1,G,1,Vaginal
4280,7940,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,754,MG,3,Intravenous (not otherwise specified)
4281,7940,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,570,MG,3,Intravenous drip
4282,7874,IS_PRIMARY_SUSPECT,Factor VIII deficiency,5600,IU,1,Intravenous drip
4283,7178,IS_PRIMARY_SUSPECT,Migraine,75,MG,1,Oral
4285,8176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,95,MG,1,Intravenous (not otherwise specified)
4286,7235,IS_PRIMARY_SUSPECT,Genital labial adhesions,0.5,G,1,Vaginal
4287,7178,IS_PRIMARY_SUSPECT,Arthralgia,50,MG,1,Oral
4288,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,75,MG,1,Oral
4290,7178,IS_PRIMARY_SUSPECT,Polyneuropathy,100,MG,1,Oral
4291,7860,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,12,MG,1,Oral
4292,8348,IS_PRIMARY_SUSPECT,Chemotherapy,52,MG,1,Unknown
4293,7178,IS_PRIMARY_SUSPECT,Neuropathy peripheral,150,MG,1,Oral
4294,8091,IS_PRIMARY_SUSPECT,Amyloidosis,80,MG,1,Oral
4295,7178,IS_PRIMARY_SUSPECT,Fibromyalgia,75,MG,1,Oral
4296,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
4297,7178,IS_PRIMARY_SUSPECT,Nerve injury,100,MG,1,Unknown
4298,7416,IS_PRIMARY_SUSPECT,Ovarian cancer recurrent,200,MG,1,Oral
4299,7490,IS_PRIMARY_SUSPECT,Muscle disorder,2,DF,1,Oral
4301,7178,IS_PRIMARY_SUSPECT,Small fibre neuropathy,300,MG,1,Unknown
4302,7338,IS_PRIMARY_SUSPECT,Alopecia areata,5,MG,1,Oral
4303,7178,IS_PRIMARY_SUSPECT,Nerve injury,150,MG,1,Oral
4304,8176,IS_PRIMARY_SUSPECT,Diffuse large B-cell lymphoma,111,MG,1,Intravenous (not otherwise specified)
4305,7646,IS_PRIMARY_SUSPECT,Dyslipidaemia,140,MG,1,Subcutaneous
4306,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Oral
4307,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,300,MG,1,Oral
4308,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,100,UG,1,Other
4309,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
4310,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Subcutaneous
4312,7383,IS_PRIMARY_SUSPECT,Neoplasm malignant,300,MG,1,Oral
4313,8151,IS_PRIMARY_SUSPECT,Severe myoclonic epilepsy of infancy,1500,MG,1,Unknown
4314,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,15,G,1,Subcutaneous
4315,7715,IS_PRIMARY_SUSPECT,Mycobacterium abscessus infection,100,MG,1,Oral
4316,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Subcutaneous
4317,7982,IS_PRIMARY_SUSPECT,Polyneuropathy chronic,40,G,1,Intravenous (not otherwise specified)
4319,7790,IS_PRIMARY_SUSPECT,Unknown,8,G,1,Subcutaneous
4320,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,1,Oral
4321,7914,IS_PRIMARY_SUSPECT,Incontinence,4,MG,1,Oral
4322,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,1,Oral
4323,7982,IS_PRIMARY_SUSPECT,Bacterial infection,35,G,1,Intravenous (not otherwise specified)
4324,7982,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,30,G,1,Intravenous (not otherwise specified)
4325,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,42.5,G,1,Subcutaneous
4326,7361,IS_PRIMARY_SUSPECT,Rheumatoid arthritis,11,MG,1,Unknown
4327,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,500,MG/KG,1,Intravenous (not otherwise specified)
4328,9599,IS_PRIMARY_SUSPECT,Non-small cell lung cancer,550,MG,1,Intravenous (not otherwise specified)
4329,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
4330,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,75,G,1,Intravenous (not otherwise specified)
4331,7178,IS_PRIMARY_SUSPECT,Headache,100,MG,1,Oral
4332,8058,IS_PRIMARY_SUSPECT,Alpha-1 antitrypsin deficiency,4476,MG,1,Intravenous (not otherwise specified)
4333,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
4334,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,5,G,1,Subcutaneous
4335,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
4336,8468,IS_PRIMARY_SUSPECT,Lung neoplasm malignant,90,MG,1,Oral
4337,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,300,MG,1,Unknown
4339,7178,IS_PRIMARY_SUSPECT,Pain,100,MG,1,Oral
4340,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,21,G,1,Subcutaneous
4341,8099,IS_PRIMARY_SUSPECT,Hepatocellular carcinoma,40,MG,1,Oral
4342,7280,IS_PRIMARY_SUSPECT,Breast cancer metastatic,125,MG,1,Unknown
4343,8098,IS_PRIMARY_SUSPECT,Vaginal haemorrhage,7.5,MG,1,Unknown
4344,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
4345,7996,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,400,MG/KG,1,Intravenous (not otherwise specified)
4346,7790,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,8,G,1,Subcutaneous
4347,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,33,G,1,Intravenous (not otherwise specified)
4349,7178,IS_PRIMARY_SUSPECT,Neuralgia,75,MG,1,Oral
4350,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,50,G,1,Subcutaneous
4351,9168,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,55,NG,1,Unknown
4352,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
4353,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,45,G,1,Intravenous (not otherwise specified)
4354,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
4355,8202,IS_PRIMARY_SUSPECT,Prophylaxis,25,MG,3,Intravenous drip
4356,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,22.5,G,1,Subcutaneous
4357,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,4,G,1,Subcutaneous
4358,7790,IS_PRIMARY_SUSPECT,Congenital hypogammaglobulinaemia,15,G,1,Subcutaneous
4359,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,60,G,1,Subcutaneous
4360,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,3.2,MG,1,Unknown
4361,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,2000,MG/KG,1,Intravenous (not otherwise specified)
4363,7288,IS_PRIMARY_SUSPECT,Congenital generalised lipodystrophy,2.5,MG,1,Unknown
4364,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,10,G,1,Subcutaneous
4365,7982,IS_PRIMARY_SUSPECT,Myasthenia gravis,1000,MG/KG,1,Intravenous (not otherwise specified)
4366,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
4367,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4368,8577,IS_PRIMARY_SUSPECT,Pulmonary fibrosis,100,MG,1,Oral
4369,7904,IS_PRIMARY_SUSPECT,Still's disease,40,MG,1,Subcutaneous
4370,7632,IS_PRIMARY_SUSPECT,Growth hormone deficiency,1.7,MG,1,Unknown
4371,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Subcutaneous
4372,8194,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,300,MG,1,Intravenous (not otherwise specified)
4373,7982,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,80,G,1,Intravenous (not otherwise specified)
4374,7979,IS_PRIMARY_SUSPECT,Immune system disorder,30,G,1,Subcutaneous
4375,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,100,MG,1,Oral
4376,8175,IS_PRIMARY_SUSPECT,B-cell lymphoma,1,MG,1,Intravenous (not otherwise specified)
4378,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,49.5,ML,1,Intravenous (not otherwise specified)
4379,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
4380,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,420,MG,1,Oral
4381,7912,IS_PRIMARY_SUSPECT,Spinal muscular atrophy,49.5,ML,1,Intravenous (not otherwise specified)
4382,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,16,G,1,Subcutaneous
4383,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
4384,7850,IS_PRIMARY_SUSPECT,Non-small cell lung cancer stage IV,60,MG,1,Unknown
4385,7961,IS_PRIMARY_SUSPECT,Hypoparathyroidism,50,UG,1,Subcutaneous
4386,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
4387,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Subcutaneous
4388,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,16,G,1,Subcutaneous
4389,8735,IS_PRIMARY_SUSPECT,Fallopian tube cancer,100,MG,1,Oral
4390,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
4391,8340,IS_PRIMARY_SUSPECT,Malignant melanoma,150,MG,1,Oral
4392,7536,IS_PRIMARY_SUSPECT,Colon cancer,840,MG,1,Intravenous (not otherwise specified)
4393,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,35,G,1,Intravenous (not otherwise specified)
4394,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,16,G,1,Subcutaneous
4395,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,8,G,1,Subcutaneous
4396,7613,IS_PRIMARY_SUSPECT,Cervix carcinoma,360,MG,1,Unknown
4397,7790,IS_PRIMARY_SUSPECT,Immunoglobulins abnormal,18,G,1,Subcutaneous
4398,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Intravenous (not otherwise specified)
4400,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,6,G,1,Subcutaneous
4401,7982,IS_PRIMARY_SUSPECT,Chronic inflammatory demyelinating polyradiculoneuropathy,42,G,1,Intravenous (not otherwise specified)
4402,7490,IS_PRIMARY_SUSPECT,Menopausal symptoms,1,DF,1,Oral
4403,7416,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Unknown
4404,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Intravenous (not otherwise specified)
4405,7982,IS_PRIMARY_SUSPECT,Selective IgG subclass deficiency,35,G,1,Intravenous (not otherwise specified)
4406,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,20,G,1,Subcutaneous
4407,8735,IS_PRIMARY_SUSPECT,Ovarian cancer,200,MG,1,Oral
4408,7688,IS_PRIMARY_SUSPECT,Hormone-refractory prostate cancer,160,MG,1,Oral
4409,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,47.5,G,1,Subcutaneous
4410,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,2900,MG,1,Intravenous (not otherwise specified)
4411,7860,IS_PRIMARY_SUSPECT,Malignant melanoma,20,MG,1,Oral
4412,7982,IS_PRIMARY_SUSPECT,Immunodeficiency,20,G,1,Intravenous (not otherwise specified)
4413,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,45,G,1,Intravenous (not otherwise specified)
4414,7280,IS_PRIMARY_SUSPECT,Breast cancer,125,MG,1,Unknown
4415,8735,IS_PRIMARY_SUSPECT,Ovarian cancer,2,DF,1,Oral
4416,8454,IS_PRIMARY_SUSPECT,Non-Hodgkin's lymphoma,40,MG,2,Intravenous (not otherwise specified)
4417,7979,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,60,G,1,Subcutaneous
4418,8419,IS_PRIMARY_SUSPECT,Duchenne muscular dystrophy,1800,MG,1,Intravenous (not otherwise specified)
4419,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,60,G,1,Intravenous (not otherwise specified)
4420,8454,IS_PRIMARY_SUSPECT,B-cell lymphoma,40,MG,1,Oral
4421,7632,IS_PRIMARY_SUSPECT,Hypopituitarism,0.4,MG,1,Subcutaneous
4422,7718,IS_PRIMARY_SUSPECT,Immune system disorder,300,MG,1,Subcutaneous
4423,8143,IS_PRIMARY_SUSPECT,Diabetes mellitus,25,MG,6,Oral
4424,7790,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,30,G,1,Subcutaneous
4425,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,25,G,1,Intravenous (not otherwise specified)
4426,8350,IS_PRIMARY_SUSPECT,Myelodysplastic syndrome,75,MG/M**2,1,Subcutaneous
4427,7860,IS_PRIMARY_SUSPECT,Colorectal cancer,20,MG,1,Oral
4428,7790,IS_PRIMARY_SUSPECT,Blood immunoglobulin A,1,G,1,Unknown
4430,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
4431,8531,IS_PRIMARY_SUSPECT,Renal cell carcinoma,5,MG,1,Oral
4432,7982,IS_PRIMARY_SUSPECT,Immunodeficiency common variable,40,G,1,Intravenous (not otherwise specified)
4433,7860,IS_PRIMARY_SUSPECT,Squamous cell carcinoma of head and neck,20,MG,1,Oral
4434,8321,IS_PRIMARY_SUSPECT,Hereditary angioedema,3000,IU,1,Subcutaneous
4435,7383,IS_PRIMARY_SUSPECT,Anaplastic thyroid cancer,150,MG,1,Oral
4436,7383,IS_PRIMARY_SUSPECT,Astrocytoma,30,MG,1,Oral
4437,8253,IS_PRIMARY_SUSPECT,Relapsing-remitting multiple sclerosis,312,MG,1,Intravenous (not otherwise specified)
4438,7790,IS_PRIMARY_SUSPECT,Primary immunodeficiency syndrome,12,G,1,Subcutaneous
4440,8204,IS_PRIMARY_SUSPECT,Endometrial cancer,500,MG,1,Unknown
4442,7384,IS_PRIMARY_SUSPECT,Malignant melanoma,0.5,MG,1,Oral
4443,7176,IS_PRIMARY_SUSPECT,Plasma cell myeloma,25,MG,1,Oral
4444,8934,IS_PRIMARY_SUSPECT,Synovitis,400,MG,1,Oral
4445,8014,IS_PRIMARY_SUSPECT,Chronic lymphocytic leukaemia,140,MG,1,Oral
4446,7860,IS_PRIMARY_SUSPECT,Bile duct cancer,20,MG,1,Oral
4447,8775,IS_PRIMARY_SUSPECT,Pulmonary arterial hypertension,1000,UG,1,Oral
